,words,labels,sentence_id,full sentence
316,The,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
317,genetic,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
318,progress,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
319,is,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
320,then,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
321,transferred,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
322,to,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
323,the,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
324,commercial,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
325,flocks,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
326,through,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
327,artificial,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
328,insemination,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
329,or,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
330,natural,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
331,-,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
332,mating,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
333,rams,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
334,.,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
1014,Obesity,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1015,plays,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1016,a,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1017,central,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1018,role,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1019,in,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1020,morbidity,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1021,and,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1022,mortality,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1023,of,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1024,diseases,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1025,of,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1026,multiple,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1027,organs,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1028,and,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1029,systems,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1030,",",O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1031,and,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1032,it,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1033,is,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1034,a,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1035,major,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1036,contributor,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1037,to,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1038,the,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1039,growing,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1040,incidence,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1041,of,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1042,cancer,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1043,.,O,32.0,"Obesity plays a central role in morbidity and mortality of diseases of multiple organs and systems , and it is a major contributor to the growing incidence of cancer ."
1102,The,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1103,risk,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1104,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1105,specific,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1106,types,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1107,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1108,cancer,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1109,is,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1110,also,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1111,directly,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1112,influenced,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1113,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1114,regardless,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1115,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1116,the,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1117,magnitude,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1118,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1119,adiposity,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1120,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1121,by,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1122,physical,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1123,inactivity,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1124,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1125,consumption,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1126,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1127,red,B-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1128,meat,I-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1129,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1130,processed,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1131,meat,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1132,and,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1133,ultra,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1134,-,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1135,processed,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1136,foods,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1137,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1138,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1139,products,I-http://purl.obolibrary.org/obo/ENVO_00003862,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1140,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1141,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1142,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1143,whole,B-http://purl.obolibrary.org/obo/FOODON_00003950,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1144,grain,I-http://purl.obolibrary.org/obo/FOODON_00003950,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1145,cereals,I-http://purl.obolibrary.org/obo/FOODON_00003950,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1146,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1147,nuts,B-http://purl.obolibrary.org/obo/FOODON_03306632,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1148,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1149,vegetables,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1150,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1151,and,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1152,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1153,.,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1767,We,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1768,investigated,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1769,this,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1770,relation,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1771,in,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1772,"490,802",O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1773,United,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1774,States,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1775,participants,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1776,of,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1777,the,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1778,NIH,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1779,-,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1780,AARP,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1781,Diet,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1782,and,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1783,Health,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1784,cohort,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1785,using,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1786,Cox,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1787,proportional,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1788,hazard,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1789,models,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1790,adjusted,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1791,for,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1792,potential,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1793,confounders,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
1794,.,O,55.0,"We investigated this relation in 490,802 United States participants of the NIH - AARP Diet and Health cohort using Cox proportional hazard models adjusted for potential confounders ."
4039,These,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4040,results,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4041,suggest,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4042,that,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4043,lower,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4044,HDL,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4045,cholesterol,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4046,concentrations,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4047,",",O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4048,as,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4049,a,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4050,result,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4051,of,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4052,canola,B-http://purl.obolibrary.org/obo/NCBITaxon_138011,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4053,and,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4054,soybean,B-http://purl.obolibrary.org/obo/FOODON_03302776;http://purl.obolibrary.org/obo/FOODON_03310387,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4055,oil,I-http://purl.obolibrary.org/obo/FOODON_03302776;http://purl.obolibrary.org/obo/FOODON_03310387,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4056,feeding,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4057,",",O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4058,may,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4059,not,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4060,be,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4061,detrimental,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4062,due,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4063,to,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4064,increases,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4065,in,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4066,components,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4067,involved,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4068,in,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4069,the,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4070,reverse,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4071,cholesterol,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4072,transport,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4073,process,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4074,in,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4075,these,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4076,hamsters,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4077,and,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4078,may,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4079,retard,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4080,the,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4081,progression,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4082,of,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4083,atherosclerosis,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4084,.,O,128.0,"These results suggest that lower HDL cholesterol concentrations , as a result of canola and soybean oil feeding , may not be detrimental due to increases in components involved in the reverse cholesterol transport process in these hamsters and may retard the progression of atherosclerosis ."
4833,We,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4834,hypothesized,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4835,that,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4836,substituting,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4837,canola,B-http://purl.obolibrary.org/obo/FOODON_03302578;http://purl.obolibrary.org/obo/NCBITaxon_138011;http://purl.obolibrary.org/obo/FOODON_03310387,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4838,oil,I-http://purl.obolibrary.org/obo/FOODON_03302578;http://purl.obolibrary.org/obo/NCBITaxon_138011;http://purl.obolibrary.org/obo/FOODON_03310387,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4839,(,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4840,10,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4841,%,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4842,ALA,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4843,),O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4844,for,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4845,the,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4846,corn,B-http://purl.obolibrary.org/obo/FOODON_03301474;http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/FOODON_03310387,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4847,oil,I-http://purl.obolibrary.org/obo/FOODON_03301474;http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/FOODON_03310387,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4848,(,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4849,1,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4850,%,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4851,ALA,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4852,),O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4853,in,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4854,the,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4855,diet,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4856,of,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4857,cancer,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4858,bearing,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4859,mice,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4860,would,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4861,slow,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4862,tumor,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4863,growth,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4864,by,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4865,increasing,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4866,n-3,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4867,fatty,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4868,acids,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4869,in,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4870,the,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4871,diet,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4872,.,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
5049,Epigenetic,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5050,therapy,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5051,induced,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5052,by,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5053,dietary,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5054,components,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5055,has,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5056,become,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5057,a,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5058,strong,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5059,interest,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5060,in,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5061,the,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5062,field,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5063,of,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5064,cancer,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5065,prevention,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5066,.,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5340,Epidemiological,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5341,studies,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5342,suggest,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5343,that,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5344,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5345,consumption,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5346,and,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5347,dietary,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5348,intake,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5349,of,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5350,dairy,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5351,proteins,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5352,are,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5353,inversely,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5354,related,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5355,to,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5356,the,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5357,risk,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5358,for,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5359,hypertension,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5360,.,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5541,A,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5542,total,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5543,of,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5544,"1,586",O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5545,cases,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5546,and,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5547,their,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5548,age-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5549,",",O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5550,sex-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5551,",",O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5552,and,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5553,race,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5554,-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5555,matched,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5556,neighborhood,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5557,controls,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5558,were,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5559,interviewed,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5560,in,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5561,-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5562,person,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5563,from,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5564,1987,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5565,to,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5566,1999,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5567,.,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5609,Daily,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5610,water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5611,intake,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5612,was,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5613,associated,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5614,with,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5615,a,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5616,slight,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5617,decrease,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5618,in,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5619,bladder,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5620,cancer,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5621,risk,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5622,",",O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5623,with,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5624,the,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5625,protection,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5626,more,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5627,pronounced,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5628,among,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5629,women,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5630,(,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5631,p,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5632,for,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5633,trend,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5634,=,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5635,0.039,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5636,),O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5637,than,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5638,among,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5639,men,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5640,(,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5641,p,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5642,for,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5643,trend,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5644,=,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5645,0.62,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5646,),O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5647,.,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
6189,These,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6190,components,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6191,provide,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6192,synergistic,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6193,effect,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6194,against,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6195,various,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6196,threats,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6197,but,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6198,still,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6199,need,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6200,further,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6201,attention,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6202,of,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6203,the,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6204,researchers,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
6205,.,O,202.0,These components provide synergistic effect against various threats but still need further attention of the researchers .
7086,Four,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7087,types,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7088,of,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7089,black,B-http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7090,coffee,I-http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7091,were,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7092,tested,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7093,:,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7094,espresso,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7095,",",O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7096,bold,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7097,",",O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7098,mild,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7099,",",O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7100,and,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7101,a,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7102,decaffeinated,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7103,mild,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7104,roast,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7105,.,O,233.0,"Four types of black coffee were tested : espresso , bold , mild , and a decaffeinated mild roast ."
7177,Adding,O,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7178,cream,O,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7179,to,O,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7180,bold,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7181,coffee,I-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7182,significantly,O,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7183,reduced,O,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7184,its,O,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7185,MG,O,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7186,level,O,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7187,in,O,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7188,comparison,O,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7189,to,O,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7190,the,O,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7191,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7192,sample,I-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7193,without,I-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7194,cream,I-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7195,.,O,237.0,Adding cream to bold coffee significantly reduced its MG level in comparison to the coffee sample without cream .
7648,No,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7649,individual,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7650,cruciferous,B-http://purl.obolibrary.org/obo/FOODON_00003816,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7651,vegetable,I-http://purl.obolibrary.org/obo/FOODON_00003816,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7652,made,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7653,an,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7654,important,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7655,contribution,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7656,to,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7657,this,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7658,effect,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7659,.,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
9009,Lactalbumin,O,295.0,Lactalbumin decreased weight and fat gain .
9010,decreased,O,295.0,Lactalbumin decreased weight and fat gain .
9011,weight,O,295.0,Lactalbumin decreased weight and fat gain .
9012,and,O,295.0,Lactalbumin decreased weight and fat gain .
9013,fat,O,295.0,Lactalbumin decreased weight and fat gain .
9014,gain,O,295.0,Lactalbumin decreased weight and fat gain .
9015,.,O,295.0,Lactalbumin decreased weight and fat gain .
9400,No,O,309.0,"No clear associations were observed for milk , soda or juice ."
9401,clear,O,309.0,"No clear associations were observed for milk , soda or juice ."
9402,associations,O,309.0,"No clear associations were observed for milk , soda or juice ."
9403,were,O,309.0,"No clear associations were observed for milk , soda or juice ."
9404,observed,O,309.0,"No clear associations were observed for milk , soda or juice ."
9405,for,O,309.0,"No clear associations were observed for milk , soda or juice ."
9406,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,309.0,"No clear associations were observed for milk , soda or juice ."
9407,",",O,309.0,"No clear associations were observed for milk , soda or juice ."
9408,soda,O,309.0,"No clear associations were observed for milk , soda or juice ."
9409,or,O,309.0,"No clear associations were observed for milk , soda or juice ."
9410,juice,B-http://purl.obolibrary.org/obo/FOODON_03315552,309.0,"No clear associations were observed for milk , soda or juice ."
9411,.,O,309.0,"No clear associations were observed for milk , soda or juice ."
9568,Two,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9569,of,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9570,the,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9571,ten,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9572,FT,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9573,homologs,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9574,(,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9575,GmFT2a,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9576,and,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9577,GmFT5a,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9578,),O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9579,have,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9580,a,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9581,role,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9582,in,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9583,the,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9584,floral,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9585,transition,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9586,while,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9587,GmFT1a,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9588,and,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9589,GmFT4,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9590,suppress,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9591,soybean,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9592,flowering,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9593,.,O,317.0,Two of the ten FT homologs ( GmFT2a and GmFT5a ) have a role in the floral transition while GmFT1a and GmFT4 suppress soybean flowering .
9768,Total,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9769,antioxidant,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9770,capacities,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9771,in,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9772,terms,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9773,of,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9774,radical,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9775,scavenging,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9776,activity,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9777,and,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9778,reducing,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9779,power,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9780,were,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9781,much,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9782,higher,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9783,in,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9784,leaves,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9785,of,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9786,both,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9787,plants,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9788,as,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9789,compared,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9790,to,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9791,their,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9792,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9793,.,O,325.0,Total antioxidant capacities in terms of radical scavenging activity and reducing power were much higher in leaves of both plants as compared to their fruits .
9855,Glutamate,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9856,treatment,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9857,caused,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9858,approximately,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9859,23,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9860,%,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9861,cell,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9862,loss,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9863,when,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9864,measured,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9865,after,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9866,24,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9867,h,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9868,of,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9869,exposure,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9870,.,O,329.0,Glutamate treatment caused approximately 23 % cell loss when measured after 24 h of exposure .
9903,The,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9904,greater,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9905,protective,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9906,effect,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9907,of,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9908,leaf,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9909,extracts,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9910,was,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9911,in,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9912,correlation,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9913,with,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9914,the,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9915,levels,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9916,of,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9917,phenolics,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9918,and,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9919,antioxidant,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9920,capacity,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9921,.,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
10095,Interim,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10096,dietary,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10097,guidelines,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10098,to,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10099,reduce,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10100,the,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10101,risk,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10102,of,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10103,cancer,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10104,were,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10105,proposed,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10106,in,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10107,accordance,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10108,with,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10109,these,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10110,conclusions,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10111,.,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10147,The,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10148,European,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10149,Commission,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10150,asked,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10151,EFSA,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10152,for,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10153,a,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10154,scientific,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10155,opinion,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10156,on,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10157,the,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10158,risks,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10159,for,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10160,animal,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10161,and,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10162,human,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10163,health,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10164,related,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10165,to,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10166,the,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10167,presence,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10168,of,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10169,glycoalkaloids,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10170,(,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10171,GAs,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10172,),O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10173,in,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10174,feed,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10175,and,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10176,food,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10177,.,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10201,In,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10202,humans,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10203,",",O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10204,acute,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10205,toxic,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10206,effects,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10207,of,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10208,potato,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10209,GAs,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10210,(,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10211,α,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10212,-,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10213,solanine,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10214,and,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10215,α,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10216,-,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10217,chaconine,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10218,),O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10219,include,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10220,gastrointestinal,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10221,symptoms,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10222,such,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10223,as,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10224,nausea,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10225,",",O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10226,vomiting,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10227,and,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10228,diarrhoea,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10229,.,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
11040,The,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11041,main,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11042,cause,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11043,of,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11044,obesity,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11045,is,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11046,energy,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11047,imbalance,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11048,",",O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11049,of,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11050,which,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11051,contributing,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11052,factors,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11053,include,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11054,a,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11055,sedentary,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11056,lifestyle,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11057,",",O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11058,epigenetic,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11059,factors,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11060,and,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11061,excessive,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11062,caloric,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11063,intake,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11064,through,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11065,food,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11066,and,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11067,beverages,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11068,.,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11323,Thus,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11324,",",O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11325,this,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11326,study,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11327,found,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11328,that,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11329,replacing,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11330,one,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11331,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_00003202,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11332,-,I-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_00003202,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11333,sweetened,I-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_00003202,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11334,soda,I-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_00003202,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11335,beverage,I-http://purl.obolibrary.org/obo/FOODON_03420108;http://purl.obolibrary.org/obo/FOODON_00003202,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11336,or,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11337,beer,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11338,with,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11339,one,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11340,serving,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11341,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11342,water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11343,per,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11344,day,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11345,at,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11346,baseline,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11347,was,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11348,related,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11349,to,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11350,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11351,lower,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11352,incidence,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11353,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11354,obesity,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11355,and,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11356,to,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11357,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11358,higher,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11359,weight,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11360,loss,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11361,over,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11362,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11363,four,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11364,-,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11365,year,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11366,period,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11367,time,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11368,in,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11369,the,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11370,case,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11371,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11372,beer,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11373,",",O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11374,based,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11375,on,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11376,mathematical,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11377,models,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11378,.,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11650,The,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11651,prevalence,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11652,of,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11653,chronic,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11654,respiratory,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11655,symptoms,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11656,was,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11657,significantly,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11658,higher,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11659,in,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11660,the,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11661,exposed,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11662,workers,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11663,than,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11664,in,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11665,the,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11666,control,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11667,workers,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11668,(,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11669,P,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11670,less,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11671,than,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11672,0.01,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11673,),O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11674,.,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11675,There,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11676,was,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11677,",",O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11678,however,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11679,",",O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11680,no,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11681,consistent,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11682,correlation,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11683,between,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11684,skin,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11685,reactivity,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11686,and,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11687,chronic,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11688,respiratory,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11689,symptoms,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11690,.,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11704,These,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11705,complaints,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11706,were,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11707,more,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11708,frequent,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11709,in,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11710,workers,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11711,with,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11712,positive,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11713,skin,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11714,tests,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11715,for,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11716,the,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11717,symptoms,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11718,of,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11719,cough,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11720,",",O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11721,chest,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11722,tightness,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11723,",",O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11724,and,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11725,irritated,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11726,and,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11727,dry,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11728,throat,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11729,.,O,393.0,"These complaints were more frequent in workers with positive skin tests for the symptoms of cough , chest tightness , and irritated and dry throat ."
11829,These,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11830,data,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11831,suggest,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11832,that,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11833,immunologic,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11834,reactions,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11835,to,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11836,spices,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11837,are,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11838,frequent,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11839,in,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11840,spice,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11841,workers,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11842,and,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11843,may,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11844,be,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11845,related,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11846,to,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11847,acute,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11848,symptoms,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11849,and,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11850,lung,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11851,function,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11852,changes,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11853,",",O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11854,but,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11855,not,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11856,to,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11857,chronic,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11858,changes,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11859,.,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11860,The,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11861,data,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11862,further,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11863,suggest,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11864,that,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11865,",",O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11866,in,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11867,addition,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11868,to,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11869,any,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11870,immunologic,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11871,response,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11872,these,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11873,spices,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11874,may,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11875,produce,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11876,in,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11877,vivo,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11878,",",O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11879,they,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11880,probably,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11881,also,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11882,provoke,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11883,direct,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11884,irritant,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11885,reactions,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11886,in,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11887,the,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11888,airways,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11889,as,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11890,suggested,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11891,by,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11892,in,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11893,vitro,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11894,data,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
11895,.,O,399.0,"The data further suggest that , in addition to any immunologic response these spices may produce in vivo , they probably also provoke direct irritant reactions in the airways as suggested by in vitro data ."
12138,PRACTICAL,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12139,APPLICATION,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12140,:,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12141,Revtech,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12142,(,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12143,RT,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12144,),O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12145,",",O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12146,a,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12147,novel,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12148,thermal,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12149,process,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12150,",",O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12151,when,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12152,applied,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12153,at,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12154,140,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12155, ,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12156,°,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12157,C,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12158,with,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12159,steam,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12160,to,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12161,split,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12162,yellow,B-http://purl.obolibrary.org/obo/PATO_0000324;http://purl.obolibrary.org/obo/FOODON_03301300,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12163,pea,I-http://purl.obolibrary.org/obo/PATO_0000324;http://purl.obolibrary.org/obo/FOODON_03301300,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12164,(,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12165,SYP,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12166,),O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12167,flour,B-http://purl.obolibrary.org/obo/FOODON_03301116,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12168,successfully,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12169,increased,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12170,the,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12171,acceptability,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12172,of,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12173,white,B-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12174,pan,I-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12175,bread,I-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12176,fortified,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12177,at,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12178,20,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12179,%,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12180,compared,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12181,to,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12182,bread,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12183,fortified,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12184,with,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12185,RT,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12186,140,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12187, ,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12188,°,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12189,C,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12190,with,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12191,no,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12192,steam,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12193,",",O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12194,and,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12195,untreated,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12196,SYP,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12197,flours,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12198,.,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   ° C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   ° C with no steam , and untreated SYP flours ."
12567,These,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12568,results,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12569,suggest,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12570,that,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12571,reducing,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12572,sodium,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12573,in,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12574,cheese,B-http://purl.obolibrary.org/obo/FOODON_03304042;http://purl.obolibrary.org/obo/FOODON_00001013;http://purl.obolibrary.org/obo/FOODON_03311146,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12575,sauce,I-http://purl.obolibrary.org/obo/FOODON_03304042;http://purl.obolibrary.org/obo/FOODON_00001013;http://purl.obolibrary.org/obo/FOODON_03311146,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12576,",",O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12577,cottage,B-http://purl.obolibrary.org/obo/FOODON_03301605;http://purl.obolibrary.org/obo/FOODON_00001013,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12578,cheese,I-http://purl.obolibrary.org/obo/FOODON_03301605;http://purl.obolibrary.org/obo/FOODON_00001013,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12579,",",O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12580,and,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12581,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12582,-,I-http://purl.obolibrary.org/obo/UBERON_0001913,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12583,based,I-http://purl.obolibrary.org/obo/UBERON_0001913,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12584,soups,I-http://purl.obolibrary.org/obo/UBERON_0001913,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12585,may,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12586,be,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12587,challenging,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12588,and,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12589,that,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12590,exploration,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12591,of,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12592,sodium,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12593,chloride,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12594,alternatives,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12595,in,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12596,these,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12597,foods,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12598,is,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12599,warranted,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
12600,.,O,420.0,"These results suggest that reducing sodium in cheese sauce , cottage cheese , and milk - based soups may be challenging and that exploration of sodium chloride alternatives in these foods is warranted ."
13040,Despite,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13041,a,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13042,different,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13043,methodology,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13044,",",O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13045,reports,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13046,from,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13047,several,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13048,Asian,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13049,centres,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13050,suggest,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13051,a,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13052,similar,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13053,frequency,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13054,of,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13055,hypersensitivity,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13056,to,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13057,these,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13058,foods,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13059,in,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13060,young,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13061,children,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13062,although,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13063,hypersensitivity,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13064,to,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13065,shellfish,B-http://purl.obolibrary.org/obo/FOODON_03411433,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13066,and,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13067,seafood,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13068,was,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13069,more,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13070,common,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13071,than,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13072,for,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13073,nuts,B-http://purl.obolibrary.org/obo/FOODON_03306632,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13074,",",O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13075,peanut,B-http://purl.obolibrary.org/obo/FOODON_00003206;http://purl.obolibrary.org/obo/NCBITaxon_3818,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13076,and,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13077,wheat,B-http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13078,",",O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13079,if,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13080,seafoods,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13081,are,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13082,part,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13083,of,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13084,the,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13085,staple,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13086,infant,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13087,diet,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13088,.,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13278,The,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13279,AUC,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13280,of,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13281,postprandial,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13282,IL-6,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13283,concentrations,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13284,was,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13285,not,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13286,significantly,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13287,(,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13288,P,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13289, ,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13290,=,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13291, ,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13292,0·77,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13293,),O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13294,different,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13295,among,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13296,the,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13297,meals,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
13298,.,O,441.0,The AUC of postprandial IL-6 concentrations was not significantly ( P   =   0·77 ) different among the meals .
14007,These,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14008,ingredients,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14009,should,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14010,be,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14011,avoided,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14012,by,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14013,consumers,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14014,with,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14015,allergies,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14016,to,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14017,the,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14018,source,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14019,material,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14020,if,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14021,the,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14022,ingredient,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14023,contains,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14024,detectable,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14025,protein,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14026,residues,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14027,.,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14118,Food,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14119,manufacturers,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14120,should,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14121,declare,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14122,the,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14123,presence,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14124,of,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14125,allergenic,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14126,food,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14127,ingredients,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14128,in,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14129,the,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14130,ingredient,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14131,listings,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14132,on,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14133,product,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14134,labels,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14135,so,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14136,that,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14137,allergic,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14138,consumers,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14139,can,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14140,know,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14141,to,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14142,avoid,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14143,these,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14144,potentially,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14145,hazardous,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14146,products,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14147,.,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14855,Increased,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14856,hepatic,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14857,glucose,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14858,production,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14859,underlies,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14860,fasting,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14861,hyperglycemia,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14862,that,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14863,defines,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14864,type,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14865,2,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14866,diabetes,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14867,",",O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14868,while,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14869,increased,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14870,production,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14871,of,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14872,atherogenic,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14873,",",O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14874,large,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14875,",",O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14876,triglyceride,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14877,-,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14878,rich,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14879,",",O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14880,very,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14881,low,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14882,-,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14883,density,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14884,lipoproteins,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14885,raises,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14886,the,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14887,risk,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14888,of,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14889,cardiovascular,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14890,disease,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14891,.,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14911,Metabolic,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14912,programming,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14913,of,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14914,the,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14915,liver,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14916,transcriptome,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14917,and,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14918,posttranslation,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14919,modifications,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14920,of,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14921,proteins,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14922,is,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14923,strongly,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14924,influenced,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14925,by,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14926,the,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14927,daily,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14928,rhythms,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14929,in,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14930,nutrient,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14931,intake,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14932,governed,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14933,by,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14934,the,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14935,circadian,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14936,clock,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14937,.,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
15358,However,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15359,",",O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15360,health,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15361,-,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15362,promoting,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15363,effects,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15364,are,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15365,associated,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15366,with,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15367,consumption,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15368,of,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15369,anhydrous,B-http://purl.obolibrary.org/obo/FOODON_03303835;http://purl.obolibrary.org/obo/FOODON_00002681;http://purl.obolibrary.org/obo/FOODON_03303837;http://purl.obolibrary.org/obo/UBERON_0001913;http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15370,milk,I-http://purl.obolibrary.org/obo/FOODON_03303835;http://purl.obolibrary.org/obo/FOODON_00002681;http://purl.obolibrary.org/obo/FOODON_03303837;http://purl.obolibrary.org/obo/UBERON_0001913;http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15371,fat,I-http://purl.obolibrary.org/obo/FOODON_03303835;http://purl.obolibrary.org/obo/FOODON_00002681;http://purl.obolibrary.org/obo/FOODON_03303837;http://purl.obolibrary.org/obo/UBERON_0001913;http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15372,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15373,AMF,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15374,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15375,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15376,ruminant,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15377,trans,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15378,fatty,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15379,acids,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15380,",",O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15381,such,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15382,as,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15383,conjugated,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15384,linoleic,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15385,acid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15386,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15387,CLA,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15388,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15389,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15390,vaccenic,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15391,acid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15392,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15393,VA,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15394,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15395,contained,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15396,in,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15397,the,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15398,lipid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15399,fraction,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15400,of,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15401,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15402,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15403,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15404,products,I-http://purl.obolibrary.org/obo/ENVO_00003862,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15405,.,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15549,The,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15550,authors,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15551,used,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15552,case,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15553,-,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15554,control,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15555,data,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15556,from,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15557,488,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15558,matched,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15559,pairs,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15560,to,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15561,evaluate,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15562,associations,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15563,of,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15564,vegetables,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15565,",",O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15566,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15567,",",O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15568,and,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15569,grains,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15570,with,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15571,polyps,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15572,.,O,520.0,"The authors used case - control data from 488 matched pairs to evaluate associations of vegetables , fruits , and grains with polyps ."
15591,Diet,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15592,in,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15593,the,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15594,year,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15595,before,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15596,sigmoidoscopy,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15597,was,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15598,measured,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15599,with,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15600,a,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15601,food,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15602,frequency,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15603,questionnaire,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15604,.,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15887,Analysis,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15888,of,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15889,blood,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15890,via,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15891,untargeted,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15892,metabolomics,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15893,analysis,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15894,identified,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15895,eight,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15896,",",O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15897,four,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15898,",",O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15899,and,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15900,four,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15901,metabolites,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15902,significantly,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15903,altered,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15904,by,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15905,protein,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15906,level,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15907,",",O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15908,protein,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15909,source,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15910,",",O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15911,and,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15912,a,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15913,protein,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15914,level,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15915,-,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15916,source,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15917,interaction,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15918,",",O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15919,respectively,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15920,.,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
16008,Dietary,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16009,patterns,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16010,were,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16011,generated,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16012,by,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16013,cluster,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16014,analysis,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16015,based,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16016,on,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16017,the,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16018,percent,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16019,contribution,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16020,to,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16021,total,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16022,energy,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16023,intake,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16024,from,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16025,30,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16026,food,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16027,groups,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16028,.,O,534.0,Dietary patterns were generated by cluster analysis based on the percent contribution to total energy intake from 30 food groups .
16812,It,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16813,is,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16814,well,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16815,known,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16816,that,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16817,there,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16818,are,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16819,J,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16820,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16821,curve,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16822,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16823,type,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16824,or,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16825,U,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16826,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16827,curve,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16828,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16829,type,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16830,associations,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16831,of,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16832,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16833,consumption,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16834,with,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16835,cardiovascular,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16836,events,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16837,including,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16838,myocardial,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16839,infarction,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16840,and,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16841,stroke,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16842,.,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16928,Different,O,565.0,Different skin test techniques using fresh fruit were compared .
16929,skin,O,565.0,Different skin test techniques using fresh fruit were compared .
16930,test,O,565.0,Different skin test techniques using fresh fruit were compared .
16931,techniques,O,565.0,Different skin test techniques using fresh fruit were compared .
16932,using,O,565.0,Different skin test techniques using fresh fruit were compared .
16933,fresh,O,565.0,Different skin test techniques using fresh fruit were compared .
16934,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,565.0,Different skin test techniques using fresh fruit were compared .
16935,were,O,565.0,Different skin test techniques using fresh fruit were compared .
16936,compared,O,565.0,Different skin test techniques using fresh fruit were compared .
16937,.,O,565.0,Different skin test techniques using fresh fruit were compared .
16990,Apple,B-http://purl.obolibrary.org/obo/FOODON_00002473;http://purl.obolibrary.org/obo/NCBITaxon_3750,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16991,",",O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16992,carrot,B-http://purl.obolibrary.org/obo/NCBITaxon_4039;http://purl.obolibrary.org/obo/FOODON_00003408,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16993,",",O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16994,potato,B-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16995,",",O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16996,hazelnut,B-http://purl.obolibrary.org/obo/FOODON_00002933,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16997,and,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16998,birch,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16999,reactivity,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17000,was,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17001,transferable,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17002,in,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17003,Prausnitz,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17004,-,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17005,Küstner,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17006,test,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17007,like,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17008,IgE,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17009,antibodies,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17010,.,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17552,In,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17553,either,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17554,study,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17555,",",O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17556,total,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17557,serum,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17558,cholesterol,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17559,levels,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17560,of,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17561,the,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17562,three,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17563,coffee,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17564,lipid,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17565,groups,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17566,were,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17567,not,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17568,significantly,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17569,different,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17570,from,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17571,each,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17572,other,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17573,.,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17680,This,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17681,study,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17682,aims,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17683,to,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17684,investigate,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17685,which,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17686,kinds,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17687,of,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17688,dietary,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17689,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17690,cause,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17691,the,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17692,intestinal,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17693,metaplasia,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17694,onset,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17695,.,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17842,Moreover,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17843,",",O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17844,mice,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17845,fed,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17846,these,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17847,HFDs,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17848,with,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17849,1,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17850,-,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17851,methyl-3,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17852,-,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17853,nitro-1,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17854,-,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17855,nitrosoguanidine,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17856,(,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17857,MNNG,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17858,),O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17859,",",O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17860,a,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17861,gastric,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17862,carcinogen,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17863,",",O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17864,and,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17865,further,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17866,accelerated,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17867,dysplasia,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17868,in,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17869,the,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17870,stomach,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17871,.,O,595.0,"Moreover , mice fed these HFDs with 1 - methyl-3 - nitro-1 - nitrosoguanidine ( MNNG ) , a gastric carcinogen , and further accelerated dysplasia in the stomach ."
17897,The,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17898,Mediterranean,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17899,diet,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17900,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17901,one,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17902,of,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17903,the,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17904,most,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17905,widely,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17906,evaluated,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17907,dietary,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17908,patterns,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17909,in,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17910,scientific,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17911,literature,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17912,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17913,includes,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17914,in,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17915,its,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17916,nutrients,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17917,two,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17918,fluid,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17919,foods,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17920,:,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17921,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17922,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17923,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17924,as,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17925,the,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17926,main,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17927,source,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17928,of,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17929,fats,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17930,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17931,and,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17932,a,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17933,low,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17934,-,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17935,to,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17936,-,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17937,moderate,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17938,consumption,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17939,of,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17940,wine,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17941,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17942,mainly,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17943,red,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17944,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17945,particularly,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17946,during,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17947,meals,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17948,.,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
18271,Indeed,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18272,",",O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18273,potatoes,B-http://purl.obolibrary.org/obo/NCBITaxon_4113,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18274,have,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18275,been,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18276,reported,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18277,to,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18278,be,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18279,more,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18280,satiating,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18281,than,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18282,other,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18283,starchy,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18284,carbohydrates,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18285,",",O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18286,such,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18287,as,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18288,pasta,B-http://purl.obolibrary.org/obo/FOODON_03306347,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18289,and,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18290,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18291,",",O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18292,which,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18293,may,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18294,aid,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18295,weight,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18296,maintenance,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18297,.,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18435,In,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18436,Wistar,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18437,rats,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18438,",",O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18439,a,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18440,daily,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18441,piece,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18442,of,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18443,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18444,coupled,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18445,to,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18446,the,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18447,onset,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18448,of,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18449,the,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18450,active,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18451,phase,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18452,(,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18453,breakfast,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18454,),O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18455,accelerated,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18456,re,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18457,-,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18458,entrainment,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18459,in,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18460,a,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18461,jet,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18462,-,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18463,lag,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18464,model,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18465,by,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18466,setting,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18467,the,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18468,activity,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18469,of,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18470,the,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18471,suprachiasmatic,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18472,nucleus,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18473,(,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18474,SCN,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18475,),O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18476,to,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18477,the,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18478,new,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18479,cycle,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18480,.,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
19485,In,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19486,men,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19487,",",O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19488,an,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19489,increase,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19490,in,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19491,total,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19492,fluid,B-http://purl.obolibrary.org/obo/UBERON_0006314,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19493,intake,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19494,was,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19495,associated,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19496,with,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19497,a,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19498,significantly,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19499,decreased,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19500,bladder,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19501,cancer,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19502,risk,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19503,(,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19504,OR,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19505,0.93,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19506,",",O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19507,95,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19508,%,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19509,CI,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19510,:,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19511,0.88,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19512,-,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19513,0.99,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19514,",",O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19515,per,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19516,cup,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19517,fluid,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19518,consumed,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19519,),O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19520,.,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19938,Cardiovascular,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19939,diseases,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19940,(,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19941,CVDs,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19942,),O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19943,are,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19944,leading,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19945,global,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19946,health,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19947,problems,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19948,.,O,665.0,Cardiovascular diseases ( CVDs ) are leading global health problems .
19966,Moreover,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19967,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19968,substantial,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19969,experimental,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19970,studies,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19971,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19972,supported,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19973,the,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19974,protective,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19975,role,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19976,of,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19977,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19978,against,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19979,CVDs,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19980,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19981,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19982,several,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19983,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19984,(,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19985,grape,B-http://purl.obolibrary.org/obo/FOODON_00003417;http://purl.obolibrary.org/obo/FOODON_03301123,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19986,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19987,blueberry,B-http://purl.obolibrary.org/obo/FOODON_03302045;http://purl.obolibrary.org/obo/FOODON_00003541,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19988,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19989,pomegranate,B-http://purl.obolibrary.org/obo/NCBITaxon_22663;http://purl.obolibrary.org/obo/FOODON_00003066,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19990,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19991,apple,B-http://purl.obolibrary.org/obo/FOODON_00002473;http://purl.obolibrary.org/obo/NCBITaxon_3750,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19992,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19993,hawthorn,B-http://purl.obolibrary.org/obo/NCBITaxon_23159,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19994,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19995,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19996,avocado,B-http://purl.obolibrary.org/obo/FOODON_00003600;http://purl.obolibrary.org/obo/FOODON_03305236;http://purl.obolibrary.org/obo/NCBITaxon_3435,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19997,),O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19998,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19999,been,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20000,widely,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20001,studied,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20002,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20003,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20004,shown,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20005,potent,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20006,cardiovascular,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20007,protective,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20008,action,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20009,.,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20327,Our,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20328,results,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20329,suggest,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20330,that,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20331,dietary,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20332,supplementation,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20333,of,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20334,figs,B-http://purl.obolibrary.org/obo/NCBITaxon_3493,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20335,may,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20336,be,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20337,useful,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20338,for,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20339,the,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20340,improvement,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20341,of,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20342,cognitive,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20343,and,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20344,behavioral,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20345,deficits,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20346,in,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20347,AD,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20348,.,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20686,The,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20687,rehabilitation,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20688,of,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20689,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20690,has,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20691,arisen,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20692,only,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20693,in,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20694,recent,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20695,times,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20696,",",O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20697,re,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20698,-,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20699,establishing,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20700,that,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20701,value,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20702,that,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20703,Linnaeus,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20704,himself,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20705,credited,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20706,to,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20707,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20708,",",O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20709,calling,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20710,the,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20711,generous,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20712,plant,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20713,Theobroma,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20714,cacao,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20715,",",O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20716,food,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20717,of,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20718,the,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20719,gods,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20720,.,O,687.0,"The rehabilitation of chocolate has arisen only in recent times , re - establishing that value that Linnaeus himself credited to chocolate , calling the generous plant Theobroma cacao , food of the gods ."
20941,Most,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20942,findings,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20943,were,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20944,similar,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20945,for,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20946,colon,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20947,and,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20948,rectum,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20949,",",O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20950,but,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20951,some,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20952,negative,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20953,associations,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20954,(,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20955,i.e.,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20956,",",O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20957,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20958,and,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20959,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20960,",",O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20961,and,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20962,fish,B-http://purl.obolibrary.org/obo/NCBITaxon_7898;http://purl.obolibrary.org/obo/FOODON_03411222;http://purl.obolibrary.org/obo/NCBITaxon_7777,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20963,),O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20964,appeared,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20965,stronger,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20966,for,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20967,colon,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20968,cancer,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20969,.,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
21139,The,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21140,cumulative,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21141,months,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21142,with,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21143,SCC,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21144,above,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21145,a,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21146,threshold,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21147,was,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21148,included,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21149,as,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21150,a,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21151,proxy,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21152,for,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21153,chronic,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21154,mastitis,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21155,.,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21156,Milk,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21157,yield,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21158,loss,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21159,increased,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21160,as,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21161,the,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21162,number,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21163,of,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21164,test,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21165,days,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21166,with,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21167,SCC,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21168,"≥100,000",O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21169,cells,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21170,/,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21171,mL,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21172,increased,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21173,.,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21249,Results,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21250,demonstrate,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21251,the,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21252,importance,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21253,of,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21254,including,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21255,the,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21256,duration,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21257,of,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21258,months,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21259,above,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21260,a,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21261,threshold,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21262,SCC,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21263,when,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21264,estimating,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21265,milk,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21266,yield,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21267,losses,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21268,.,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21327,Oral,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21328,and,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21329,external,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21330,dosing,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21331,methods,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21332,replicating,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21333,field,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21334,exposure,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21335,were,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21336,developed,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21337,using,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21338,the,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21339,double,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21340,crested,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21341,cormorant,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21342,(,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21343,DCCO,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21344,),O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21345,to,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21346,test,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21347,the,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21348,toxicity,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21349,of,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21350,artificially,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21351,weathered,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21352,Deepwater,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21353,Horizon,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21354,Mississippi,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21355,Canyon,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21356,252,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21357,oil,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21358,.,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21398,In,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21399,the,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21400,present,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21401,studies,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21402,",",O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21403,dosing,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21404,relied,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21405,on,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21406,injection,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21407,of,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21408,oil,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21409,into,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21410,live,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21411,feeder,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21412,fish,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21413,for,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21414,oral,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21415,dosing,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21416,of,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21417,these,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21418,piscivorous,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21419,birds,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21420,",",O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21421,or,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21422,applying,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21423,oil,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21424,to,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21425,body,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21426,contour,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21427,feathers,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21428,resulting,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21429,in,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21430,transdermal,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21431,oil,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21432,exposure,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21433,and,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21434,oral,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21435,exposure,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21436,through,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21437,preening,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21438,.,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21439,Both,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21440,oral,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21441,and,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21442,external,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21443,oil,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21444,dosing,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21445,studies,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21446,identified,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21447,oil,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21448,-,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21449,related,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21450,toxicity,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21451,endpoints,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21452,associated,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21453,with,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21454,oxidative,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21455,stress,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21456,such,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21457,as,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21458,hemolytic,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21459,anemia,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21460,",",O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21461,liver,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21462,and,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21463,kidney,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21464,damage,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21465,",",O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21466,and,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21467,immuno,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21468,-,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21469,modulation,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21470,or,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21471,compromise,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21472,.,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21566,Cinnamon,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21567,",",O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21568,from,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21569,the,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21570,genus,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21571,Cinnamomum,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21572,and,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21573,Lauraceae,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21574,family,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21575,",",O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21576,has,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21577,been,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21578,used,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21579,as,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21580,a,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21581,popular,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21582,spice,B-http://purl.obolibrary.org/obo/FOODON_03303380,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21583,for,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21584,thousands,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21585,of,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21586,years,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21587,around,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21588,the,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21589,world,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21590,.,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21818,Biogenic,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21819,amines,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21820,have,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21821,been,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21822,reported,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21823,in,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21824,a,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21825,variety,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21826,of,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21827,foods,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21828,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21829,such,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21830,as,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21831,fish,B-http://purl.obolibrary.org/obo/NCBITaxon_7898;http://purl.obolibrary.org/obo/FOODON_03411222;http://purl.obolibrary.org/obo/NCBITaxon_7777,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21832,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21833,meat,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21834,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21835,cheese,B-http://purl.obolibrary.org/obo/FOODON_00001013,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21836,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21837,vegetables,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21838,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21839,and,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21840,wines,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21841,.,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
22160,All,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22161,fractions,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22162,showed,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22163,bioactivity,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22164,in,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22165,PPAR,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22166,activation,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22167,assays,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22168,",",O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22169,but,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22170,quantitative,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22171,responses,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22172,showed,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22173,marked,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22174,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22175,-,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22176,to,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22177,-,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22178,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22179,variability,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22180,",",O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22181,highlighting,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22182,the,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22183,need,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22184,to,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22185,bulk,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22186,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22187,prior,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22188,to,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22189,extraction,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22190,for,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22191,activity,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22192,-,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22193,guided,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22194,fractionation,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22195,of,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22196,bioactive,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22197,components,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22198,.,O,742.0,"All fractions showed bioactivity in PPAR activation assays , but quantitative responses showed marked fruit - to - fruit variability , highlighting the need to bulk fruit prior to extraction for activity - guided fractionation of bioactive components ."
22582,Both,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22583,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22584,and,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22585,fresh,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22586,cream,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22587,were,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22588,shown,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22589,by,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22590,quantitative,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22591,real,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22592,-,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22593,time,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22594,PCR,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22595,to,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22596,increase,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22597,the,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22598,quantity,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22599,of,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22600,mRNA,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22601,for,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22602,uncoupling,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22603,protein,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22604,2,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22605,(,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22606,UCP2,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22607,),O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22608,",",O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22609,an,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22610,energy,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22611,expenditure,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22612,gene,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22613,",",O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22614,in,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22615,a,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22616,dose,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22617,-,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22618,dependent,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22619,manner,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22620,.,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22665,The,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22666,possible,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22667,role,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22668,in,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22669,enhancing,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22670,the,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22671,activities,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22672,of,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22673,PPARalpha,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22674,",",O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22675,PPARdelta,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22676,",",O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22677,and,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22678,RXRalpha,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22679,",",O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22680,and,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22681,the,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22682,health,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22683,benefits,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22684,of,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22685,cow,B-http://purl.obolibrary.org/obo/NCBITaxon_9913;http://purl.obolibrary.org/obo/UBERON_0001913,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22686,'s,I-http://purl.obolibrary.org/obo/NCBITaxon_9913;http://purl.obolibrary.org/obo/UBERON_0001913,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22687,milk,I-http://purl.obolibrary.org/obo/NCBITaxon_9913;http://purl.obolibrary.org/obo/UBERON_0001913,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22688,were,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22689,discussed,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22690,.,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22942,Enrichment,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22943,of,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22944,lipoproteins,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22945,with,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22946,fatty,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22947,acids,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22948,derived,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22949,from,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22950,animal,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22951,and/or,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22952,plant,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22953,fats,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22954,may,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22955,modify,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22956,the,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22957,oxidizability,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22958,of,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22959,lipoproteins,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22960,and,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22961,their,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22962,effects,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22963,on,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22964,endothelial,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22965,barrier,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22966,function,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22967,.,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
23081,LDL,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23082,vitamin,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23083,E,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23084,levels,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23085,were,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23086,highest,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23087,in,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23088,rabbits,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23089,fed,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23090,corn,B-http://purl.obolibrary.org/obo/FOODON_03301474;http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/FOODON_03310387,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23091,oil,I-http://purl.obolibrary.org/obo/FOODON_03301474;http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/FOODON_03310387,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23092,with,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23093,added,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23094,cholesterol,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23095,.,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23155,Their,O,775.0,Their oxidative modification further contributed to endothelial barrier dysfunction .
23156,oxidative,O,775.0,Their oxidative modification further contributed to endothelial barrier dysfunction .
23157,modification,O,775.0,Their oxidative modification further contributed to endothelial barrier dysfunction .
23158,further,O,775.0,Their oxidative modification further contributed to endothelial barrier dysfunction .
23159,contributed,O,775.0,Their oxidative modification further contributed to endothelial barrier dysfunction .
23160,to,O,775.0,Their oxidative modification further contributed to endothelial barrier dysfunction .
23161,endothelial,O,775.0,Their oxidative modification further contributed to endothelial barrier dysfunction .
23162,barrier,O,775.0,Their oxidative modification further contributed to endothelial barrier dysfunction .
23163,dysfunction,O,775.0,Their oxidative modification further contributed to endothelial barrier dysfunction .
23164,.,O,775.0,Their oxidative modification further contributed to endothelial barrier dysfunction .
23348,Moderate,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23349,wine,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23350,drinking,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23351,is,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23352,part,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23353,of,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23354,the,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23355,Mediterranean,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23356,diet,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23357,",",O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23358,together,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23359,with,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23360,abundant,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23361,and,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23362,variable,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23363,plant,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23364,foods,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23365,",",O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23366,high,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23367,consumption,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23368,of,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23369,cereals,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23370,",",O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23371,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23372,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23373,as,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23374,the,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23375,main,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23376,(,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23377,added,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23378,),O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23379,fat,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23380,and,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23381,a,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23382,low,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23383,intake,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23384,of,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23385,(,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23386,red,B-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23387,),O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23388,meat,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23389,.,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23738,Conversely,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23739,",",O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23740,what,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23741,is,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23742,available,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23743,on,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23744,the,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23745,shelf,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23746,will,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23747,have,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23748,an,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23749,impact,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23750,on,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23751,the,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23752,choices,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23753,consumers,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23754,make,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23755,",",O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23756,thereby,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23757,affecting,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23758,their,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23759,health,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23760,.,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
24424,They,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24425,have,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24426,been,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24427,shown,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24428,to,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24429,improve,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24430,mineral,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24431,balance,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24432,and,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24433,bone,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24434,properties,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24435,as,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24436,well,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24437,as,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24438,causing,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24439,increases,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24440,in,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24441,bifidobacteria,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24442,in,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24443,the,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24444,gut,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24445,",",O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24446,therefore,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24447,a,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24448,prebiotic,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24449,effect,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24450,.,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24480,Fermented,B-http://purl.obolibrary.org/obo/UBERON_0001913,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24481,milk,I-http://purl.obolibrary.org/obo/UBERON_0001913,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24482,is,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24483,now,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24484,also,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24485,recognized,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24486,to,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24487,contain,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24488,highly,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24489,active,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24490,components,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24491,such,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24492,as,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24493,vitamins,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24494,",",O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24495,peptides,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24496,",",O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24497,oligosaccharides,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24498,",",O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24499,and,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24500,organic,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24501,acids,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24502,.,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
25280,A,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25281,population,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25282,-,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25283,based,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25284,",",O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25285,case,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25286,-,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25287,control,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25288,study,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25289,of,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25290,prostate,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25291,cancer,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25292,in,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25293,Utah,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25294,was,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25295,used,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25296,to,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25297,assess,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25298,reported,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25299,food,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25300,-,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25301,consumption,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25302,patterns,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25303,for,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25304,the,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25305,adolescent,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25306,and,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25307,adult,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25308,years,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25309,.,O,854.0,"A population - based , case - control study of prostate cancer in Utah was used to assess reported food - consumption patterns for the adolescent and adult years ."
25813,Gastric,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25814,proteolysis,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25815,was,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25816,not,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25817,influenced,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25818,by,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25819,the,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25820,nature,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25821,of,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25822,dietary,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25823,fats,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25824,.,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
26468,The,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26469,literature,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26470,reviews,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26471,revealed,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26472,similar,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26473,aspects,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26474,of,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26475,the,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26476,challenges,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26477,of,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26478,smallholder,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26479,crop,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26480,-,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26481,livestock,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26482,mixed,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26483,farming,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26484,systems,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26485,in,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26486,both,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26487,countries,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26488,.,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26656,Training,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26657,-,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26658,of,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26659,-,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26660,trainers,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26661,workshops,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26662,in,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26663,milk,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26664,processing,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26665,and,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26666,hygiene,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26667,were,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26668,developed,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26669,and,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26670,given,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26671,in,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26672,Rwanda,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26673,and,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26674,Nepal,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26675,based,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26676,on,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26677,the,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26678,rapid,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26679,needs,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26680,assessments,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26681,",",O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26682,and,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26683,these,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26684,were,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26685,well,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26686,received,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26687,.,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
27004,In,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27005,conclusion,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27006,",",O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27007,flaxseed,B-http://purl.obolibrary.org/obo/FOODON_00003683;http://purl.obolibrary.org/obo/FOODON_03309718,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27008,supplementation,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27009,improves,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27010,composition,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27011,and,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27012,nutritional,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27013,properties,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27014,of,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27015,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27016,from,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27017,cows,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27018,milked,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27019,during,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27020,times,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27021,of,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27022,high,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27023,ambient,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27024,temperature,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27025,.,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27203,Sunflower,B-http://purl.obolibrary.org/obo/FOODON_03310387,924.0,Sunflower oil avoided gene expression changes related to age .
27204,oil,I-http://purl.obolibrary.org/obo/FOODON_03310387,924.0,Sunflower oil avoided gene expression changes related to age .
27205,avoided,O,924.0,Sunflower oil avoided gene expression changes related to age .
27206,gene,O,924.0,Sunflower oil avoided gene expression changes related to age .
27207,expression,O,924.0,Sunflower oil avoided gene expression changes related to age .
27208,changes,O,924.0,Sunflower oil avoided gene expression changes related to age .
27209,related,O,924.0,Sunflower oil avoided gene expression changes related to age .
27210,to,O,924.0,Sunflower oil avoided gene expression changes related to age .
27211,age,O,924.0,Sunflower oil avoided gene expression changes related to age .
27212,.,O,924.0,Sunflower oil avoided gene expression changes related to age .
27287,The,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27288,recent,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27289,study,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27290,was,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27291,designed,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27292,to,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27293,assess,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27294,the,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27295,effects,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27296,of,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27297,household,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27298,processing,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27299,treatments,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27300,such,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27301,as,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27302,acidic,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27303,solutions,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27304,(,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27305,acidic,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27306,acid,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27307,and,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27308,citric,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27309,acid,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27310,),O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27311,",",O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27312,alkaline,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27313,solutions,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27314,(,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27315,sodium,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27316,chloride,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27317,and,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27318,sodium,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27319,carbonate,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27320,),O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27321,and,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27322,biological,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27323,solutions,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27324,(,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27325,radish,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27326,",",O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27327,ginger,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27328,",",O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27329,garlic,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27330,",",O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27331,and,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27332,lemon,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27333,extracts,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27334,),O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27335,were,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27336,evaluated,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27337,for,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27338,their,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27339,efficiency,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27340,for,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27341,removal,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27342,of,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27343,pesticides,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27344,in,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27345,spinach,B-http://purl.obolibrary.org/obo/FOODON_00003496;http://purl.obolibrary.org/obo/NCBITaxon_3562;http://purl.obolibrary.org/obo/FOODON_03301716,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27346,by,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27347,gas,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27348,chromatography,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27349,with,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27350,electron,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27351,capture,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27352,detector,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27353,(,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27354,GC,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27355,-,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27356,ECD,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27357,),O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27358,.,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27684,Plausible,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27685,evidence,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27686,was,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27687,based,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27688,on,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27689,strong,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27690,evidence,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27691,from,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27692,prospective,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27693,cohort,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27694,studies,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27695,only,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27696,.,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27863,Furthermore,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27864,",",O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27865,three,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27866,vegetables,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27867,(,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27868,water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340;http://purl.obolibrary.org/obo/FOODON_00003496;http://purl.obolibrary.org/obo/NCBITaxon_3562;http://purl.obolibrary.org/obo/FOODON_03301716,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27869,spinach,I-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340;http://purl.obolibrary.org/obo/FOODON_00003496;http://purl.obolibrary.org/obo/NCBITaxon_3562;http://purl.obolibrary.org/obo/FOODON_03301716,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27870,",",O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27871,potato,B-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27872,",",O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27873,and,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27874,summer,B-http://purl.obolibrary.org/obo/FOODON_00003708;http://purl.obolibrary.org/obo/FOODON_03310107;http://purl.obolibrary.org/obo/FOODON_00003539;http://purl.obolibrary.org/obo/FOODON_03301577,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27875,squash,I-http://purl.obolibrary.org/obo/FOODON_00003708;http://purl.obolibrary.org/obo/FOODON_03310107;http://purl.obolibrary.org/obo/FOODON_00003539;http://purl.obolibrary.org/obo/FOODON_03301577,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27876,),O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27877,containing,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27878,high,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27879,metal,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27880,concentrations,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27881,were,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27882,selected,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27883,to,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27884,further,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27885,analyze,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27886,metal,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27887,speciation,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
27888,.,O,946.0,"Furthermore , three vegetables ( water spinach , potato , and summer squash ) containing high metal concentrations were selected to further analyze metal speciation ."
28013,A,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28014,high,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28015,proportion,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28016,of,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28017,ethanol,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28018,-,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28019,extractable,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28020,As,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28021,showed,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28022,that,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28023,As,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28024,bioactivity,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28025,and,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28026,toxic,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28027,effects,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28028,were,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28029,the,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28030,highest,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28031,.,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28378,This,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28379,pooled,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28380,analysis,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28381,adds,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28382,evidence,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28383,for,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28384,a,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28385,carcinogenic,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28386,effect,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28387,of,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28388,chronic,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28389,thermal,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28390,injury,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28391,in,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28392,the,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28393,esophagus,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28394,induced,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28395,by,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28396,the,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28397,consumption,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28398,of,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28399,very,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28400,hot,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28401,drinks,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28402,",",O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28403,including,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28404,mate,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28405,.,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28523,In,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28524,recent,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28525,findings,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28526,on,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28527,food,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28528,science,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28529,research,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28530,gut,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28531,microbiota,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28532,plays,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28533,a,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28534,significant,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28535,role,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28536,and,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28537,vastly,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28538,studied,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28539,for,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28540,its,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28541,intermediate,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28542,role,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28543,in,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28544,regulating,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28545,health,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28546,.,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28674,Fluid,O,972.0,Fluid milk consumption among children has declined for decades .
28675,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,972.0,Fluid milk consumption among children has declined for decades .
28676,consumption,O,972.0,Fluid milk consumption among children has declined for decades .
28677,among,O,972.0,Fluid milk consumption among children has declined for decades .
28678,children,O,972.0,Fluid milk consumption among children has declined for decades .
28679,has,O,972.0,Fluid milk consumption among children has declined for decades .
28680,declined,O,972.0,Fluid milk consumption among children has declined for decades .
28681,for,O,972.0,Fluid milk consumption among children has declined for decades .
28682,decades,O,972.0,Fluid milk consumption among children has declined for decades .
28683,.,O,972.0,Fluid milk consumption among children has declined for decades .
28684,Adequate,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28685,consumption,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28686,of,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28687,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28688,and,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28689,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28690,products,I-http://purl.obolibrary.org/obo/ENVO_00003862,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28691,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28692,especially,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28693,during,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28694,childhood,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28695,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28696,has,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28697,beneficial,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28698,health,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28699,outcomes,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28700,for,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28701,growth,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28702,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28703,development,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28704,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28705,and,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28706,reduced,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28707,risk,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28708,of,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28709,osteoporosis,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28710,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28711,hypertension,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28712,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28713,obesity,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28714,",",O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28715,and,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28716,cancer,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28717,during,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28718,adulthood,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28719,.,O,973.0,"Adequate consumption of milk and dairy products , especially during childhood , has beneficial health outcomes for growth , development , and reduced risk of osteoporosis , hypertension , obesity , and cancer during adulthood ."
28742,Child,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28743,preferences,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28744,and,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28745,attitudes,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28746,for,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28747,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28748,may,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28749,differ,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28750,from,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28751,those,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28752,of,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28753,adults,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28754,",",O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28755,and,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28756,as,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28757,such,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28758,",",O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28759,understanding,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28760,and,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28761,fulfilling,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28762,the,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28763,needs,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28764,of,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28765,children,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28766,is,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28767,crucial,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28768,to,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28769,reverse,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28770,the,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28771,decline,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28772,in,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28773,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28774,consumption,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28775,.,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
29209,Fewer,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29210,studies,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29211,investigated,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29212,the,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29213,association,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29214,between,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29215,green,B-http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29216,tea,I-http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29217,and,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29218,other,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29219,health,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29220,outcomes,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29221,such,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29222,as,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29223,cognitive,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29224,outcomes,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29225,",",O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29226,dental,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29227,health,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29228,",",O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29229,injuries,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29230,and,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29231,respiratory,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29232,disease,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29233,.,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29273,There,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29274,are,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29275,more,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29276,than,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29277,30,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29278,spices,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29279,and,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29280,herbs,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29281,of,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29282,global,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29283,economic,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29284,and,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29285,culinary,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29286,importance,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29287,.,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29385,This,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29386,review,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29387,provides,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29388,an,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29389,overview,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29390,on,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29391,the,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29392,mycotoxin,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29393,risk,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29394,in,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29395,widely,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29396,consumed,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29397,spices,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29398,and,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29399,aromatic,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29400,herbs,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29401,.,O,996.0,This review provides an overview on the mycotoxin risk in widely consumed spices and aromatic herbs .
29628,Liking,O,1004.0,Liking of all 3 sausage conditions was similar .
29629,of,O,1004.0,Liking of all 3 sausage conditions was similar .
29630,all,O,1004.0,Liking of all 3 sausage conditions was similar .
29631,3,O,1004.0,Liking of all 3 sausage conditions was similar .
29632,sausage,O,1004.0,Liking of all 3 sausage conditions was similar .
29633,conditions,O,1004.0,Liking of all 3 sausage conditions was similar .
29634,was,O,1004.0,Liking of all 3 sausage conditions was similar .
29635,similar,O,1004.0,Liking of all 3 sausage conditions was similar .
29636,.,O,1004.0,Liking of all 3 sausage conditions was similar .
30063,N,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30064,-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30065,terminal,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30066,sequence,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30067,analysis,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30068,of,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30069,the,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30070,14-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30071,and,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30072,28,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30073,-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30074,kDa,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30075,pepper,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30076,and,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30077,23,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30078,-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30079,kDa,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30080,paprika,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30081,allergens,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30082,revealed,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30083,no,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30084,homology,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30085,to,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30086,known,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30087,allergens,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30088,.,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30568,The,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30569,results,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30570,show,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30571,that,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30572,COVID-19,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30573,confinement,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30574,did,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30575,influence,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30576,their,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30577,dietary,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30578,habits,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30579,.,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30844,The,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30845,vegetable,B-http://purl.obolibrary.org/obo/FOODON_00003816;http://purl.obolibrary.org/obo/NCIT_C45305;http://purl.obolibrary.org/obo/CHEBI_60004,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30846,mixture,I-http://purl.obolibrary.org/obo/FOODON_00003816;http://purl.obolibrary.org/obo/NCIT_C45305;http://purl.obolibrary.org/obo/CHEBI_60004,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30847,used,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30848,in,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30849,diets,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30850,2,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30851,to,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30852,4,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30853,consisted,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30854,of,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30855,the,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30856,4,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30857,individual,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30858,vegetables,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30859,used,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30860,in,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30861,diets,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30862,5,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30863,to,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30864,8,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30865,:,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30866,cauliflower,B-http://purl.obolibrary.org/obo/NCBITaxon_3715;http://purl.obolibrary.org/obo/FOODON_03302732;http://purl.obolibrary.org/obo/FOODON_00003410,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30867,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30868,30,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30869,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30870,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30871,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30872,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30873,",",O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30874,carrots,B-http://purl.obolibrary.org/obo/NCBITaxon_4039,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30875,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30876,30,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30877,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30878,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30879,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30880,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30881,",",O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30882,peas,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30883,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30884,30,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30885,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30886,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30887,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30888,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30889,",",O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30890,and,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30891,onions,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30892,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30893,10,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30894,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30895,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30896,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30897,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30898,.,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
31017,These,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31018,genes,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31019,are,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31020,of,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31021,particular,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31022,interest,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31023,because,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31024,they,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31025,were,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31026,consistently,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31027,affected,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31028,and,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31029,could,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31030,be,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31031,involved,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31032,in,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31033,the,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31034,prevention,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31035,of,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31036,CRC,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31037,by,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31038,vegetable,B-http://purl.obolibrary.org/obo/FOODON_00003816,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31039,consumption,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31040,.,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31327,TPL,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31328,and,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31329,TNL,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31330,of,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31331,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31332,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31333,were,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31334,fractionated,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31335,by,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31336,HPLC,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31337,for,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31338,further,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31339,study,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31340,.,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31558,A,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31559,protective,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31560,effect,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31561,of,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31562,green,B-http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31563,tea,I-http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31564,on,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31565,the,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31566,development,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31567,of,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31568,colon,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31569,cancer,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31570,is,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31571,suggested,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31572,.,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31618,The,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31619,range,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31620,and,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31621,crude,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31622,categorization,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31623,of,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31624,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31625,consumption,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31626,",",O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31627,choice,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31628,of,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31629,control,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31630,groups,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31631,",",O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31632,and,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31633,inadequate,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31634,control,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31635,for,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31636,confounding,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31637,might,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31638,have,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31639,obscured,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31640,possible,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31641,relationships,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31642,.,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31985,These,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31986,results,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31987,may,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31988,also,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31989,explain,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31990,some,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31991,of,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31992,the,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31993,ethnic,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31994,differences,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31995,in,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31996,colon,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31997,cancer,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31998,incidence,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
31999,.,O,1084.0,These results may also explain some of the ethnic differences in colon cancer incidence .
32128,The,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32129,weight,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32130,of,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32131,data,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32132,indicate,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32133,favourable,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32134,effects,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32135,on,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32136,diabetes,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32137,risk,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32138,factors,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32139,for,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32140,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32141,",",O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32142,red,B-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32143,wine,I-http://purl.obolibrary.org/obo/FOODON_03310272;http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32144,and,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32145,cocoa,B-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32146,intake,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32147,",",O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32148,and,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32149,a,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32150,number,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32151,of,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32152,plausible,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32153,mechanisms,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32154,have,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32155,been,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32156,elucidated,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32157,in,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32158,human,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32159,studies,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32160,.,O,1090.0,"The weight of data indicate favourable effects on diabetes risk factors for tea , red wine and cocoa intake , and a number of plausible mechanisms have been elucidated in human studies ."
32583,A,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32584,total,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32585,of,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32586,558,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32587,patients,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32588,with,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32589,ovarian,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32590,cancer,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32591,diagnosed,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32592,in,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32593,1993,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32594,-,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32595,1999,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32596,and,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32597,607,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32598,controls,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32599,were,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32600,interviewed,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32601,regarding,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32602,their,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32603,diet,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32604,.,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
33216,Food,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33217,availability,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33218,was,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33219,estimated,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33220,using,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33221,FAO,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33222,Food,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33223,Balance,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33224,Sheet,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33225,data,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33226,on,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33227,country,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33228,-,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33229,level,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33230,food,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33231,supply,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33232,.,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33297,However,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33298,",",O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33299,the,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33300,food,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33301,potential,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33302,of,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33303,Bamboo,B-http://purl.obolibrary.org/obo/FOODON_03307912,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33304,shoot,I-http://purl.obolibrary.org/obo/FOODON_03307912,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33305,per,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33306,se,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33307,remains,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33308,unexploited,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33309,.,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33506,are,O,1141.0,are now gaining importance .
33507,now,O,1141.0,are now gaining importance .
33508,gaining,O,1141.0,are now gaining importance .
33509,importance,O,1141.0,are now gaining importance .
33510,.,O,1141.0,are now gaining importance .
33557,Male,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33558,BHE,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33559,weanling,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33560,rats,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33561,were,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33562,fed,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33563,a,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33564,65,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33565,%,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33566,starch,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33567,diet,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33568,containing,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33569,5,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33570,%,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33571,corn,B-http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/FOODON_03310046;http://purl.obolibrary.org/obo/FOODON_03303085;http://purl.obolibrary.org/obo/FOODON_00003449;http://purl.obolibrary.org/obo/FOODON_03310387,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33572,or,I-http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/FOODON_03310046;http://purl.obolibrary.org/obo/FOODON_03303085;http://purl.obolibrary.org/obo/FOODON_00003449;http://purl.obolibrary.org/obo/FOODON_03310387,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33573,coconut,I-http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/FOODON_03310046;http://purl.obolibrary.org/obo/FOODON_03303085;http://purl.obolibrary.org/obo/FOODON_00003449;http://purl.obolibrary.org/obo/FOODON_03310387,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33574,oil,I-http://purl.obolibrary.org/obo/NCBITaxon_381124;http://purl.obolibrary.org/obo/FOODON_03310046;http://purl.obolibrary.org/obo/FOODON_03303085;http://purl.obolibrary.org/obo/FOODON_00003449;http://purl.obolibrary.org/obo/FOODON_03310387,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33575,.,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
34359,A,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34360,partial,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34361,life,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34362,cycle,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34363,assessment,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34364,detailed,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34365,flows,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34366,of,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34367,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913;http://purl.obolibrary.org/obo/NCBITaxon_9913,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34368,from,I-http://purl.obolibrary.org/obo/UBERON_0001913;http://purl.obolibrary.org/obo/NCBITaxon_9913,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34369,cow,I-http://purl.obolibrary.org/obo/UBERON_0001913;http://purl.obolibrary.org/obo/NCBITaxon_9913,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34370,to,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34371,farm,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34372,gate,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34373,and,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34374,captured,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34375,farm,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34376,inputs,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34377,such,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34378,as,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34379,imported,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34380,feeds,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34381,and,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34382,fertilizers,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34383,.,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34734,The,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34735,optimum,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34736,formulation,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34737,for,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34738,mayonnaise,B-http://purl.obolibrary.org/obo/FOODON_03301440,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34739,-,I-http://purl.obolibrary.org/obo/FOODON_03301440,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34740,type,I-http://purl.obolibrary.org/obo/FOODON_03301440,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34741,spreads,I-http://purl.obolibrary.org/obo/FOODON_03301440,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34742,containing,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34743,rice,B-http://purl.obolibrary.org/obo/FOODON_00003226;http://purl.obolibrary.org/obo/FOODON_03306185;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641;http://purl.obolibrary.org/obo/FOODON_03310387,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34744,bran,I-http://purl.obolibrary.org/obo/FOODON_00003226;http://purl.obolibrary.org/obo/FOODON_03306185;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641;http://purl.obolibrary.org/obo/FOODON_03310387,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34745,oil,I-http://purl.obolibrary.org/obo/FOODON_00003226;http://purl.obolibrary.org/obo/FOODON_03306185;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641;http://purl.obolibrary.org/obo/FOODON_03310387,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34746,(,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34747,RBO,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34748,),O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34749,and,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34750,soy,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34751,protein,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34752,concentrate,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34753,(,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34754,SPC,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34755,),O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34756,was,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34757,determined,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34758,based,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34759,on,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34760,sensory,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34761,acceptability,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34762,.,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
35430, ,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35431,Conversely,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35432,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35433,Hong,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35434,Kong,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35435,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35436,Japan,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35437,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35438,Shanghai,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35439,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35440,and,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35441,Singapore,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35442,have,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35443,low,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35444,ovarian,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35445,cancer,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35446,risk,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35447,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35448,low,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35449,consumption,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35450,of,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35451,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35452,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35453,and,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35454,low,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35455,levels,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35456,of,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35457,lactase,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35458,persistence,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35459,.,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35485, ,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35486,Lactase,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35487,persistence,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35488,did,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35489,have,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35490,an,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35491,independent,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35492,association,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35493,",",O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35494,however,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35495,",",O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35496,but,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35497,data,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35498,was,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35499,not,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35500,standardized,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35501,across,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35502,populations,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35503,.,O,1211.0,"  Lactase persistence did have an independent association , however , but data was not standardized across populations ."
35586, ,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35587,The,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35588,strongest,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35589,predictor,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35590,to,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35591,date,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35592,is,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35593,the,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35594,lactose,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35595,/,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35596,transferase,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35597,ratio,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35598,",",O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35599,yet,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35600,those,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35601,who,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35602,found,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35603,this,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35604,association,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35605,did,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35606,not,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35607,define,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35608,this,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35609,index,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35610,based,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35611,on,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35612,an,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35613,earlier,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35614,study,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35615,or,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35616,examination,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35617,.,O,1216.0,"  The strongest predictor to date is the lactose / transferase ratio , yet those who found this association did not define this index based on an earlier study or examination ."
35618, ,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35619,1,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35620,problem,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35621,with,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35622,these,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35623,studies,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35624,is,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35625,that,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35626,dietary,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35627,fat,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35628,confounds,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35629,the,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35630,association,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35631,.,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35750,However,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35751,",",O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35752,there,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35753,is,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35754,evidence,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35755,that,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35756,up,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35757,to,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35758,80,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35759,%,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35760,of,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35761,dietary,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35762,perchlorate,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35763,is,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35764,metabolized,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35765,in,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35766,clinically,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35767,healthy,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35768,cows,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35769,",",O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35770,thereby,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35771,restricting,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35772,the,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35773,available,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35774,transfer,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35775,of,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35776,ingested,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35777,perchlorate,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35778,into,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35779,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35780,.,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
36133,Short,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36134,-,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36135,chain,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36136,fatty,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36137,acid,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36138,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36139,SCFA,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36140,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36141,",",O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36142,hydrogen,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36143,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36144,H2,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36145,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36146,",",O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36147,and,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36148,methane,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36149,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36150,CH4,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36151,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36152,productions,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36153,and,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36154,neutral,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36155,-,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36156,detergent,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36157,fiber,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36158,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36159,NDF,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36160,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36161,digestibility,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36162,differed,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36163,significantly,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36164,with,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36165,fiber,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36166,source,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36167,.,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36168,The,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36169,vegetable,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36170,fibers,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36171,were,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36172,significantly,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36173,more,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36174,fermentable,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36175,than,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36176,were,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36177,the,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36178,cereal,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36179,brans,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36180,",",O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36181,as,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36182,evidenced,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36183,by,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36184,greater,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36185,NDF,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36186,digestibility,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36187,and,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36188,increased,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36189,productions,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36190,of,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36191,SCFA,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36192,",",O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36193,H2,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36194,",",O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36195,and,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36196,CH4,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36197,",",O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36198,despite,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36199,the,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36200,presence,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36201,of,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36202,fermentable,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36203,starch,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36204,and,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36205,protein,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36206,in,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36207,the,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36208,latter,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36209,.,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36607,Cancer,O,1251.0,Cancer is increasing worldwide .
36608,is,O,1251.0,Cancer is increasing worldwide .
36609,increasing,O,1251.0,Cancer is increasing worldwide .
36610,worldwide,O,1251.0,Cancer is increasing worldwide .
36611,.,O,1251.0,Cancer is increasing worldwide .
36619,The,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36620,evidence,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36621,is,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36622,summarised,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36623,in,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36624,the,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36625,2018,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36626,World,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36627,Cancer,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36628,Research,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36629,Fund,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36630,/,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36631,American,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36632,Institute,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36633,for,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36634,Cancer,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36635,Research,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36636,report,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36637,Diet,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36638,",",O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36639,Nutrition,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36640,",",O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36641,Physical,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36642,Activity,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36643,and,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36644,Cancer,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36645,:,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36646,a,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36647,Global,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36648,Perspective,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36649,.,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
37341,Reference,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37342,Doses,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37343,were,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37344,not,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37345,established,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37346,for,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37347,fish,B-http://purl.obolibrary.org/obo/NCBITaxon_7898;http://purl.obolibrary.org/obo/FOODON_03411222;http://purl.obolibrary.org/obo/NCBITaxon_7777,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37348,or,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37349,celery,B-http://purl.obolibrary.org/obo/FOODON_03301727;http://purl.obolibrary.org/obo/NCBITaxon_117781,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37350,due,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37351,to,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37352,poor,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37353,model,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37354,fits,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37355,with,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37356,existing,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37357,data,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37358,.,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37359,Reference,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37360,Doses,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37361,were,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37362,not,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37363,established,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37364,for,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37365,other,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37366,tree,B-http://purl.obolibrary.org/obo/FOODON_03306632,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37367,nuts,I-http://purl.obolibrary.org/obo/FOODON_03306632,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37368,beyond,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37369,hazelnut,B-http://purl.obolibrary.org/obo/FOODON_00002933,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37370,and,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37371,cashew,B-http://purl.obolibrary.org/obo/FOODON_03301357;http://purl.obolibrary.org/obo/NCBITaxon_171929,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37372,because,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37373,of,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37374,the,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37375,absence,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37376,of,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37377,data,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37378,on,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37379,NOAELs,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37380,and,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37381,LOAELs,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37382,from,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37383,individual,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37384,subjects,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37385,.,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37745,Promotion,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37746,was,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37747,assessed,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37748,by,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37749,the,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37750,multiplicity,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37751,of,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37752,ACF,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37753,(,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37754,crypts,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37755,per,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37756,ACF,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37757,),O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37758,in,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37759,rats,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37760,given,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37761,experimental,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37762,diets,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37763,for,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37764,100,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37765,days,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37766,starting,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37767,7,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37768,days,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37769,after,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37770,an,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37771,azoxymethane,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37772,injection,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37773,.,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
38011,The,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38012,association,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38013,of,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38014,habitual,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38015,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38016,consumption,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38017,with,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38018,a,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38019,lower,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38020,risk,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38021,of,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38022,diseases,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38023,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38024,like,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38025,type,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38026,2,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38027,diabetes,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38028,mellitus,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38029,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38030,chronic,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38031,liver,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38032,disease,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38033,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38034,certain,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38035,cancer,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38036,types,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38037,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38038,or,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38039,with,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38040,reduced,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38041,all,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38042,-,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38043,cause,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38044,mortality,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38045,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38046,has,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38047,been,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38048,confirmed,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38049,in,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38050,prospective,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38051,cohort,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38052,studies,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38053,in,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38054,many,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38055,regions,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38056,of,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38057,the,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38058,world,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38059,.,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38184,Coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38185,plays,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38186,a,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38187,dominant,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38188,role,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38189,in,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38190,that,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38191,regard,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38192,because,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38193,it,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38194,is,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38195,the,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38196,major,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38197,dietary,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38198,source,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38199,of,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38200,phenolic,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38201,acids,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38202,and,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38203,polyphenols,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38204,in,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38205,the,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38206,developed,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38207,world,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38208,.,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38501,The,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38502,plant,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38503,foods,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38504,used,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38505,were,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38506,avocado,B-http://purl.obolibrary.org/obo/FOODON_00003600;http://purl.obolibrary.org/obo/FOODON_03305236;http://purl.obolibrary.org/obo/NCBITaxon_3435,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38507,",",O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38508,black,B-http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/NCBITaxon_233744,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38509,sapote,I-http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/NCBITaxon_233744,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38510,",",O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38511,guava,B-http://purl.obolibrary.org/obo/FOODON_00003622;http://purl.obolibrary.org/obo/NCBITaxon_120290;http://purl.obolibrary.org/obo/FOODON_03305317,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38512,",",O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38513,mango,B-http://purl.obolibrary.org/obo/FOODON_00003538;http://purl.obolibrary.org/obo/NCBITaxon_29780;http://purl.obolibrary.org/obo/FOODON_03301813,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38514,",",O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38515,prickly,B-http://purl.obolibrary.org/obo/NCBITaxon_23211;http://purl.obolibrary.org/obo/FOODON_00003041;http://purl.obolibrary.org/obo/FOODON_03301724,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38516,pear,I-http://purl.obolibrary.org/obo/NCBITaxon_23211;http://purl.obolibrary.org/obo/FOODON_00003041;http://purl.obolibrary.org/obo/FOODON_03301724,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38517,cactus,I-http://purl.obolibrary.org/obo/NCBITaxon_23211;http://purl.obolibrary.org/obo/FOODON_00003041;http://purl.obolibrary.org/obo/FOODON_03301724,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38518,stems,I-http://purl.obolibrary.org/obo/NCBITaxon_23211;http://purl.obolibrary.org/obo/FOODON_00003041;http://purl.obolibrary.org/obo/FOODON_03301724,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38519,(,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38520,called,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38521,nopal,B-http://purl.obolibrary.org/obo/FOODON_00003078,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38522,in,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38523,Mexico,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38524,",",O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38525,cooked,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38526,and,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38527,raw,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38528,),O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38529,",",O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38530,papaya,B-http://purl.obolibrary.org/obo/FOODON_03301830;http://purl.obolibrary.org/obo/NCBITaxon_3649,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38531,",",O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38532,pineapple,B-http://purl.obolibrary.org/obo/FOODON_03301831;http://purl.obolibrary.org/obo/NCBITaxon_4615,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38533,",",O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38534,four,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38535,different,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38536,cultivars,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38537,of,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38538,prickly,B-http://purl.obolibrary.org/obo/NCBITaxon_23211;http://purl.obolibrary.org/obo/FOODON_00003041;http://purl.obolibrary.org/obo/FOODON_03301724;http://purl.obolibrary.org/obo/PO_0009001,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38539,pear,I-http://purl.obolibrary.org/obo/NCBITaxon_23211;http://purl.obolibrary.org/obo/FOODON_00003041;http://purl.obolibrary.org/obo/FOODON_03301724;http://purl.obolibrary.org/obo/PO_0009001,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38540,fruit,I-http://purl.obolibrary.org/obo/NCBITaxon_23211;http://purl.obolibrary.org/obo/FOODON_00003041;http://purl.obolibrary.org/obo/FOODON_03301724;http://purl.obolibrary.org/obo/PO_0009001,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38541,",",O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38542,grapes,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38543,and,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38544,tomato,B-http://purl.obolibrary.org/obo/FOODON_03301453;http://purl.obolibrary.org/obo/FOODON_03309927;http://purl.obolibrary.org/obo/NCBITaxon_4081,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38545,.,O,1324.0,"The plant foods used were avocado , black sapote , guava , mango , prickly pear cactus stems ( called nopal in Mexico , cooked and raw ) , papaya , pineapple , four different cultivars of prickly pear fruit , grapes and tomato ."
38772,Alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38773,consumption,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38774,was,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38775,categorized,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38776,into,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38777,amounts,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38778,consumed,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38779,(,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38780,grams,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38781,per,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38782,day,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38783,),O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38784,and,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38785,also,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38786,modelled,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38787,as,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38788,a,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38789,continuous,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38790,variable,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38791,using,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38792,restricted,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38793,cubic,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38794,splines,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38795,for,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38796,potential,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38797,non,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38798,-,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38799,linearity,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38800,.,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38801,Analyses,O,1335.0,Analyses by histologic sub - type were included .
38802,by,O,1335.0,Analyses by histologic sub - type were included .
38803,histologic,O,1335.0,Analyses by histologic sub - type were included .
38804,sub,O,1335.0,Analyses by histologic sub - type were included .
38805,-,O,1335.0,Analyses by histologic sub - type were included .
38806,type,O,1335.0,Analyses by histologic sub - type were included .
38807,were,O,1335.0,Analyses by histologic sub - type were included .
38808,included,O,1335.0,Analyses by histologic sub - type were included .
38809,.,O,1335.0,Analyses by histologic sub - type were included .
38940,The,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38941,results,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38942,indicate,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38943,that,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38944,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38945,consumption,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38946,is,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38947,inversely,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38948,associated,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38949,with,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38950,lung,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38951,cancer,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38952,risk,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38953,",",O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38954,particularly,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38955,among,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38956,subjects,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38957,with,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38958,low,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38959,to,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38960,moderate,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38961,consumption,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38962,levels,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38963,",",O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38964,and,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38965,among,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38966,wine,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38967,and,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38968,liquor,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38969,drinkers,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38970,",",O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38971,but,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38972,not,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38973,beer,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38974,drinkers,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
38975,.,O,1339.0,"The results indicate that alcohol consumption is inversely associated with lung cancer risk , particularly among subjects with low to moderate consumption levels , and among wine and liquor drinkers , but not beer drinkers ."
39337,Mortality,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39338,of,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39339,severely,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39340,ill,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39341,patients,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39342,with,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39343,liver,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39344,disease,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39345,in,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39346,district,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39347,general,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39348,hospitals,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39349,is,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39350,unacceptably,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39351,high,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39352,",",O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39353,indicating,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39354,the,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39355,need,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39356,to,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39357,develop,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39358,a,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39359,masterplan,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39360,for,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39361,improving,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39362,hospital,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39363,care,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39364,.,O,1352.0,"Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high , indicating the need to develop a masterplan for improving hospital care ."
39522,The,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39523,Lancet,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39524,Commission,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39525,has,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39526,serious,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39527,doubts,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39528,about,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39529,whether,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39530,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39531,initiatives,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39532,described,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39533,in,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39534,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39535,Prevention,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39536,Green,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39537,Paper,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39538,",",O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39539,with,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39540,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39541,onus,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39542,placed,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39543,on,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39544,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39545,individual,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39546,based,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39547,on,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39548,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39549,use,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39550,of,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39551,information,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39552,technology,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39553,and,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39554,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39555,latest,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39556,in,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39557,behavioural,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39558,science,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39559,",",O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39560,will,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39561,be,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39562,effective,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39563,.,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39640,Ghee,B-http://purl.obolibrary.org/obo/FOODON_03310185,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39641,contains,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39642,high,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39643,levels,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39644,of,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39645,saturated,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39646,fatty,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39647,acids,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39648,and,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39649,cholesterol,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39650,",",O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39651,which,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39652,are,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39653,considered,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39654,risk,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39655,factors,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39656,for,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39657,cardiovascular,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39658,diseases,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39659,.,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
40062,When,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40063,the,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40064,data,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40065,from,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40066,all,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40067,dietary,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40068,phases,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40069,were,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40070,pooled,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40071,",",O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40072,LDL,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40073,alpha,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40074,-,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40075,tocopherol,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40076,level,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40077,(,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40078,r,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40079,=,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40080,0.30,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40081,",",O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40082,P,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40083,=,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40084,0.01,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40085,),O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40086,and,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40087,plasma,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40088,18:1/18:2,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40089,ratio,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40090,(,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40091,r,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40092,=,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40093,0.22,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40094,",",O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40095,P,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40096,=,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40097,0.08,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40098,),O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40099,were,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40100,positively,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40101,related,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40102,to,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40103,resistance,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40104,of,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40105,LDL,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40106,to,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40107,oxidation,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40108,.,O,1375.0,"When the data from all dietary phases were pooled , LDL alpha - tocopherol level ( r = 0.30 , P = 0.01 ) and plasma 18:1/18:2 ratio ( r = 0.22 , P = 0.08 ) were positively related to resistance of LDL to oxidation ."
40484,Weight,O,1388.0,Weight was closely associated with skinfold thickness .
40485,was,O,1388.0,Weight was closely associated with skinfold thickness .
40486,closely,O,1388.0,Weight was closely associated with skinfold thickness .
40487,associated,O,1388.0,Weight was closely associated with skinfold thickness .
40488,with,O,1388.0,Weight was closely associated with skinfold thickness .
40489,skinfold,O,1388.0,Weight was closely associated with skinfold thickness .
40490,thickness,O,1388.0,Weight was closely associated with skinfold thickness .
40491,.,O,1388.0,Weight was closely associated with skinfold thickness .
40676,Overweight,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40677,teen,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40678,-,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40679,agers,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40680,appear,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40681,to,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40682,be,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40683,more,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40684,conscious,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40685,of,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40686,their,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40687,food,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40688,intake,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40689,than,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40690,under-,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40691,and,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40692,normal,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40693,-,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40694,weight,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40695,children,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40696,.,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
41006,We,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41007,report,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41008,on,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41009,an,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41010,association,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41011,between,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41012,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41013,consumption,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41014,and,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41015,the,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41016,concentration,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41017,of,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41018,total,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41019,homocysteine,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41020,(,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41021,tHcy,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41022,),O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41023,in,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41024,plasma,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41025,",",O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41026,a,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41027,risk,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41028,factor,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41029,for,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41030,cardiovascular,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41031,disease,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41032,and,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41033,for,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41034,adverse,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41035,pregnancy,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41036,outcome,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41037,.,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41194,Although,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41195,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41196,drinking,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41197,was,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41198,associated,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41199,with,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41200,smoking,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41201,and,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41202,lower,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41203,intake,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41204,of,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41205,vitamin,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41206,supplements,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41207,and,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41208,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41209,and,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41210,vegetables,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41211,",",O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41212,the,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41213,coffee,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41214,-,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41215,tHcy,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41216,association,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41217,was,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41218,only,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41219,moderately,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41220,reduced,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41221,after,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41222,these,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41223,variables,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41224,were,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41225,adjusted,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41226,for,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41227,.,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
42016,A,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42017,total,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42018,of,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42019,"13,609",O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42020,subjects,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42021,aged,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42022,between,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42023,20,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42024,and,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42025,50,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42026,years,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42027,were,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42028,selected,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42029,.,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42222,Our,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42223,results,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42224,support,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42225,that,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42226,the,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42227,dietary,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42228,pattern,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42229,may,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42230,have,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42231,a,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42232,role,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42233,in,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42234,the,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42235,prevention,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42236,and,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42237,management,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42238,of,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42239,dyslipidemia,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42240,and,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42241,abnormal,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42242,fasting,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42243,plasma,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42244,glucose,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42245,.,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42470,Therefore,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42471,",",O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42472,the,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42473,results,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42474,are,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42475,clearly,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42476,indicative,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42477,of,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42478,the,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42479,beneficial,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42480,effects,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42481,of,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42482,garlic,B-http://purl.obolibrary.org/obo/FOODON_03305208;http://purl.obolibrary.org/obo/FOODON_00003582;http://purl.obolibrary.org/obo/NCBITaxon_4682,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42483,in,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42484,reducing,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42485,lateral,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42486,side,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42487,effects,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42488,of,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42489,hyperlipidemia,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42490,.,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42911,Epidemiological,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42912,studies,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42913,have,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42914,shown,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42915,that,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42916,consumption,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42917,of,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42918,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42919,and,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42920,vegetables,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42921,is,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42922,associated,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42923,with,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42924,reduced,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42925,risk,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42926,of,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42927,chronic,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42928,diseases,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42929,.,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
43194,Polyphenols,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43195,and,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43196,other,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43197,compounds,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43198,found,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43199,in,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43200,cocoa,B-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43201,and,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43202,chocolate,B-http://purl.obolibrary.org/obo/FOODON_03307240;http://purl.obolibrary.org/obo/NCBITaxon_3641,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43203,have,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43204,therapeutic,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43205,potential,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43206,in,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43207,the,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43208,management,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43209,of,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43210,diabetes,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43211,in,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43212,humans,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43213,.,O,1483.0,Polyphenols and other compounds found in cocoa and chocolate have therapeutic potential in the management of diabetes in humans .
43587,Urinary,O,1497.0,Urinary arsenic was measured in 310 participants .
43588,arsenic,O,1497.0,Urinary arsenic was measured in 310 participants .
43589,was,O,1497.0,Urinary arsenic was measured in 310 participants .
43590,measured,O,1497.0,Urinary arsenic was measured in 310 participants .
43591,in,O,1497.0,Urinary arsenic was measured in 310 participants .
43592,310,O,1497.0,Urinary arsenic was measured in 310 participants .
43593,participants,O,1497.0,Urinary arsenic was measured in 310 participants .
43594,.,O,1497.0,Urinary arsenic was measured in 310 participants .
43805,Every,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43806,dietary,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43807,plant,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43808,contains,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43809,numerous,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43810,types,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43811,of,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43812,antioxidants,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43813,with,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43814,different,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43815,properties,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43816,.,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43866,Several,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43867,nuts,B-http://purl.obolibrary.org/obo/FOODON_03306632,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43868,are,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43869,among,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43870,the,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43871,dietary,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43872,plants,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43873,with,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43874,the,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43875,highest,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43876,content,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43877,of,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43878,total,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43879,antioxidants,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
43880,.,O,1509.0,Several nuts are among the dietary plants with the highest content of total antioxidants .
44230,60,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44231,migraine,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44232,patients,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44233,completed,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44234,elimination,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44235,diets,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44236,after,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44237,a,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44238,5,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44239,-,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44240,day,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44241,period,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44242,of,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44243,withdrawal,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44244,from,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44245,their,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44246,normal,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44247,diet,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44248,.,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44400,Both,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44401,immunological,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44402,and,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44403,non,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44404,-,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44405,immunological,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44406,mechanisms,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44407,may,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44408,play,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44409,a,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44410,part,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44411,in,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44412,the,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44413,pathogenesis,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44414,of,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44415,migraine,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44416,caused,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44417,by,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44418,food,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44419,intolerance,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44420,.,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44564,By,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44565,ELISA,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44566,-,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44567,inhibition,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44568,assays,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44569,",",O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44570,a,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44571,partial,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44572,cross,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44573,-,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44574,reactivity,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44575,was,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44576,found,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44577,among,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44578,IgE,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44579,-,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44580,binding,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44581,components,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44582,from,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44583,paprika,B-http://purl.obolibrary.org/obo/FOODON_03301105,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44584,and,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44585,mace,B-http://purl.obolibrary.org/obo/FOODON_00002014;http://purl.obolibrary.org/obo/NCBITaxon_51089,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44586,.,O,1536.0,"By ELISA - inhibition assays , a partial cross - reactivity was found among IgE - binding components from paprika and mace ."
44587,The,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44588,immunoblot,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44589,analysis,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44590,showed,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44591,two,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44592,IgE,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44593,-,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44594,reactive,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44595,protein,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44596,bands,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44597,able,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44598,to,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44599,bind,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44600,to,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44601,IgE,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44602,from,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44603,mace,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44604,of,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44605,20,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44606,and,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44607,40,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44608,kDa,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44609,and,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44610,two,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44611,other,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44612,bands,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44613,from,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44614,coriander,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44615,extract,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44616,of,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44617,50,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44618,and,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44619,56,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44620,kDa,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44621,.,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44781,One,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44782,hundred,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44783,female,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44784,Fischer,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44785,344,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44786,rats,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44787,were,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44788,given,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44789,a,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44790,single,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44791,injection,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44792,of,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44793,azoxymethane,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44794,(,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44795,20,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44796,mg,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44797,/,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44798,kg,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44799,i.p,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44800,.,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
45010,The,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45011,water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45012,intake,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45013,was,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45014,higher,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45015,in,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45016,bacon,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45017,-,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45018,fed,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45019,rats,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45020,than,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45021,in,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45022,controls,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45023,(,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45024,p,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45025,<,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45026,0.0001,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45027,),O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45028,.,O,1553.0,The water intake was higher in bacon - fed rats than in controls ( p < 0.0001 ) .
45029,The,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45030,concentrations,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45031,of,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45032,iron,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45033,and,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45034,bile,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45035,acids,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45036,in,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45037,fecal,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45038,water,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45039,and,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45040,total,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45041,fatty,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45042,acids,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45043,in,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45044,feces,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45045,changed,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45046,with,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45047,diet,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45048,",",O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45049,but,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45050,there,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45051,was,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45052,no,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45053,correlation,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45054,between,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45055,these,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45056,concentrations,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45057,and,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45058,the,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45059,ACF,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45060,multiplicity,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45061,.,O,1554.0,"The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet , but there was no correlation between these concentrations and the ACF multiplicity ."
45112,A,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45113,bacon,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45114,-,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45115,based,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45116,diet,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45117,appears,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45118,to,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45119,protect,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45120,against,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45121,carcinogenesis,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45122,",",O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45123,perhaps,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45124,because,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45125,bacon,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45126,contains,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45127,5,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45128,%,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45129,NaCl,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45130,and,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45131,increased,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45132,the,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45133,rats,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45134,',O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45135,water,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45136,intake,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45137,.,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45236,Finally,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45237,",",O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45238,human,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45239,volunteers,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45240,consumed,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45241,this,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45242,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45243,product,I-http://purl.obolibrary.org/obo/ENVO_00003862,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45244,and,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45245,24,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45246,-,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45247,h,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45248,urine,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45249,Ca,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45250,was,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45251,measured,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45252,.,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45253,Results,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45254,showed,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45255,that,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45256,the,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45257,beverage,B-http://purl.obolibrary.org/obo/FOODON_00003202,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45258,has,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45259,lower,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45260,lactose,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45261,and,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45262,higher,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45263,Ca,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45264,than,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45265,untreated,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45266,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45267,and,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45268,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913;http://purl.obolibrary.org/obo/FOODON_03310290,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45269,with,I-http://purl.obolibrary.org/obo/UBERON_0001913;http://purl.obolibrary.org/obo/FOODON_03310290,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45270,kefir,I-http://purl.obolibrary.org/obo/UBERON_0001913;http://purl.obolibrary.org/obo/FOODON_03310290,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45271,.,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45382,Dietary,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45383,habits,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45384,were,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45385,established,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45386,through,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45387,a,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45388,self,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45389,-,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45390,administered,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45391,semi,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45392,-,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45393,quantitative,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45394,food,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45395,frequency,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45396,questionnaire,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45397,.,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45846,Of,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45847,the,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45848,six,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45849,subspecies,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45850,of,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45851,spinach,B-http://purl.obolibrary.org/obo/FOODON_00003496;http://purl.obolibrary.org/obo/NCBITaxon_3562;http://purl.obolibrary.org/obo/FOODON_03301716,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45852,(,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45853,Spinacia,B-http://purl.obolibrary.org/obo/NCBITaxon_3562,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45854,oleracea,I-http://purl.obolibrary.org/obo/NCBITaxon_3562,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45855,),O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45856,tested,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45857,",",O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45858,"""",O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45859,Anna,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45860,"""",O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45861,had,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45862,the,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45863,largest,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45864,amount,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45865,of,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45866,SQDG,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45867,",",O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45868,strongest,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45869,inhibitory,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45870,activity,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45871,toward,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45872,DNA,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45873,polymerase,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45874,and,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45875,greatest,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45876,effect,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45877,on,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45878,human,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45879,cancer,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45880,cell,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45881,proliferation,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
45882,.,O,1587.0,"Of the six subspecies of spinach ( Spinacia oleracea ) tested , "" Anna "" had the largest amount of SQDG , strongest inhibitory activity toward DNA polymerase and greatest effect on human cancer cell proliferation ."
46174,Our,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46175,group,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46176,found,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46177,",",O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46178,for,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46179,example,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46180,",",O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46181,that,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46182,the,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46183,vitamin,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46184,C,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46185,in,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46186,apples,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46187,with,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46188,skin,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46189,accounts,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46190,for,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46191,only,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46192,0.4,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46193,%,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46194,of,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46195,the,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46196,total,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46197,antioxidant,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46198,activity,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46199,",",O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46200,suggesting,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46201,that,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46202,most,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46203,of,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46204,the,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46205,antioxidant,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46206,activity,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46207,of,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46208,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46209,and,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46210,vegetables,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46211,may,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46212,come,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46213,from,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46214,phenolics,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46215,and,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46216,flavonoids,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46217,in,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46218,apples,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46219,.,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46373,In,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46374,particular,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46375,",",O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46376,rates,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46377,of,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46378,breast,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46379,and,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46380,prostate,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46381,cancers,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46382,remain,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46383,high,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46384,among,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46385,Adventist,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46386,populations,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46387,despite,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46388,an,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46389,overall,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46390,healthy,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46391,lifestyle,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46392,and,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46393,long,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46394,life,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46395,expectancy,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46396,.,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46877,The,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46878,highest,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46879,oxalate,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46880,content,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46881,was,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46882,demonstrated,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46883,for,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46884,wheat,B-http://purl.obolibrary.org/obo/FOODON_03304608;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46885,bran,I-http://purl.obolibrary.org/obo/FOODON_03304608;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46886,(,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46887,457.4,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46888,mg/100,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46889,g,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46890,),O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46891,.,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46934,Vegetarian,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46935,diets,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46936,may,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46937,contain,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46938,high,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46939,amounts,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46940,of,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46941,oxalate,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46942,when,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46943,whole,B-http://purl.obolibrary.org/obo/FOODON_00003950;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184;http://purl.obolibrary.org/obo/FOODON_03315184,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46944,grain,I-http://purl.obolibrary.org/obo/FOODON_00003950;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184;http://purl.obolibrary.org/obo/FOODON_03315184,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46945,wheat,I-http://purl.obolibrary.org/obo/FOODON_00003950;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184;http://purl.obolibrary.org/obo/FOODON_03315184,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46946,and,I-http://purl.obolibrary.org/obo/FOODON_00003950;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184;http://purl.obolibrary.org/obo/FOODON_03315184,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46947,wheat,I-http://purl.obolibrary.org/obo/FOODON_00003950;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184;http://purl.obolibrary.org/obo/FOODON_03315184,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46948,products,I-http://purl.obolibrary.org/obo/FOODON_00003950;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184;http://purl.obolibrary.org/obo/FOODON_03315184,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46949,are,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46950,ingested,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46951,.,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46952,Recommendations,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46953,for,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46954,prevention,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46955,of,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46956,recurrence,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46957,of,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46958,calcium,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46959,oxalate,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46960,stone,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46961,disease,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46962,have,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46963,to,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46964,take,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46965,into,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46966,account,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46967,the,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46968,oxalate,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46969,content,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46970,of,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46971,these,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46972,foodstuffs,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46973,.,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
47226,Heavy,O,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47227,consumption,O,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47228,of,O,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47229,black,B-http://purl.obolibrary.org/obo/NCBITaxon_4442;http://purl.obolibrary.org/obo/FOODON_03304640;http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/FOODON_03315081,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47230,tea,I-http://purl.obolibrary.org/obo/NCBITaxon_4442;http://purl.obolibrary.org/obo/FOODON_03304640;http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/FOODON_03315081,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47231,thus,O,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47232,appears,O,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47233,to,O,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47234,elevate,O,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47235,circulating,O,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47236,antioxidant,O,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47237,potentials,O,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47238,in,O,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47239,vivo,O,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47240,.,O,1634.0,Heavy consumption of black tea thus appears to elevate circulating antioxidant potentials in vivo .
47708,The,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47709,',O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47710,high,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47711,-,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47712,fat,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47713,/,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47714,low,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47715,-,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47716,fibre,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47717,',O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47718,dietary,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47719,pattern,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47720,was,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47721,associated,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47722,with,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47723,an,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47724,increased,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47725,risk,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47726,of,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47727,all,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47728,-,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47729,cause,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47730,mortality,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47731,only,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47732,",",O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47733,after,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47734,adjustment,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47735,for,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47736,confounders,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47737,(,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47738,highest,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47739,v.,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47740,lowest,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47741,quartile,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47742,;,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47743,hazard,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47744,ratio,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47745,1·44,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47746,;,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47747,95,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47748,%,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47749,CI,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47750,1·13,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47751,",",O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47752,1·84,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47753,),O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47754,.,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
48348,Our,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48349,findings,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48350,suggest,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48351,that,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48352,more,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48353,than,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48354,one,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48355,-,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48356,third,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48357,of,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48358,the,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48359,high,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48360,incidence,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48361,of,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48362,oesophageal,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48363,cancer,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48364,in,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48365,northwest,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48366,France,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48367,could,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48368,be,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48369,explained,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48370,by,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48371,the,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48372,local,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48373,excess,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48374,in,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48375,butter,B-http://purl.obolibrary.org/obo/FOODON_03310351,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48376,consumption,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48377,",",O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48378,whereas,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48379,geographical,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48380,variations,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48381,in,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48382,consumption,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48383,of,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48384,dietary,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48385,protective,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48386,factors,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48387,could,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48388,explain,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48389,no,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48390,more,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48391,than,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48392,10,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48393,%,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48394,of,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48395,it,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48396,.,O,1672.0,"Our findings suggest that more than one - third of the high incidence of oesophageal cancer in northwest France could be explained by the local excess in butter consumption , whereas geographical variations in consumption of dietary protective factors could explain no more than 10 % of it ."
48459,There,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48460,is,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48461,a,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48462,lack,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48463,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48464,information,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48465,on,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48466,sodium,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48467,reduction,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48468,in,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48469,potato,B-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48470,chips,I-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48471,and,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48472,puffed,B-http://purl.obolibrary.org/obo/FOODON_00002656;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48473,rice,I-http://purl.obolibrary.org/obo/FOODON_00002656;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48474,",",O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48475,which,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48476,comprise,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48477,a,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48478,large,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48479,percentage,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48480,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48481,salty,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48482,snack,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48483,sales,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48484,",",O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48485,and,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48486,the,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48487,use,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48488,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48489,flavor,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48490,enhancers,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48491,to,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48492,maintain,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48493,consumer,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48494,acceptability,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48495,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48496,these,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48497,products,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48498,.,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48760,Previous,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48761,reports,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48762,have,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48763,documented,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48764,the,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48765,fact,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48766,that,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48767,plasma,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48768,glucose,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48769,and,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48770,insulin,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48771,responses,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48772,can,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48773,vary,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48774,in,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48775,response,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48776,to,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48777,the,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48778,ingestion,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48779,of,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48780,different,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48781,carbohydrate,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48782,-,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48783,rich,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48784,foods,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48785,.,O,1685.0,Previous reports have documented the fact that plasma glucose and insulin responses can vary in response to the ingestion of different carbohydrate - rich foods .
48959,The,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48960,plasma,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48961,insulin,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48962,responses,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48963,to,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48964,the,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48965,four,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48966,carbohydrate,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48967,foods,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48968,paralleled,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48969,the,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48970,glucose,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48971,responses,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48972,.,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48973,Changes,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48974,in,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48975,gastric,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48976,inhibitory,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48977,polypeptide,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48978,levels,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48979,did,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48980,not,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48981,account,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48982,for,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48983,the,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48984,effect,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48985,of,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48986,potato,B-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
48987,.,O,1692.0,Changes in gastric inhibitory polypeptide levels did not account for the effect of potato .
49364,The,O,1703.0,The automatic milking system allowed us to precisely determine the daily qMY .
49365,automatic,O,1703.0,The automatic milking system allowed us to precisely determine the daily qMY .
49366,milking,O,1703.0,The automatic milking system allowed us to precisely determine the daily qMY .
49367,system,O,1703.0,The automatic milking system allowed us to precisely determine the daily qMY .
49368,allowed,O,1703.0,The automatic milking system allowed us to precisely determine the daily qMY .
49369,us,O,1703.0,The automatic milking system allowed us to precisely determine the daily qMY .
49370,to,O,1703.0,The automatic milking system allowed us to precisely determine the daily qMY .
49371,precisely,O,1703.0,The automatic milking system allowed us to precisely determine the daily qMY .
49372,determine,O,1703.0,The automatic milking system allowed us to precisely determine the daily qMY .
49373,the,O,1703.0,The automatic milking system allowed us to precisely determine the daily qMY .
49374,daily,O,1703.0,The automatic milking system allowed us to precisely determine the daily qMY .
49375,qMY,O,1703.0,The automatic milking system allowed us to precisely determine the daily qMY .
49376,.,O,1703.0,The automatic milking system allowed us to precisely determine the daily qMY .
49377,A,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49378,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49379,sample,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49380,from,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49381,each,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49382,quarter,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49383,was,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49384,collected,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49385,in,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49386,early,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49387,lactation,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49388,(,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49389,between,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49390,1,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49391,and,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49392,4,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49393,d,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49394,in,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49395,milk,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49396,),O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49397,for,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49398,bacteriological,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49399,culturing,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49400,and,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49401,measurement,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49402,of,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49403,the,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49404,qSCC,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49405,.,O,1704.0,A milk sample from each quarter was collected in early lactation ( between 1 and 4 d in milk ) for bacteriological culturing and measurement of the qSCC .
49565,The,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49566,main,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49567,operators,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49568,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49569,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49570,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49571,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49572,sector,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49573,are,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49574,continuously,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49575,involved,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49576,in,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49577,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49578,development,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49579,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49580,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49581,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49582,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49583,mechanical,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49584,extraction,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49585,process,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49586,with,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49587,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49588,common,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49589,aim,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49590,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49591,increasing,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49592,both,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49593,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49594,quality,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49595,and,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49596,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49597,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49598,extraction,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49599,yield,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49600,coupled,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49601,with,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49602,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49603,potential,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49604,enhancement,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49605,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49606,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49607,working,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49608,efficiency,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49609,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49610,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49611,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49612,mill,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49613,.,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49711,The,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49712,PEF,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49713,was,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49714,tested,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49715,on,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49716,three,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49717,Italian,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49718,olive,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49719,cultivars,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49720,(,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49721,Carolea,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49722,",",O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49723,Coratina,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49724,",",O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49725,and,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49726,Ottobratica,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49727,),O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49728,.,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49882,The,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49883,objective,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49884,of,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49885,this,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49886,study,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49887,was,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49888,to,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49889,evaluate,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49890,the,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49891,effects,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49892,of,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49893,fat,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/FOODON_00003206;http://purl.obolibrary.org/obo/NCBITaxon_3818;http://purl.obolibrary.org/obo/FOODON_03301116,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49894,free,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/FOODON_00003206;http://purl.obolibrary.org/obo/NCBITaxon_3818;http://purl.obolibrary.org/obo/FOODON_03301116,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49895,peanut,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/FOODON_00003206;http://purl.obolibrary.org/obo/NCBITaxon_3818;http://purl.obolibrary.org/obo/FOODON_03301116,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49896,flour,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/FOODON_00003206;http://purl.obolibrary.org/obo/NCBITaxon_3818;http://purl.obolibrary.org/obo/FOODON_03301116,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49897,(,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49898,FFPF,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49899,),O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49900,",",O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49901,peanuts,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49902,",",O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49903,and,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49904,peanut,B-http://purl.obolibrary.org/obo/FOODON_03309857;http://purl.obolibrary.org/obo/FOODON_00003206;http://purl.obolibrary.org/obo/NCBITaxon_3818;http://purl.obolibrary.org/obo/FOODON_03310387,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49905,oil,I-http://purl.obolibrary.org/obo/FOODON_03309857;http://purl.obolibrary.org/obo/FOODON_00003206;http://purl.obolibrary.org/obo/NCBITaxon_3818;http://purl.obolibrary.org/obo/FOODON_03310387,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49906,on,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49907,cardiovascular,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49908,disease,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49909,(,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49910,CVD,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49911,),O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49912,risk,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49913,factors,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49914,and,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49915,the,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49916,development,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49917,of,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49918,atherosclerosis,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49919,in,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49920,male,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49921,Syrian,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49922,golden,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49923,hamsters,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49924,.,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
50502,The,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50503,analysis,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50504,demonstrated,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50505,that,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50506,PS,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50507,significantly,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50508,increased,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50509,for,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50510,five,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50511,foods,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50512,(,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50513,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50514,white,B-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323;http://purl.obolibrary.org/obo/FOODON_03430137,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50515,sliced,I-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323;http://purl.obolibrary.org/obo/FOODON_03430137,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50516,bread,I-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323;http://purl.obolibrary.org/obo/FOODON_03430137,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50517,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50518,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50519,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50520,brown,B-http://purl.obolibrary.org/obo/PATO_0000952,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50521,/,I-http://purl.obolibrary.org/obo/PATO_0000952,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50522,wholemeal,I-http://purl.obolibrary.org/obo/PATO_0000952,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50523,breads,I-http://purl.obolibrary.org/obo/PATO_0000952,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50524,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50525,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50526,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50527,all,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50528,meat,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50529,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50530,cooked,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50531,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50532,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50533,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50534,poultry,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50535,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50536,roasted,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50537,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50538,and,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50539,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50540,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50541,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50542,),O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50543,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50544,significantly,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50545,decreased,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50546,for,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50547,three,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50548,(,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50549,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50550,potatoes,B-http://purl.obolibrary.org/obo/NCBITaxon_4113,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50551,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50552,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50553,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50554,chips,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50555,/,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50556,wedges,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50557,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50558,and,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50559,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50560,ham,B-http://purl.obolibrary.org/obo/FOODON_00002502,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50561,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50562,sliced,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50563,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50564,),O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50565,and,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50566,did,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50567,not,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50568,significantly,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50569,change,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50570,for,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50571,five,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50572,foods,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50573,(,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50574,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50575,processed,B-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50576,potato,I-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50577,products,I-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50578,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50579,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50580,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50581,bacon,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50582,/,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50583,ham,B-http://purl.obolibrary.org/obo/FOODON_00002502,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50584,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50585,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50586,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50587,cheese,B-http://purl.obolibrary.org/obo/FOODON_00001013,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50588,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50589,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50590,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50591,yogurt,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50592,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50593,and,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50594,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50595,butter,B-http://purl.obolibrary.org/obo/FOODON_03310351,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50596,/,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50597,spreads,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50598,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50599,),O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50600,between,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50601,the,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50602,NSIFCS,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50603,and,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50604,the,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50605,NANS,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50606,.,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
51353,L.,O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51354,),O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51355,",",O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51356,rye,B-http://purl.obolibrary.org/obo/FOODON_00003734;http://purl.obolibrary.org/obo/NCBITaxon_4550,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51357,(,I-http://purl.obolibrary.org/obo/FOODON_00003734;http://purl.obolibrary.org/obo/NCBITaxon_4550,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51358,Secale,I-http://purl.obolibrary.org/obo/FOODON_00003734;http://purl.obolibrary.org/obo/NCBITaxon_4550,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51359,cereal,I-http://purl.obolibrary.org/obo/FOODON_00003734;http://purl.obolibrary.org/obo/NCBITaxon_4550,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51360,L.,I-http://purl.obolibrary.org/obo/FOODON_00003734;http://purl.obolibrary.org/obo/NCBITaxon_4550,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51361,),O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51362,",",O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51363,and,O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51364,barley,B-http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/FOODON_00003108,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51365,(,I-http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/FOODON_00003108,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51366,Hordeum,I-http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/FOODON_00003108,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51367,vulgare,I-http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/FOODON_00003108,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51368,L.,O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51369,),O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51370,seeds,O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51371,contain,O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51372,peptides,O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51373,toxic,O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51374,to,O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51375,celiac,O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51376,patients,O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51377,.,O,1763.0,"L. ) , rye ( Secale cereal L. ) , and barley ( Hordeum vulgare L. ) seeds contain peptides toxic to celiac patients ."
51465,In,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51466,silico,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51467,analysis,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51468,of,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51469,the,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51470,recently,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51471,published,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51472,sorghum,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51473,genome,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51474,predicts,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51475,that,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51476,sorghum,B-http://purl.obolibrary.org/obo/FOODON_03309978;http://purl.obolibrary.org/obo/NCBITaxon_4557,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51477,does,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51478,not,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51479,contain,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51480,peptides,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51481,that,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51482,are,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51483,toxic,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51484,for,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51485,celiac,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51486,patients,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51487,.,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51763,After,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51764,42,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51765,d,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51766,total,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51767,cholesterol,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51768,and,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51769,HDL,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51770,-,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51771,cholesterol,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51772,levels,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51773,were,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51774,raised,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51775,significantly,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51776,in,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51777,all,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51778,groups,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51779,",",O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51780,but,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51781,to,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51782,different,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51783,extents,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51784,.,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
52221,The,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52222,30,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52223,papers,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52224,examine,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52225,populations,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52226,in,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52227,12,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52228,countries,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52229,and,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52230,provide,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52231,data,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52232,on,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52233,consumption,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52234,of,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52235,both,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52236,black,B-http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52237,and,I-http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52238,green,I-http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52239,tea,I-http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52240,.,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52533,A,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52534,Mediterranean,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52535,diet,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52536,score,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52537,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52538,including,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52539,foods,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52540,considered,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52541,to,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52542,be,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52543,characteristic,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52544,components,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52545,of,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52546,the,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52547,traditional,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52548,Mediterranean,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52549,diet,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52550,(,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52551,vegetables,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52552,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52553,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52554,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52555,pulses,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52556,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52557,nuts,B-http://purl.obolibrary.org/obo/FOODON_03306632,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52558,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52559,fish,B-http://purl.obolibrary.org/obo/NCBITaxon_7898;http://purl.obolibrary.org/obo/FOODON_03411222;http://purl.obolibrary.org/obo/NCBITaxon_7777,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52560,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52561,meat,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52562,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52563,cereals,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52564,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52565,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52566,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52567,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52568,and,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52569,wine,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52570,),O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52571,was,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52572,created,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52573,.,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52574,An,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52575,increase,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52576,of,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52577,5,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52578,U,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52579,in,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52580,the,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52581,dietary,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52582,score,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52583,was,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52584,associated,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52585,with,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52586,a,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52587,change,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52588,in,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52589,the,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52590,BMI,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52591,of,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52592,0.43,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52593,(,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52594,P,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52595,=,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52596,0.030,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52597,),O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52598,and,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52599,0.68,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52600,(,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52601,P,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52602,=,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52603,0.007,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52604,),O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52605,",",O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52606,after,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52607,controlling,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52608,for,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52609,potential,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52610,confounders,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52611,",",O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52612,in,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52613,men,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52614,and,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52615,women,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52616,",",O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52617,respectively,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52618,.,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52863,Spice,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52864,extracts,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52865,exhibited,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52866,high,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52867,antioxidant,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52868,capacity,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52869,that,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52870,correlated,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52871,with,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52872,the,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52873,total,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52874,amount,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52875,of,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52876,major,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52877,chemicals,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52878,.,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52910,Cinnamon,B-http://purl.obolibrary.org/obo/FOODON_03301175;http://purl.obolibrary.org/obo/NCBITaxon_128608,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52911,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52912,oregano,B-http://purl.obolibrary.org/obo/FOODON_03301482;http://purl.obolibrary.org/obo/NCBITaxon_39352,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52913,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52914,and,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52915,rosemary,B-http://purl.obolibrary.org/obo/NCBITaxon_39367;http://purl.obolibrary.org/obo/FOODON_00002212,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52916,were,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52917,active,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52918,against,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52919,selected,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52920,Fusobacterium,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52921,strains,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52922,and,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52923,cinnamon,B-http://purl.obolibrary.org/obo/FOODON_03301175;http://purl.obolibrary.org/obo/NCBITaxon_128608,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52924,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52925,rosemary,B-http://purl.obolibrary.org/obo/NCBITaxon_39367;http://purl.obolibrary.org/obo/FOODON_00002212,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52926,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52927,and,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52928,turmeric,B-http://purl.obolibrary.org/obo/NCBITaxon_136217;http://purl.obolibrary.org/obo/FOODON_00003753,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52929,were,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52930,active,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52931,against,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52932,selected,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52933,Clostridium,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52934,spp,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52935,.,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52936,Some,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52937,spices,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52938,displayed,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52939,prebiotic,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52940,-,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52941,like,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52942,activity,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52943,by,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52944,promoting,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52945,the,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52946,growth,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52947,of,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52948,beneficial,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52949,bacteria,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52950,and,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52951,suppressing,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52952,the,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52953,growth,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52954,of,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52955,pathogenic,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52956,bacteria,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52957,",",O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52958,suggesting,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52959,their,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52960,potential,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52961,role,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52962,in,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52963,the,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52964,regulation,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52965,of,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52966,intestinal,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52967,microbiota,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52968,and,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52969,the,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52970,enhancement,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52971,of,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52972,gastrointestinal,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52973,health,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52974,.,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52975,The,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52976,identification,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52977,and,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52978,quantification,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52979,of,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52980,spice,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52981,-,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52982,specific,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52983,phytochemicals,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52984,provided,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52985,insight,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52986,into,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52987,the,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52988,potential,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52989,influence,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52990,of,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52991,these,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52992,chemicals,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52993,on,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52994,the,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52995,gut,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52996,microbial,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52997,communities,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52998,and,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52999,activities,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
53000,.,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
53282,In,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53283,conclusion,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53284,",",O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53285,the,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53286,protein,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53287,",",O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53288,fat,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53289,and,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53290,salad,B-http://purl.obolibrary.org/obo/FOODON_03316042,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53291,contents,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53292,of,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53293,a,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53294,meal,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53295,exert,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53296,considerable,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53297,influence,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53298,on,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53299,the,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53300,glycaemic,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53301,and,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53302,insulinaemic,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53303,responses,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53304,to,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53305,mashed,B-http://purl.obolibrary.org/obo/NCBITaxon_4113,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53306,potatoes,I-http://purl.obolibrary.org/obo/NCBITaxon_4113,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53307,.,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53511,Patients,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53512,with,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53513,more,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53514,aggressive,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53515,disease,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53516,presented,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53517,a,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53518,lower,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53519,adherence,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53520,to,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53521,MD,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53522,according,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53523,to,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53524,PREDIMED,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53525,categories,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53526,in,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53527,comparison,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53528,to,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53529,G1,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53530,",",O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53531,localized,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53532,and,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53533,free,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53534,/,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53535,stable,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53536,disease,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53537,status,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53538,.,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53591,Moreover,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53592,",",O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53593,higher,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53594,intakes,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53595,of,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53596,food,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53597,of,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53598,MD,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53599,",",O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53600,may,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53601,represent,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53602,a,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53603,potential,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53604,tool,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53605,for,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53606,prevention,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53607,of,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53608,tumor,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53609,aggressiveness,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53610,.,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53788,Based,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53789,on,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53790,available,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53791,evidence,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53792,",",O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53793,a,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53794,well,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53795,-,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53796,formulated,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53797,ketogenic,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53798,diet,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53799,does,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53800,not,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53801,appear,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53802,to,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53803,have,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53804,major,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53805,safety,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53806,concerns,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53807,for,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53808,the,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53809,general,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53810,public,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53811,and,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53812,can,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53813,be,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53814,considered,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53815,a,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53816,first,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53817,-,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53818,line,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53819,approach,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53820,for,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53821,obesity,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53822,and,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53823,diabetes,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53824,.,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
54097,During,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54098,the,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54099,observation,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54100,period,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54101,",",O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54102,63,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54103,men,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54104,and,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54105,25,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54106,women,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54107,died,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54108,of,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54109,urothelial,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54110,cancer,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54111,.,O,1866.0,"During the observation period , 63 men and 25 women died of urothelial cancer ."
54531,The,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54532,relation,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54533,between,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54534,vegetable,B-http://purl.obolibrary.org/obo/FOODON_00003816;http://purl.obolibrary.org/obo/PO_0009001,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54535,and,I-http://purl.obolibrary.org/obo/FOODON_00003816;http://purl.obolibrary.org/obo/PO_0009001,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54536,fruit,I-http://purl.obolibrary.org/obo/FOODON_00003816;http://purl.obolibrary.org/obo/PO_0009001,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54537,consumption,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54538,and,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54539,colorectal,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54540,cancer,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54541,risk,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54542,was,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54543,comprehensively,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54544,assessed,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54545,in,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54546,the,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54547,Netherlands,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54548,Cohort,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54549,Study,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54550,on,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54551,Diet,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54552,and,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54553,Cancer,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54554,using,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54555,a,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54556,validated,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54557,150,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54558,-,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54559,item,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54560,food,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54561,frequency,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54562,questionnaire,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54563,.,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
55229,Preliminary,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55230,clinical,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55231,trials,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55232,provided,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55233,evidence,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55234,that,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55235,resveratrol,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55236,had,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55237,anti,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55238,-,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55239,diabetic,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55240,activity,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55241,in,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55242,humans,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55243,by,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55244,improving,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55245,glycemic,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55246,control,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55247,in,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55248,subjects,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55249,with,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55250,insulin,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55251,resistance,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55252,.,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55253,Besides,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55254,",",O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55255,anthocyanins,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55256,exhibited,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55257,anti,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55258,-,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55259,diabetic,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55260,properties,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55261,by,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55262,reducing,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55263,blood,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55264,glucose,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55265,and,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55266,HbA1c,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55267,levels,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55268,or,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55269,the,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55270,improvement,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55271,of,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55272,insulin,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55273,secretion,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55274,and,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55275,resistance,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55276,.,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55354,Polyunsaturated,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55355,margarine,B-http://purl.obolibrary.org/obo/FOODON_03301672,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55356,and,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55357,low,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/FOODON_00001873,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55358,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/FOODON_00001873,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55359,spread,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/FOODON_00001873,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55360,were,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55361,chosen,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55362,significantly,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55363,more,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55364,frequently,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55365,by,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55366,those,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55367,in,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55368,the,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55369,higher,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55370,socio,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55371,-,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55372,economic,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55373,groups,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55374,and,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55375,by,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55376,non,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55377,-,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55378,smokers,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55379,in,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55380,each,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55381,group,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55382,.,O,1914.0,Polyunsaturated margarine and low fat spread were chosen significantly more frequently by those in the higher socio - economic groups and by non - smokers in each group .
55541,These,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55542,findings,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55543,suggest,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55544,that,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55545,current,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55546,recommendations,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55547,to,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55548,reduce,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55549,total,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55550,fat,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55551,intake,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55552,and,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55553,to,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55554,reduce,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55555,the,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55556,proportion,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55557,of,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55558,saturated,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55559,fats,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55560,used,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55561,are,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55562,not,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55563,being,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55564,followed,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55565,",",O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55566,at,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55567,least,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55568,in,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55569,respect,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55570,of,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55571,spread,B-http://purl.obolibrary.org/obo/FOODON_00001873,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55572,",",O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55573,by,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55574,those,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55575,at,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55576,greatest,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55577,risk,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55578,of,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55579,coronary,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55580,heart,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55581,disease,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55582,.,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55801,Additionally,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55802,",",O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55803,the,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55804,translocation,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55805,of,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55806,horseradish,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55807,peroxidase,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55808,in,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55809,isolated,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55810,segments,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55811,of,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55812,ileum,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55813,and,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55814,colon,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55815,tended,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55816,to,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55817,be,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55818,lower,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55819,in,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55820,mice,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55821,fed,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55822,Yukihikari,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55823,",",O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55824,suggesting,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55825,a,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55826,reduction,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55827,in,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55828,gut,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55829,permeability,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55830,in,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55831,mice,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55832,fed,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55833,Yukihikari,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55834,.,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
56405,This,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56406,study,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56407,investigated,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56408,the,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56409,application,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56410,of,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56411,oxidized,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56412,starch,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56413,in,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56414,bake,B-http://purl.obolibrary.org/obo/NCBITaxon_9031;http://purl.obolibrary.org/obo/FOODON_03411457,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56415,-,I-http://purl.obolibrary.org/obo/NCBITaxon_9031;http://purl.obolibrary.org/obo/FOODON_03411457,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56416,only,I-http://purl.obolibrary.org/obo/NCBITaxon_9031;http://purl.obolibrary.org/obo/FOODON_03411457,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56417,chicken,I-http://purl.obolibrary.org/obo/NCBITaxon_9031;http://purl.obolibrary.org/obo/FOODON_03411457,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56418,nuggets,I-http://purl.obolibrary.org/obo/NCBITaxon_9031;http://purl.obolibrary.org/obo/FOODON_03411457,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56419,.,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56602,Potatoes,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56603,(,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56604,Solanum,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56605,tuberosum,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56606,),O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56607,are,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56608,an,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56609,important,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56610,global,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56611,crop,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56612,that,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56613,can,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56614,be,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56615,transformed,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56616,into,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56617,many,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56618,products,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56619,impacting,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56620,several,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56621,health,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56622,dimensions,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56623,ranging,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56624,from,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56625,undernutrition,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56626,",",O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56627,food,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56628,security,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56629,and,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56630,disease,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56631,prevention,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56632,to,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56633,issues,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56634,of,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56635,overnutrition,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56636,including,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56637,obesity,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56638,",",O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56639,diabetes,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56640,",",O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56641,heart,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56642,disease,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56643,.,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56755,This,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56756,review,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56757,summarizes,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56758,critical,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56759,information,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56760,on,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56761,nutritional,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56762,profiles,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56763,of,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56764,potatoes,B-http://purl.obolibrary.org/obo/NCBITaxon_4113,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56765,and,I-http://purl.obolibrary.org/obo/NCBITaxon_4113,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56766,their,I-http://purl.obolibrary.org/obo/NCBITaxon_4113,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56767,processed,I-http://purl.obolibrary.org/obo/NCBITaxon_4113,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56768,products,I-http://purl.obolibrary.org/obo/NCBITaxon_4113,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56769,and,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56770,describes,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56771,the,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56772,state,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56773,of,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56774,the,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56775,science,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56776,relative,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56777,to,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56778,the,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56779,influence,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56780,of,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56781,in,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56782,-,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56783,home,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56784,and,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56785,common,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56786,commercial,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56787,processing,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56788,on,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56789,nutritional,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56790,quality,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56791,and,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56792,potential,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56793,impacts,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56794,on,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56795,human,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56796,health,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56797,.,O,1959.0,This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in - home and common commercial processing on nutritional quality and potential impacts on human health .
56916,In,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56917,view,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56918,of,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56919,the,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56920,available,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56921,evidence,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56922,",",O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56923,it,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56924,has,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56925,become,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56926,acceptable,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56927,to,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56928,emphasize,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56929,the,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56930,role,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56931,of,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56932,optimum,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56933,nutrition,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56934,to,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56935,maintain,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56936,arterial,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56937,and,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56938,CV,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56939,health,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56940,.,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
57732,This,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57733,study,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57734,compared,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57735,the,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57736,plasma,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57737,glucose,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57738,(,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57739,PG,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57740,),O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57741,",",O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57742,serum,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57743,insulin,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57744,(,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57745,SI,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57746,),O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57747,",",O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57748,and,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57749,C,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57750,-,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57751,peptide,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57752,(,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57753,CP,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57754,),O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57755,responses,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57756,to,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57757,three,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57758,different,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57759,isocaloric,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57760,test,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57761,breakfasts,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57762,given,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57763,in,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57764,random,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57765,order,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57766,to,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57767,eight,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57768,insulin,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57769,-,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57770,treated,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57771,non,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57772,-,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57773,insulin,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57774,-,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57775,dependent,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57776,diabetes,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57777,mellitus,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57778,(,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57779,NIDDM,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57780,),O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57781,patients,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
57782,.,O,1998.0,"This study compared the plasma glucose ( PG ) , serum insulin ( SI ) , and C - peptide ( CP ) responses to three different isocaloric test breakfasts given in random order to eight insulin - treated non - insulin - dependent diabetes mellitus ( NIDDM ) patients ."
58053,Rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58054,is,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58055,rarely,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58056,eaten,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58057,alone,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58058,such,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58059,that,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58060,it,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58061,is,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58062,of,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58063,interest,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58064,to,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58065,investigate,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58066,the,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58067,effects,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58068,of,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58069,co,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58070,-,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58071,ingesting,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58072,different,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58073,protein,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58074,-,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58075,rich,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58076,meals,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58077,with,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58078,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58079,on,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58080,insulin,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58081,and,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58082,glycaemic,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58083,response,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58084,.,O,2002.0,Rice is rarely eaten alone such that it is of interest to investigate the effects of co - ingesting different protein - rich meals with rice on insulin and glycaemic response .
58166,The,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58167,control,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58168,meal,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58169,consisted,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58170,of,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58171,50,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58172,g,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58173,of,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58174,available,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58175,carbohydrate,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58176,",",O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58177,whereas,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58178,all,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58179,other,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58180,test,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58181,meals,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58182,contained,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58183,additional,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58184,25,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58185,g,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58186,of,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58187,protein,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58188,.,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58273,Therefore,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58274,",",O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58275,the,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58276,ingestion,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58277,of,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58278,soya,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58279,beancurd,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58280,with,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58281,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58282,may,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58283,have,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58284,a,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58285,direct,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58286,impact,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58287,on,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58288,reducing,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58289,the,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58290,risk,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58291,in,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58292,Asians,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58293,transiting,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58294,from,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58295,being,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58296,pre,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58297,-,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58298,diabetics,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58299,to,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58300,diabetics,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58301,.,O,2010.0,"Therefore , the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre - diabetics to diabetics ."
58356,We,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58357,aimed,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58358,to,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58359,estimate,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58360,the,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58361,associations,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58362,between,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58363,consumption,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58364,of,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58365,UPF,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58366,(,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58367,total,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58368,",",O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58369,liquid,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58370,and,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58371,solid,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58372,),O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58373,and,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58374,UPF,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58375,subgroups,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58376,and,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58377,incident,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58378,hypertension,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58379,in,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58380,a,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58381,prospective,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58382,cohort,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58383,study,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58384,.,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58491,Mean,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58492,contribution,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58493,of,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58494,UPF,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58495,to,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58496,total,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58497,energy,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58498,intake,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58499,was,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58500,29·8,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58501,(,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58502,SD,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58503,9·4,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58504,),O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58505,%,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58506,energy,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58507,(,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58508,23·4,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58509,(,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58510,SD,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58511,8·9,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58512,),O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58513,%,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58514,solid,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58515,",",O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58516,6·4,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58517,(,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58518,SD,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58519,4·8,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58520,),O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58521,%,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58522,liquid,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58523,),O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58524,.,O,2020.0,"Mean contribution of UPF to total energy intake was 29·8 ( SD 9·4 ) % energy ( 23·4 ( SD 8·9 ) % solid , 6·4 ( SD 4·8 ) % liquid ) ."
58794,Whether,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58795,these,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58796,milk,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58797,bioactive,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58798,components,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58799,will,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58800,replace,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58801,drugs,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58802,entirely,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58803,in,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58804,the,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58805,immediate,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58806,future,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58807,is,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58808,still,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58809,unclear,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58810,",",O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58811,but,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58812,the,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58813,increasing,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58814,appreciation,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58815,of,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58816,"""",O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58817,drug,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58818,foods,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58819,"""",O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58820,or,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58821,nutraceuticals,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58822,plays,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58823,a,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58824,complementary,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58825,rather,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58826,than,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58827,a,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58828,substitutional,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58829,role,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58830,to,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58831,the,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58832,synthetic,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58833,pharmacological,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58834,drugs,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58835,.,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58971,This,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58972,table,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58973,was,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58974,linked,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58975,to,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58976,dietary,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58977,data,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58978,from,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58979,2106,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58980,adults,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58981,in,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58982,the,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58983,Dutch,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58984,National,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58985,Food,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58986,Consumption,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58987,Survey,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58988,2007,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58989,-,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58990,2010,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
58991,.,O,2039.0,This table was linked to dietary data from 2106 adults in the Dutch National Food Consumption Survey 2007 - 2010 .
59405,The,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59406,olive,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59407,tree,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59408,(,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59409,Olea,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59410,europaea,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59411,),O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59412,is,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59413,widely,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59414,cultivated,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59415,for,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59416,the,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59417,production,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59418,of,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59419,both,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59420,oil,B-http://purl.obolibrary.org/obo/FOODON_03310387,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59421,and,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59422,table,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59423,olives,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59424,and,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59425,very,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59426,significant,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59427,because,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59428,of,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59429,its,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59430,economic,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59431,value,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59432,.,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59486,Olive,B-http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59487,and,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59488,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59489,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59490,may,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59491,have,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59492,a,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59493,role,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59494,in,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59495,the,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59496,prevention,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59497,of,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59498,coronary,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59499,heart,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59500,disease,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59501,and,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59502,certain,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59503,cancers,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59504,because,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59505,of,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59506,their,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59507,high,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59508,levels,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59509,of,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59510,monosaturated,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59511,fatty,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59512,acids,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59513,and,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59514,phenolic,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59515,compounds,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59516,.,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59903,The,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
59904,J,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
59905,-,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
59906,shaped,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
59907,alcohol,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
59908,-,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
59909,mortality,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
59910,relation,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
59911,was,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
59912,stable,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
59913,for,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
59914,20,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
59915,years,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
59916,.,O,2073.0,The J - shaped alcohol - mortality relation was stable for 20 years .
60269,Information,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60270,on,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60271,demographic,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60272,and,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60273,lifestyle,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60274,factors,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60275,was,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60276,collected,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60277,using,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60278,mailed,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60279,questionnaires,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60280,between,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60281,2002,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60282,and,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60283,2003,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60284,.,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60349,Hazard,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60350,ratio,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60351,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60352,HR,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60353,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60354,estimates,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60355,for,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60356,consuming,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60357,<,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60358,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60359,drink,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60360,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60361,week,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60362,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60363,>,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60364,or,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60365,=,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60366,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60367,drink,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60368,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60369,week,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60370,but,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60371,<,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60372,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60373,drink,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60374,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60375,day,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60376,and,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60377,>,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60378,or,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60379,=,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60380,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60381,drink,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60382,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60383,day,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60384,were,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60385,0.89,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60386,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60387,95,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60388,%,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60389,confidence,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60390,interval,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60391,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60392,0.74,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60393,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60394,1.07,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60395,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60396,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60397,0.99,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60398,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60399,0.83,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60400,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60401,1.17,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60402,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60403,and,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60404,0.88,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60405,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60406,0.70,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60407,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60408,1.12,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60409,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60410,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60411,respectively,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60412,.,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60739,Silymarin,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60740,",",O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60741,a,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60742,natural,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60743,acknowledged,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60744,hepatoprotector,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60745,used,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60746,in,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60747,humans,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60748,to,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60749,treat,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60750,liver,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60751,diseases,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60752,",",O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60753,has,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60754,been,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60755,tested,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60756,in,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60757,dairy,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60758,cows,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60759,during,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60760,peripartum,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60761,",",O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60762,a,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60763,period,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60764,during,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60765,which,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60766,animals,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60767,are,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60768,subject,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60769,to,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60770,subclinical,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60771,fatty,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60772,liver,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60773,.,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60961,Glucose,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60962,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60963,urea,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60964,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60965,triglycerides,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60966,(,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60967,TG,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60968,),O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60969,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60970,total,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60971,cholesterol,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60972,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60973,beta,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60974,-,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60975,hydroxibutyrate,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60976,(,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60977,BHBA,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60978,),O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60979,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60980,and,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60981,gamma,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60982,-,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60983,glutamyl,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60984,transferase,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60985,(,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60986,GGT,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60987,),O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60988,in,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60989,plasma,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60990,were,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60991,unaffected,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60992,by,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60993,treatment,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60994,.,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
61023,From,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61024,this,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61025,evidence,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61026,",",O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61027,it,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61028,is,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61029,possible,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61030,to,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61031,conclude,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61032,that,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61033,silymarin,B-http://purl.obolibrary.org/obo/CHEBI_125451,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61034,beneficially,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61035,affected,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61036,lactation,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61037,performances,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61038,and,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61039,body,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61040,condition,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61041,of,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61042,treated,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61043,animals,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61044,.,O,2117.0,"From this evidence , it is possible to conclude that silymarin beneficially affected lactation performances and body condition of treated animals ."
61078,Cocoa,B-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61079,has,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61080,been,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61081,shown,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61082,to,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61083,exert,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61084,anti,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61085,-,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61086,diabetic,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61087,effects,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61088,by,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61089,lowering,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61090,glucose,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61091,levels,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61092,.,O,2120.0,Cocoa has been shown to exert anti - diabetic effects by lowering glucose levels .
61992,This,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61993,review,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61994,summarizes,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61995,the,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61996,potential,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61997,role,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61998,of,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61999,dietary,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62000,natural,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62001,products,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62002,and,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62003,their,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62004,major,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62005,bioactive,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62006,components,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62007,in,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62008,prevention,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62009,and,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62010,treatment,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62011,of,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62012,breast,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62013,cancer,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62014,",",O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62015,and,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62016,special,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62017,attention,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62018,was,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62019,paid,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62020,to,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62021,the,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62022,mechanisms,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62023,of,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62024,action,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62025,.,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62197,No,O,2157.0,No associations with risk of rectal cancer were observed .
62198,associations,O,2157.0,No associations with risk of rectal cancer were observed .
62199,with,O,2157.0,No associations with risk of rectal cancer were observed .
62200,risk,O,2157.0,No associations with risk of rectal cancer were observed .
62201,of,O,2157.0,No associations with risk of rectal cancer were observed .
62202,rectal,O,2157.0,No associations with risk of rectal cancer were observed .
62203,cancer,O,2157.0,No associations with risk of rectal cancer were observed .
62204,were,O,2157.0,No associations with risk of rectal cancer were observed .
62205,observed,O,2157.0,No associations with risk of rectal cancer were observed .
62206,.,O,2157.0,No associations with risk of rectal cancer were observed .
62500,This,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62501,was,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62502,confirmed,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62503,by,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62504,bronchial,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62505,challenge,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62506,testing,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62507,",",O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62508,but,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62509,the,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62510,comparison,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62511,was,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62512,not,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62513,obviously,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62514,consistent,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62515,with,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62516,the,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62517,results,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62518,of,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62519,prick,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62520,testing,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62521,or,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62522,estimation,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62523,of,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62524,histamine,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62525,released,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62526,from,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62527,his,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62528,leucocytes,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62529,.,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62780,When,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62781,extracts,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62782,from,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62783,nonthermally,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62784,and,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62785,thermally,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62786,processed,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62787,celeriac,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62788,were,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62789,subjected,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62790,to,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62791,an,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62792,RBL,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62793,-,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62794,cell,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62795,mediator,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62796,release,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62797,assay,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62798,with,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62799,these,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62800,sera,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62801,",",O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62802,an,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62803,inverse,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62804,ranking,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62805,was,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62806,obtained,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62807,with,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62808,anti,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62809,-,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62810,heated,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62811,celeriac,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62812,IgE,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62813,and,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62814,anti,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62815,-,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62816,native,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62817,celeriac,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62818,IgE,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62819,",",O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62820,respectively,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62821,.,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
63171,Although,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63172,associations,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63173,between,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63174,fruit,B-http://purl.obolibrary.org/obo/PO_0009001;http://purl.obolibrary.org/obo/FOODON_00003816,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63175,and,I-http://purl.obolibrary.org/obo/PO_0009001;http://purl.obolibrary.org/obo/FOODON_00003816,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63176,vegetable,I-http://purl.obolibrary.org/obo/PO_0009001;http://purl.obolibrary.org/obo/FOODON_00003816,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63177,intake,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63178,and,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63179,both,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63180,ESCC,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63181,and,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63182,EAC,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63183,have,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63184,been,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63185,found,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63186,in,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63187,multiple,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63188,ecological,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63189,and,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63190,case,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63191,-,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63192,control,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63193,studies,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63194,",",O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63195,few,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63196,prospective,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63197,studies,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63198,have,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63199,investigated,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63200,these,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63201,associations,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63202,.,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63482,Instant,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63483,rice,I-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63484,is,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63485,increasing,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63486,in,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63487,popularity,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63488,and,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63489,is,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63490,produced,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63491,by,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63492,dehydrating,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63493,whole,B-http://purl.obolibrary.org/obo/FOODON_00003950;http://purl.obolibrary.org/obo/FOODON_00001181;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63494,grain,I-http://purl.obolibrary.org/obo/FOODON_00003950;http://purl.obolibrary.org/obo/FOODON_00001181;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63495,cooked,I-http://purl.obolibrary.org/obo/FOODON_00003950;http://purl.obolibrary.org/obo/FOODON_00001181;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63496,rice,I-http://purl.obolibrary.org/obo/FOODON_00003950;http://purl.obolibrary.org/obo/FOODON_00001181;http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63497,",",O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63498,therefore,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63499,",",O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63500,to,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63501,make,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63502,it,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63503,more,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63504,suitable,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63505,for,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63506,diabetics,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63507,",",O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63508,the,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63509,effect,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63510,of,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63511,the,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63512,processes,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63513,involved,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63514,in,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63515,the,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63516,production,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63517,on,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63518,GI,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63519,were,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63520,tested,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63521,.,O,2204.0,"Instant rice is increasing in popularity and is produced by dehydrating whole grain cooked rice , therefore , to make it more suitable for diabetics , the effect of the processes involved in the production on GI were tested ."
63522,The,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63523,objective,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63524,was,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63525,to,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63526,optimize,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63527,cooking,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63528,temperature,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63529,and,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63530,the,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63531,ratio,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63532,of,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63533,water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63534,to,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63535,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63536,to,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63537,reduce,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63538,in,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63539,vitro,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63540,starch,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63541,digestibility,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63542,and,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63543,GI,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63544,of,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63545,instant,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63546,rice,I-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63547,made,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63548,from,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63549,three,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63550,Thai,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63551,rice,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63552,cultivars,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63553,(,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63554,Hom,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63555,Mali,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63556,(,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63557,KDML105,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63558,),O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63559,",",O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63560,Pathumthani,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63561,Fragrant,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63562,(,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63563,PT,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63564,),O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63565,and,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63566,Sao,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63567,Hai,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63568,(,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63569,SH,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63570,),O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63571,),O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63572,that,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63573,had,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63574,different,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63575,amylose,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63576,contents,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63577,.,O,2205.0,"The objective was to optimize cooking temperature and the ratio of water to rice to reduce in vitro starch digestibility and GI of instant rice made from three Thai rice cultivars ( Hom Mali ( KDML105 ) , Pathumthani Fragrant ( PT ) and Sao Hai ( SH ) ) that had different amylose contents ."
63592,The,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63593,rapidly,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63594,digestible,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63595,starch,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63596,(,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63597,RDS,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63598,),O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63599,content,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63600,and,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63601,estimated,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63602,glycemic,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63603,index,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63604,(,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63605,eGI,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63606,),O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63607,decreased,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63608,as,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63609,cooking,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63610,temperature,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63611,decreased,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63612,and,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63613,the,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63614,ratio,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63615,of,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63616,water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63617,to,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63618,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63619,increased,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63620,.,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63621,The,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63622,decrease,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63623,in,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63624,RDS,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63625,content,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63626,was,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63627,associated,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63628,with,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63629,the,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63630,increase,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63631,in,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63632,both,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63633,slowly,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63634,digestible,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63635,starch,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63636,(,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63637,SDS,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63638,),O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63639,and,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63640,resistant,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63641,starch,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63642,(,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63643,RS,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63644,),O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63645,contents,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63646,.,O,2208.0,The decrease in RDS content was associated with the increase in both slowly digestible starch ( SDS ) and resistant starch ( RS ) contents .
63681,Rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63682,cooked,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63683,at,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63684,higher,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63685,temperature,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63686,(,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63687,90,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63688,°,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63689,C,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63690,),O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63691,showed,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63692,lower,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63693,peak,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63694,viscosity,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63695,and,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63696,breakdown,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63697,in,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63698,pasting,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63699,properties,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63700,",",O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63701,compared,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63702,with,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63703,lower,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63704,temperature,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63705,82,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63706,°,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63707,C,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63708,.,O,2210.0,"Rice cooked at higher temperature ( 90 ° C ) showed lower peak viscosity and breakdown in pasting properties , compared with lower temperature 82 ° C ."
63760,Therefore,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63761,",",O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63762,preparation,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63763,of,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63764,an,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63765,instant,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63766,rice,I-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63767,product,I-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63768,with,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63769,a,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63770,lower,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63771,GI,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63772,would,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63773,ensure,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63774,the,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63775,product,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63776,was,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63777,beneficial,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63778,to,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63779,a,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63780,wider,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63781,range,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63782,of,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63783,the,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63784,population,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63785,.,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
64096,Epidemiologic,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64097,evidence,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64098,of,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64099,a,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64100,protective,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64101,role,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64102,for,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64103,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64104,and,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64105,vegetables,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64106,in,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64107,cancer,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64108,prevention,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64109,is,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64110,substantial,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64111,.,O,2229.0,Epidemiologic evidence of a protective role for fruits and vegetables in cancer prevention is substantial .
64627,These,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64628,results,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64629,strengthen,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64630,the,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64631,argument,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64632,that,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64633,calves,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64634,can,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64635,be,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64636,fed,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64637,large,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64638,milk,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64639,meals,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64640,without,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64641,risk,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64642,of,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64643,causing,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64644,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64645,in,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64646,the,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64647,rumen,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64648,",",O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64649,even,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64650,cold,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64651,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64652,drunk,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64653,at,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64654,high,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64655,speed,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64656,.,O,2248.0,"These results strengthen the argument that calves can be fed large milk meals without risk of causing milk in the rumen , even cold milk drunk at high speed ."
64962,A,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64963,case,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64964,-,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64965,control,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64966,study,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64967,of,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64968,cancer,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64969,of,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64970,the,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64971,colon,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64972,and,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64973,rectum,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64974,was,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64975,conducted,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64976,in,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64977,the,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64978,Marseilles,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64979,region,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64980,of,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64981,southern,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64982,France,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64983,.,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
65220,We,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65221,assessed,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65222,wine,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65223,",",O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65224,beer,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65225,",",O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65226,and,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65227,spirits,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65228,intake,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65229,separately,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65230,.,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65686,In,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65687,age-,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65688,and,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65689,energy,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65690,-,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65691,adjusted,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65692,models,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65693,for,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65694,all,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65695,centers,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65696,combined,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65697,",",O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65698,the,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65699,odds,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65700,ratio,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65701,(,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65702,OR,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65703,),O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65704,for,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65705,the,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65706,highest,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65707,quintile,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65708,of,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65709,total,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65710,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65711,intake,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65712,was,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65713,0.89,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65714,.,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
66127,After,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66128,8,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66129,weeks,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66130,",",O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66131,the,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66132,animals,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66133,were,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66134,subjected,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66135,to,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66136,a,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66137,2,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66138,-,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66139,hour,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66140,middle,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66141,cerebral,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66142,artery,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66143,occlusion,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66144,(,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66145,MCAO,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66146,),O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66147,and,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66148,sacrificed,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66149,at,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66150,24,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66151, ,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66152,hours,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66153,of,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66154,reperfusion,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66155,.,O,2307.0,"After 8 weeks , the animals were subjected to a 2 - hour middle cerebral artery occlusion ( MCAO ) and sacrificed at 24   hours of reperfusion ."
66302,Epidemiological,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66303,studies,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66304,have,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66305,noted,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66306,a,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66307,consistent,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66308,association,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66309,between,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66310,the,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66311,consumption,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66312,of,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66313,diets,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66314,rich,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66315,in,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66316,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66317,and,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66318,vegetables,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66319,and,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66320,a,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66321,lower,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66322,risk,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66323,for,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66324,chronic,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66325,diseases,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66326,including,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66327,cancer,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66328,and,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66329,cardiovascular,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66330,disease,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66331,.,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66446,Individual,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66447,compounds,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66448,in,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66449,strawberries,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66450,have,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66451,demonstrated,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66452,anticancer,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66453,activity,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66454,in,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66455,several,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66456,different,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66457,experimental,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66458,systems,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66459,",",O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66460,blocking,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66461,initiation,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66462,of,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66463,carcinogenesis,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66464,",",O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66465,and,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66466,suppressing,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66467,progression,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66468,and,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66469,proliferation,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66470,of,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66471,tumors,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66472,.,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66611,In,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66612,this,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66613,review,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66614,(,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66615,Part,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66616,2,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66617,),O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66618,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66619,we,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66620,present,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66621,a,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66622,research,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66623,overview,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66624,conducted,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66625,on,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66626,some,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66627,plants,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66628,and,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66629,vegetables,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66630,(,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66631,spirulina,B-http://purl.obolibrary.org/obo/FOODON_03412039,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66632,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66633,broccoli,B-http://purl.obolibrary.org/obo/FOODON_03301713;http://purl.obolibrary.org/obo/FOODON_00003405;http://purl.obolibrary.org/obo/NCBITaxon_36774,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66634,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66635,chamomile,B-http://purl.obolibrary.org/obo/CHEBI_18388,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66636,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66637,cocoa,B-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66638,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66639,ginger,B-http://purl.obolibrary.org/obo/FOODON_00002718;http://purl.obolibrary.org/obo/FOODON_00003717;http://purl.obolibrary.org/obo/FOODON_00001901;http://purl.obolibrary.org/obo/NCBITaxon_94328,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66640,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66641,laurel,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66642,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66643,marigold,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66644,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66645,roselle,B-http://purl.obolibrary.org/obo/FOODON_00003092;http://purl.obolibrary.org/obo/NCBITaxon_183260,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66646,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66647,and,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66648,rosemary,B-http://purl.obolibrary.org/obo/NCBITaxon_39367;http://purl.obolibrary.org/obo/FOODON_00002212,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66649,),O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66650,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66651,which,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66652,are,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66653,frequently,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66654,consumed,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66655,by,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66656,humans,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66657,.,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66658,In,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66659,addition,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66660,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66661,an,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66662,analysis,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66663,of,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66664,some,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66665,phytochemicals,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66666,extracted,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66667,from,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66668,those,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66669,vegetables,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66670,and,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66671,the,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66672,analysis,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66673,of,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66674,a,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66675,resin,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66676,(,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66677,"propolis),whose",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66678,antigenotoxic,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66679,power,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66680,has,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66681,been,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66682,demonstrated,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66683,in,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66684,various,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66685,tests,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66686,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66687,including,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66688,the,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66689,Ames,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66690,assay,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66691,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66692,sister,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66693,chromatid,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66694,exchange,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66695,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66696,chromosomal,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66697,aberrations,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66698,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66699,micronucleus,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66700,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66701,and,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66702,comet,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66703,assay,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66704,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66705,was,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66706,also,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66707,performed,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66708,.,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66943,More,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66944,detailed,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66945,assessment,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66946,of,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66947,specific,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66948,alcoholic,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66949,beverages,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66950,is,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66951,warranted,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66952,in,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66953,future,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66954,studies,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66955,.,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
67417,Among,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67418,men,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67419,",",O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67420,the,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67421,risk,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67422,of,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67423,stomach,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67424,cancer,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67425,was,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67426,significantly,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67427,elevated,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67428,among,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67429,current,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67430,smokers,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67431,(,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67432,OR,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67433,=,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67434,1.7,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67435,",",O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67436,95,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67437,%,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67438,CI,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67439,=,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67440,1.1,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67441,-,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67442,2.7,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67443,),O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67444,but,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67445,not,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67446,among,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67447,former,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67448,smokers,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67449,.,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67635,Here,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67636,we,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67637,will,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67638,summarize,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67639,the,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67640,nutrient,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67641,and,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67642,the,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67643,phytochemical,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67644,content,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67645,of,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67646,tomatoes,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67647,and,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67648,tomato,B-http://purl.obolibrary.org/obo/FOODON_03301453;http://purl.obolibrary.org/obo/FOODON_03309927;http://purl.obolibrary.org/obo/NCBITaxon_4081,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67649,products,I-http://purl.obolibrary.org/obo/FOODON_03301453;http://purl.obolibrary.org/obo/FOODON_03309927;http://purl.obolibrary.org/obo/NCBITaxon_4081,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67650,",",O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67651,and,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67652,how,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67653,these,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67654,bioactive,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67655,components,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67656,might,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67657,act,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67658,together,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67659,to,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67660,modulate,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67661,disease,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67662,development,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
67663,.,O,2363.0,"Here we will summarize the nutrient and the phytochemical content of tomatoes and tomato products , and how these bioactive components might act together to modulate disease development ."
68638,Over,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68639,one,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68640,third,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68641,of,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68642,Australians,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68643,',O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68644,daily,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68645,energy,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68646,intake,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68647,is,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68648,from,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68649,discretionary,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68650,foods,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68651,and,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68652,drinks,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68653,.,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
69413,Insulinemic,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69414,indexes,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69415,do,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69416,not,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69417,improve,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69418,discrimination,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69419,between,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69420,foods,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69421,taken,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69422,alone,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69423,in,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69424,type,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69425,2,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69426,diabetics,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69427,:,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69428,they,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69429,only,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69430,discriminate,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69431,between,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69432,foods,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69433,during,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69434,mixed,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69435,meals,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69436,",",O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69437,similarly,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69438,to,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69439,glycemic,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69440,indexes,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69441,.,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69453,Most,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69454,Nigerians,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69455,',O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69456,cultural,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69457,diet,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69458,is,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69459,based,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69460,on,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69461,staple,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69462,food,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69463,accompanied,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69464,by,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69465,stew,B-http://purl.obolibrary.org/obo/FOODON_00002276;http://purl.obolibrary.org/obo/FOODON_00003140,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69466,.,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69816,Yersinia,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69817,enterocolitica,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69818,",",O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69819,another,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69820,psychrotrophic,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69821,food,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69822,-,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69823,borne,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69824,pathogen,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69825,of,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69826,recent,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69827,concern,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69828,",",O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69829,was,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69830,linked,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69831,to,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69832,several,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69833,outbreaks,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69834,of,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69835,yersiniosis,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69836,associated,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69837,with,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69838,consumption,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69839,of,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69840,both,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69841,raw,B-http://purl.obolibrary.org/obo/FOODON_00002654;http://purl.obolibrary.org/obo/UBERON_0001913,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69842,and,I-http://purl.obolibrary.org/obo/FOODON_00002654;http://purl.obolibrary.org/obo/UBERON_0001913,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69843,pasteurized,I-http://purl.obolibrary.org/obo/FOODON_00002654;http://purl.obolibrary.org/obo/UBERON_0001913,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69844,milk,I-http://purl.obolibrary.org/obo/FOODON_00002654;http://purl.obolibrary.org/obo/UBERON_0001913,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69845,",",O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69846,as,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69847,well,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69848,as,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69849,contaminated,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69850,water,B-http://purl.obolibrary.org/obo/CHEBI_15377;http://purl.obolibrary.org/obo/FOODON_00002340,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69851,.,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69921,Notable,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69922,outbreaks,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69923,of,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69924,campylobacteriosis,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69925,linked,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69926,to,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69927,consumption,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69928,of,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69929,raw,B-http://purl.obolibrary.org/obo/FOODON_03307455;http://purl.obolibrary.org/obo/UBERON_0001913,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69930,milk,I-http://purl.obolibrary.org/obo/FOODON_03307455;http://purl.obolibrary.org/obo/UBERON_0001913,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69931,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69932,cake,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69933,icing,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69934,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69935,eggs,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69936,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69937,poultry,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69938,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69939,and,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69940,beef,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69941,have,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69942,underscored,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69943,the,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69944,need,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69945,for,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69946,thorough,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69947,cooking,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69948,and,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69949,proper,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69950,handling,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69951,of,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69952,raw,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69953,products.(ABSTRACT,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69954,TRUNCATED,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69955,AT,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69956,250,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69957,WORDS,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69958,),O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69959,Work,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69960,from,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69961,our,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69962,laboratory,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69963,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69964,as,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69965,well,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69966,as,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69967,others,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69968,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69969,suggests,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69970,a,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69971,protective,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69972,role,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69973,of,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69974,phytosterols,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69975,(,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69976,PS,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69977,),O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69978,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69979,especially,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69980,beta,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69981,-,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69982,sitosterol,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69983,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69984,from,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69985,colon,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69986,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69987,prostate,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69988,",",O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69989,and,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69990,breast,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69991,cancer,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
69992,.,O,2437.0,"Notable outbreaks of campylobacteriosis linked to consumption of raw milk , cake icing , eggs , poultry , and beef have underscored the need for thorough cooking and proper handling of raw products.(ABSTRACT TRUNCATED AT 250 WORDS ) Work from our laboratory , as well as others , suggests a protective role of phytosterols ( PS ) , especially beta - sitosterol , from colon , prostate , and breast cancer ."
70228,Glycemic,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70229,effect,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70230,of,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70231,adding,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70232,10,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70233,-,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70234,g,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70235,carbohydrate,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70236,portions,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70237,of,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70238,apple,B-http://purl.obolibrary.org/obo/FOODON_00002473;http://purl.obolibrary.org/obo/NCBITaxon_3750,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70239,",",O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70240,banana,B-http://purl.obolibrary.org/obo/FOODON_03311513;http://purl.obolibrary.org/obo/FOODON_03316257;http://purl.obolibrary.org/obo/NCBITaxon_4641,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70241,",",O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70242,grapes,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70243,",",O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70244,honeydew,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70245,",",O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70246,orange,B-http://purl.obolibrary.org/obo/PATO_0000953;http://purl.obolibrary.org/obo/FOODON_03315106,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70247,",",O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70248,or,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70249,strawberries,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70250,to,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70251,a,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70252,standard,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70253,meal,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70254,on,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70255,separate,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70256,occasions,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70257,was,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70258,measured,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70259,in,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70260,10,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70261,insulin,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70262,-,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70263,dependent,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70264,diabetics,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70265,monitored,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70266,at,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70267,home,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70268,.,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70360,Age,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70361,",",O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70362,duration,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70363,of,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70364,diabetes,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70365,",",O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70366,or,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70367,insulin,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70368,regimen,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70369,did,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70370,not,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70371,correlate,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70372,with,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70373,subjects,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70374,',O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70375,responses,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70376,to,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70377,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70378,.,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70424,Dietary,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70425,EW,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70426,and,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70427,EWH,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70428,decreased,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70429,food,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70430,intake,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70431,",",O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70432,body,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70433,weight,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70434,gain,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70435,and,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70436,fat,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70437,accumulation,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70438,in,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70439,the,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70440,carcass,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70441,",",O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70442,liver,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70443,",",O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70444,muscles,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70445,and,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70446,adipose,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70447,tissues,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70448,",",O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70449,but,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70450,muscle,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70451,weight,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70452,was,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70453,increased,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70454,.,O,2454.0,"Dietary EW and EWH decreased food intake , body weight gain and fat accumulation in the carcass , liver , muscles and adipose tissues , but muscle weight was increased ."
70853,Using,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70854,multivariate,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70855,relative,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70856,risks,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70857,(,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70858,RR,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70859,),O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70860,and,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70861,95,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70862,%,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70863,confidence,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70864,intervals,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70865,(,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70866,95,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70867,%,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70868,CI,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70869,),O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70870,",",O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70871,we,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70872,evaluated,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70873,the,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70874,association,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70875,of,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70876,flavonol,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70877,intake,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70878,with,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70879,breast,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70880,cancer,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70881,risk,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70882,in,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70883,women,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70884,who,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70885,were,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70886,premenopausal,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70887,and,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70888,aged,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70889,between,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70890,26,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70891,and,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70892,46,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70893,years,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70894,at,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70895,baseline,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70896,in,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70897,1991,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70898,.,O,2470.0,"Using multivariate relative risks ( RR ) and 95 % confidence intervals ( 95 % CI ) , we evaluated the association of flavonol intake with breast cancer risk in women who were premenopausal and aged between 26 and 46 years at baseline in 1991 ."
70916,The,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70917,multivariate,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70918,RR,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70919,(,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70920,95,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70921,%,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70922,CI,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70923,),O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70924,",",O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70925,comparing,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70926,highest,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70927,to,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70928,lowest,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70929,quintiles,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70930,of,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70931,cumulative,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70932,average,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70933,intake,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70934,",",O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70935,was,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70936,1.05,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70937,(,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70938,0.83,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70939,",",O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70940,1.34,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70941,;,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70942,p,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70943,-,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70944,value,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70945,for,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70946,test,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70947,of,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70948,trend=0.96,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70949,),O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70950,for,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70951,the,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70952,sum,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70953,of,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70954,flavonols,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70955,and,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70956,there,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70957,were,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70958,no,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70959,associations,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70960,seen,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70961,between,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70962,individual,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70963,flavonols,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70964,such,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70965,as,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70966,kaempferol,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70967,",",O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70968,quercetin,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70969,and,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70970,myricetin,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70971,and,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70972,breast,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70973,cancer,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70974,risk,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70975,.,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
71434,In,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71435,this,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71436,specific,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71437,study,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71438,",",O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71439,1182,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71440,adults,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71441,(,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71442,545,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71443,males,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71444,",",O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71445,45·9,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71446,%,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71447,),O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71448,had,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71449,dietary,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71450,data,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71451,collected,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71452,using,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71453,a,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71454,FFQ,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71455,and,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71456,also,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71457,had,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71458,BMD,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71459,measurements,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71460,taken,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71461,using,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71462,dual,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71463,-,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71464,energy,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71465,X,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71466,-,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71467,ray,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71468,absorptiometry,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71469,.,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71470,Factor,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71471,analysis,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71472,with,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71473,principal,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71474,component,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71475,method,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71476,was,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71477,applied,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71478,to,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71479,ascertain,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71480,dietary,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71481,patterns,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71482,.,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71524,In,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71525,contrast,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71526,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71527,pattern,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71528,2,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71529,(,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71530,',O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71531,Western,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71532,pattern,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71533,',O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71534,),O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71535,was,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71536,characterised,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71537,by,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71538,high,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71539,levels,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71540,of,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71541,processed,B-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71542,and,I-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71543,red,I-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71544,meat,I-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71545,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71546,snacks,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71547,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71548,takeaway,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71549,foods,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71550,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71551,jam,B-http://purl.obolibrary.org/obo/FOODON_03309973,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71552,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71553,beer,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71554,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71555,soft,B-http://purl.obolibrary.org/obo/PATO_0000387,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71556,drinks,I-http://purl.obolibrary.org/obo/PATO_0000387,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71557,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71558,white,B-http://purl.obolibrary.org/obo/FOODON_03301055;http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71559,bread,I-http://purl.obolibrary.org/obo/FOODON_03301055;http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71560,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71561,poultry,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71562,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71563,potato,B-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449;http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71564,with,I-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449;http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71565,fat,I-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449;http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71566,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71567,high,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71568,-,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71569,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71570,dairy,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71571,products,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71572,and,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71573,eggs,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71574,.,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71698,The,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71699,aim,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71700,of,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71701,this,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71702,study,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71703,was,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71704,to,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71705,test,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71706,the,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71707,effect,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71708,of,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71709,replacing,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71710,soybean,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71711,hulls,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71712,with,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71713,different,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71714,doses,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71715,of,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71716,cocoa,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71717,husk,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71718,(,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71719,CH,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71720,),O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71721,on,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71722,milk,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71723,production,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71724,traits,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71725,and,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71726,the,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71727,hematological,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71728,profile,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71729,of,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71730,dairy,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71731,ewes,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71732,.,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71799,In,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71800,the,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71801,second,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71802,group,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71803,",",O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71804,soybean,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71805,hulls,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71806,were,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71807,replaced,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71808,with,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71809,50,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71810,g,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71811,of,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71812,CH,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71813,/,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71814,d,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71815,(,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71816,CH50,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71817,group,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71818,),O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71819,.,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71971,In,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71972,conclusion,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71973,",",O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71974,CH,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71975,can,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71976,be,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71977,substituted,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71978,for,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71979,soybean,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71980,hulls,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71981,in,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71982,the,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71983,diet,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71984,of,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71985,dairy,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71986,sheep,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71987,without,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71988,adverse,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71989,effects,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71990,on,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71991,milk,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71992,production,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71993,or,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71994,apparent,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71995,negative,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71996,effects,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71997,on,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71998,animal,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
71999,health,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
72000,conditions,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
72001,.,O,2504.0,"In conclusion , CH can be substituted for soybean hulls in the diet of dairy sheep without adverse effects on milk production or apparent negative effects on animal health conditions ."
72844,Mean,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72845,(,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72846,SD,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72847,),O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72848,age,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72849,",",O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72850,weight,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72851,and,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72852,BMI,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72853,of,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72854,the,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72855,population,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72856,were,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72857,51,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72858,±,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72859,10,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72860,year,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72861,",",O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72862,94,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72863,±,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72864,18,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72865,kg,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72866,and,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72867,32.4,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72868,±,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72869,5.7,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72870,kg,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72871,/,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72872,m2,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72873,",",O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72874,respectively,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72875,.,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
73068,Numerous,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73069,animal,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73070,studies,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73071,as,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73072,well,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73073,as,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73074,in,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73075,vitro,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73076,ones,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73077,have,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73078,demonstrated,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73079,the,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73080,hypolipidemic,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73081,effects,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73082,of,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73083,garlic,B-http://purl.obolibrary.org/obo/FOODON_03305208;http://purl.obolibrary.org/obo/FOODON_00003582;http://purl.obolibrary.org/obo/NCBITaxon_4682,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73084,",",O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73085,while,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73086,clinical,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73087,trials,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73088,are,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73089,highly,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73090,inconsistent,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73091,.,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73202,In,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73203,addition,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73204,",",O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73205,the,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73206,biological,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73207,availability,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73208,of,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73209,garlic,B-http://purl.obolibrary.org/obo/FOODON_03305208;http://purl.obolibrary.org/obo/FOODON_00003582;http://purl.obolibrary.org/obo/NCBITaxon_4682,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73210,products,I-http://purl.obolibrary.org/obo/FOODON_03305208;http://purl.obolibrary.org/obo/FOODON_00003582;http://purl.obolibrary.org/obo/NCBITaxon_4682,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73211,is,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73212,of,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73213,importance,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73214,",",O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73215,which,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73216,was,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73217,omitted,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73218,in,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73219,many,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73220,studies,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73221,.,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73359,We,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73360,evaluated,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73361,cross,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73362,-,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73363,sectional,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73364,data,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73365,from,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73366,12,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73367,065,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73368,adults,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73369,aged,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73370,30,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73371,-,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73372,65,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73373,years,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73374,recruited,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73375,to,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73376,the,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73377,Fenland,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73378,Study,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73379,between,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73380,2005,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73381,and,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73382,2015,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73383,in,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73384,Cambridgeshire,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73385,",",O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73386,UK,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73387,.,O,2548.0,"We evaluated cross - sectional data from 12 065 adults aged 30 - 65 years recruited to the Fenland Study between 2005 and 2015 in Cambridgeshire , UK ."
73528,Other,O,2554.0,Other associations were not significant after false discovery correction .
73529,associations,O,2554.0,Other associations were not significant after false discovery correction .
73530,were,O,2554.0,Other associations were not significant after false discovery correction .
73531,not,O,2554.0,Other associations were not significant after false discovery correction .
73532,significant,O,2554.0,Other associations were not significant after false discovery correction .
73533,after,O,2554.0,Other associations were not significant after false discovery correction .
73534,false,O,2554.0,Other associations were not significant after false discovery correction .
73535,discovery,O,2554.0,Other associations were not significant after false discovery correction .
73536,correction,O,2554.0,Other associations were not significant after false discovery correction .
73537,.,O,2554.0,Other associations were not significant after false discovery correction .
73802,Although,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73803,not,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73804,statistically,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73805,significant,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73806,",",O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73807,the,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73808,mean,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73809,was,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73810,greater,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73811,than,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73812,predicted,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73813,for,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73814,every,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73815,other,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73816,food,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73817,except,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73818,potatoes,B-http://purl.obolibrary.org/obo/NCBITaxon_4113,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73819,when,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73820,the,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73821,insulin,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73822,response,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73823,to,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73824,50,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73825,g,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73826,glucose,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73827,was,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73828,used,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73829,as,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73830,a,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73831,standard,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73832,.,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73849,Maternal,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73850,nutrition,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73851,can,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73852,have,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73853,a,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73854,profound,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73855,effect,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73856,on,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73857,fetal,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73858,growth,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73859,",",O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73860,development,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73861,",",O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73862,and,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73863,subsequent,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73864,infant,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73865,birth,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73866,weight,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73867,.,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
74279,An,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74280,association,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74281,between,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74282,allergy,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74283,to,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74284,latex,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74285,and,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74286,allergy,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74287,to,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74288,various,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74289,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74290,has,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74291,been,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74292,reported,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74293,.,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74701,To,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74702,date,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74703,",",O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74704,over,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74705,"10,000",O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74706, ,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74707,PAs,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74708,poisoning,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74709,cases,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74710,have,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74711,been,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74712,reported,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74713,worldwide,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74714,.,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
75222,Also,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75223,",",O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75224,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75225,MRP,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75226,showed,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75227,higher,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75228,antioxidant,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75229,activities,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75230,than,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75231,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75232,intact,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75233,milk,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75234,protein,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75235,",",O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75236,and,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75237,they,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75238,reduced,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75239,intracellular,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75240,reactive,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75241,oxygen,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75242,species,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75243,production,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75244,and,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75245,inhibited,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75246,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75247,depletion,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75248,of,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75249,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75250,reduced,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75251,glutathione,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75252,concentrations,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75253,in,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75254,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75255,HepG2,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75256,cells,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75257,.,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75537,Since,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75538,1982,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75539,",",O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75540,13,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75541,further,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75542,publications,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75543,reported,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75544,additional,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75545,cases,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75546,of,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75547,dietary,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75548,chloride,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75549,depletion,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75550,.,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75584,We,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75585,review,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75586,and,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75587,compare,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75588,trends,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75589,in,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75590,coronary,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75591,heart,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75592,disease,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75593,(,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75594,CHD,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75595,),O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75596,and,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75597,stroke,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75598,mortality,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75599,in,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75600,Spain,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75601,from,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75602,1966,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75603,to,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75604,1990,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75605,and,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75606,changes,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75607,in,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75608,food,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75609,consumption,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75610,at,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75611,national,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75612,and,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75613,regional,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75614,levels,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75615,.,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75709,This,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75710,paradoxical,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75711,situation,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75712,can,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75713,be,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75714,explained,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75715,by,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75716,expanded,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75717,access,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75718,to,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75719,clinical,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75720,care,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75721,",",O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75722,increased,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75723,consumption,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75724,of,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75725,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75726,and,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75727,fish,B-http://purl.obolibrary.org/obo/NCBITaxon_7898;http://purl.obolibrary.org/obo/FOODON_03411222;http://purl.obolibrary.org/obo/NCBITaxon_7777,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75728,",",O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75729,improved,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75730,control,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75731,of,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75732,hypertension,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75733,",",O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75734,and,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75735,a,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75736,reduction,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75737,in,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75738,cigarette,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75739,smoking,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75740,.,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
76183,A,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76184,wealth,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76185,of,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76186,epidemiologic,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76187,evidence,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76188,supports,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76189,a,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76190,potent,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76191,protective,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76192,effect,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76193,of,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76194,moderate,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76195,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76196,consumption,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76197,against,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76198,CHD,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76199,",",O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76200,probably,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76201,in,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76202,part,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76203,by,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76204,increasing,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76205,HDL,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76206,concentrations,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76207,.,O,2646.0,"A wealth of epidemiologic evidence supports a potent protective effect of moderate alcohol consumption against CHD , probably in part by increasing HDL concentrations ."
76370,Pirlimycin,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76371,milk,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76372,pharmacokinetics,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76373,were,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76374,adequately,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76375,described,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76376,by,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76377,the,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76378,model,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76379,across,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76380,the,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76381,range,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76382,of,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76383,observed,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76384,concentrations,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76385,.,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
77282,These,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77283,drugs,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77284,are,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77285,excreted,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77286,in,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77287,urine,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77288,and,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77289,faeces,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77290,as,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77291,metabolite,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77292,or,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77293,conjugated,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77294,forms,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77295,",",O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77296,leading,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77297,to,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77298,contamination,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77299,of,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77300,water,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77301,",",O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77302,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77303,and,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77304,animal,B-http://purl.obolibrary.org/obo/FOODON_00002452;http://purl.obolibrary.org/obo/FOODON_03411297;http://purl.obolibrary.org/obo/FOODON_00003004,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77305,produce,I-http://purl.obolibrary.org/obo/FOODON_00002452;http://purl.obolibrary.org/obo/FOODON_03411297;http://purl.obolibrary.org/obo/FOODON_00003004,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77306,",",O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77307,which,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77308,are,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77309,consumed,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77310,directly,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77311,by,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77312,humans,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77313,as,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77314,well,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77315,as,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77316,animals,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77317,.,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77512,Mortality,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77513,rates,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77514,for,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77515,these,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77516,diseases,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77517,subsequently,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77518,decreased,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77519,significantly,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77520,while,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77521,the,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77522,already,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77523,low,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77524,rates,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77525,for,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77526,ischemic,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77527,heart,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77528,disease,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77529,and,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77530,cancer,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77531,also,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77532,decreased,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77533,",",O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77534,resulting,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77535,in,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77536,Japanese,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77537,life,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77538,expectancy,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77539,becoming,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77540,the,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77541,longest,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77542,.,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77825,In,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77826,the,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77827,multivariable,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77828,models,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77829,",",O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77830,no,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77831,significant,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77832,associations,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77833,between,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77834,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77835,(,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77836,mostly,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77837,black,B-http://purl.obolibrary.org/obo/NCBITaxon_4442;http://purl.obolibrary.org/obo/FOODON_03304640;http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/FOODON_03315081,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77838,tea,I-http://purl.obolibrary.org/obo/NCBITaxon_4442;http://purl.obolibrary.org/obo/FOODON_03304640;http://purl.obolibrary.org/obo/PATO_0000317;http://purl.obolibrary.org/obo/FOODON_03315081,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77839,),O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77840,",",O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77841,and,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77842,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77843,intake,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77844,and,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77845,risk,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77846,of,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77847,EC,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77848,",",O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77849,EAC,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77850,and,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77851,ESCC,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77852,were,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77853,observed,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
77854,.,O,2701.0,"In the multivariable models , no significant associations between tea ( mostly black tea ) , and coffee intake and risk of EC , EAC and ESCC were observed ."
78011,Ovarian,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78012,cancer,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78013,is,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78014,commonly,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78015,a,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78016,fatal,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78017,disease,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78018,and,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78019,",",O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78020,despite,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78021,advances,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78022,in,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78023,screening,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78024,and,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78025,treatment,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78026,",",O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78027,the,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78028,lack,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78029,of,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78030,understanding,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78031,of,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78032,the,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78033,underlying,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78034,etiology,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78035,has,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78036,limited,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78037,prevention,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78038,strategies,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78039,.,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78209,In,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78210,conclusion,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78211,",",O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78212,a,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78213,typical,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78214,Western,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78215,diet,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78216,",",O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78217,which,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78218,is,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78219,high,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78220,in,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78221,meats,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78222,and,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78223,low,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78224,in,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78225,vegetables,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78226,",",O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78227,may,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78228,be,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78229,positively,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78230,associated,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78231,with,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78232,ovarian,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78233,cancer,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78234,incidence,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78235,.,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78670,Among,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78671,men,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78672,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78673,consumed,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78674,one,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78675,cup,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78676,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78677,month,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78678,to,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78679,six,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78680,cups,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78681,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78682,week,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78683,and,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78684,among,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78685,those,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78686,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78687,consumed,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78688,one,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78689,cup,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78690,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78691,d,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78692,or,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78693,more,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78694,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78695,the,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78696,associated,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78697,hazard,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78698,ratios,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78699,were,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78700,0.69,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78701,(,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78702,95,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78703,%,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78704,CI,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78705,0.50,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78706,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78707,0.97,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78708,),O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78709,and,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78710,0.69,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78711,(,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78712,95,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78713,%,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78714,CI,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78715,0.49,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78716,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78717,0.98,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78718,),O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78719,compared,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78720,with,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78721,those,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78722,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78723,drank,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78724,little,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78725,to,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78726,no,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78727,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78728,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78729,with,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78730,a,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78731,P,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78732,value,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78733,for,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78734,trend,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78735,of,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78736,0.32,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78737,.,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
79293,Overall,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79294,",",O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79295,incorporating,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79296,an,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79297,80,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79298,-,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79299,90,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79300,g,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79301,portion,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79302,of,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79303,raisins,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79304,(,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79305,half,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79306,a,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79307,cup,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79308,),O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79309,into,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79310,the,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79311,daily,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79312,diet,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79313,may,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79314,be,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79315,favorable,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79316,for,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79317,human,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79318,health,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79319,.,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79419,Multivariable,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79420,-,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79421,adjusted,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79422,hazard,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79423,ratios,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79424,were,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79425,obtained,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79426,from,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79427,Cox,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79428,proportional,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79429,hazards,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79430,regression,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79431,models,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79432,.,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79956,Yellow,B-http://purl.obolibrary.org/obo/PATO_0000324;http://purl.obolibrary.org/obo/PATO_0000320,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79957,-,I-http://purl.obolibrary.org/obo/PATO_0000324;http://purl.obolibrary.org/obo/PATO_0000320,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79958,green,I-http://purl.obolibrary.org/obo/PATO_0000324;http://purl.obolibrary.org/obo/PATO_0000320,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79959,vegetables,I-http://purl.obolibrary.org/obo/PATO_0000324;http://purl.obolibrary.org/obo/PATO_0000320,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79960,",",O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79961,such,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79962,as,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79963,corn,B-http://purl.obolibrary.org/obo/NCBITaxon_381124,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79964,and,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79965,leafy,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79966,greens,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79967,",",O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79968,contain,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79969,lutein,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79970,and,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79971,zeaxanthin,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79972,",",O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79973,which,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79974,are,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79975,localized,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79976,in,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79977,the,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79978,retina,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79979,where,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79980,age,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79981,-,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79982,related,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79983,macular,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79984,degeneration,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79985,occurs,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79986,.,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
80029,Orange,B-http://purl.obolibrary.org/obo/PATO_0000953;http://purl.obolibrary.org/obo/FOODON_03315106;http://purl.obolibrary.org/obo/PATO_0000324,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80030,-,I-http://purl.obolibrary.org/obo/PATO_0000953;http://purl.obolibrary.org/obo/FOODON_03315106;http://purl.obolibrary.org/obo/PATO_0000324,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80031,yellow,I-http://purl.obolibrary.org/obo/PATO_0000953;http://purl.obolibrary.org/obo/FOODON_03315106;http://purl.obolibrary.org/obo/PATO_0000324,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80032,foods,I-http://purl.obolibrary.org/obo/PATO_0000953;http://purl.obolibrary.org/obo/FOODON_03315106;http://purl.obolibrary.org/obo/PATO_0000324,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80033,",",O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80034,including,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80035,oranges,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80036,",",O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80037,tangerines,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80038,and,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80039,lemons,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80040,contain,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80041,citrus,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80042,flavonoids,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80043,.,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80324,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80325,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80326,light,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80327,yogurt,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80328,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80329,125,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80330, ,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80331,ml,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80332,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80333,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80334,skim,B-http://purl.obolibrary.org/obo/UBERON_0001913,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80335,milk,I-http://purl.obolibrary.org/obo/UBERON_0001913,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80336,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80337,200,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80338, ,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80339,ml,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80340,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80341,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80342,1,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80343,glass,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80344,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80345,125,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80346, ,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80347,ml,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80348,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80349,of,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80350,wine,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80351,and,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80352,extra,B-http://purl.obolibrary.org/obo/FOODON_00002808;http://purl.obolibrary.org/obo/FOODON_03306633;http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80353,virgin,I-http://purl.obolibrary.org/obo/FOODON_00002808;http://purl.obolibrary.org/obo/FOODON_03306633;http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80354,olive,I-http://purl.obolibrary.org/obo/FOODON_00002808;http://purl.obolibrary.org/obo/FOODON_03306633;http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80355,oil,I-http://purl.obolibrary.org/obo/FOODON_00002808;http://purl.obolibrary.org/obo/FOODON_03306633;http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80356,;,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80357,weekly,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80358,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80359,fish,B-http://purl.obolibrary.org/obo/NCBITaxon_7898;http://purl.obolibrary.org/obo/FOODON_03411222;http://purl.obolibrary.org/obo/NCBITaxon_7777,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80360,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80361,3,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80362,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80363,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80364,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80365,white,B-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80366,meat,I-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80367,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80368,3,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80369,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80370,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80371,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80372,legumes,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80373,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80374,2,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80375,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80376,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80377,eggs,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80378,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80379,2,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80380,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80381,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80382,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80383,seasoned,B-http://purl.obolibrary.org/obo/FOODON_00002733,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80384,cheeses,I-http://purl.obolibrary.org/obo/FOODON_00002733,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80385,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80386,2,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80387,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80388,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80389,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80390,and,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80391,red,B-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80392,or,I-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80393,processed,I-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80394,meats,I-http://purl.obolibrary.org/obo/PATO_0000322;http://purl.obolibrary.org/obo/NCBITaxon_8023,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80395,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80396,once,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80397,a,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80398,week,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80399,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80400,.,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80524,Dietary,O,2787.0,Dietary data were collected through a food frequency questionnaire .
80525,data,O,2787.0,Dietary data were collected through a food frequency questionnaire .
80526,were,O,2787.0,Dietary data were collected through a food frequency questionnaire .
80527,collected,O,2787.0,Dietary data were collected through a food frequency questionnaire .
80528,through,O,2787.0,Dietary data were collected through a food frequency questionnaire .
80529,a,O,2787.0,Dietary data were collected through a food frequency questionnaire .
80530,food,O,2787.0,Dietary data were collected through a food frequency questionnaire .
80531,frequency,O,2787.0,Dietary data were collected through a food frequency questionnaire .
80532,questionnaire,O,2787.0,Dietary data were collected through a food frequency questionnaire .
80533,.,O,2787.0,Dietary data were collected through a food frequency questionnaire .
81032,Wine,O,2807.0,Wine can be considered an integral part of the Mediterranean diet .
81033,can,O,2807.0,Wine can be considered an integral part of the Mediterranean diet .
81034,be,O,2807.0,Wine can be considered an integral part of the Mediterranean diet .
81035,considered,O,2807.0,Wine can be considered an integral part of the Mediterranean diet .
81036,an,O,2807.0,Wine can be considered an integral part of the Mediterranean diet .
81037,integral,O,2807.0,Wine can be considered an integral part of the Mediterranean diet .
81038,part,O,2807.0,Wine can be considered an integral part of the Mediterranean diet .
81039,of,O,2807.0,Wine can be considered an integral part of the Mediterranean diet .
81040,the,O,2807.0,Wine can be considered an integral part of the Mediterranean diet .
81041,Mediterranean,O,2807.0,Wine can be considered an integral part of the Mediterranean diet .
81042,diet,O,2807.0,Wine can be considered an integral part of the Mediterranean diet .
81043,.,O,2807.0,Wine can be considered an integral part of the Mediterranean diet .
81651,Sensitivities,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81652,and,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81653,negative,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81654,predictive,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81655,accuracies,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81656,were,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81657,generally,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81658,high,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81659,with,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81660,egg,B-http://purl.obolibrary.org/obo/FOODON_03304840;http://purl.obolibrary.org/obo/UBERON_0008944;http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81661,white,I-http://purl.obolibrary.org/obo/FOODON_03304840;http://purl.obolibrary.org/obo/UBERON_0008944;http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81662,and,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81663,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81664,",",O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81665,but,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81666,low,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81667,with,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81668,egg,B-http://purl.obolibrary.org/obo/UBERON_0007378;http://purl.obolibrary.org/obo/FOODON_03315772,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81669,yolk,I-http://purl.obolibrary.org/obo/UBERON_0007378;http://purl.obolibrary.org/obo/FOODON_03315772,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81670,.,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
82053,An,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82054,evidence-,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82055,based,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82056,review,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82057,showed,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82058,that,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82059,vegetarian,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82060,diets,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82061,can,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82062,be,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82063,nutritionally,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82064,adequate,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82065,in,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82066,pregnancy,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82067,and,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82068,result,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82069,in,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82070,positive,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82071,maternal,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82072,and,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82073,infant,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82074,health,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82075,outcomes,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82076,.,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82077,The,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82078,results,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82079,of,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82080,an,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82081,evidence,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82082,-,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82083,based,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82084,review,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82085,showed,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82086,that,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82087,a,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82088,vegetarian,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82089,diet,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82090,is,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82091,associated,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82092,with,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82093,a,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82094,lower,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82095,risk,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82096,of,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82097,death,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82098,from,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82099,ischemic,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82100,heart,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82101,disease,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82102,.,O,2845.0,The results of an evidence - based review showed that a vegetarian diet is associated with a lower risk of death from ischemic heart disease .
82149,Features,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82150,of,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82151,a,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82152,vegetarian,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82153,diet,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82154,that,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82155,may,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82156,reduce,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82157,risk,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82158,of,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82159,chronic,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82160,disease,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82161,include,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82162,lower,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82163,intakes,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82164,of,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82165,saturated,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82166,fat,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82167,and,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82168,cholesterol,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82169,and,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82170,higher,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82171,intakes,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82172,of,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82173,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82174,",",O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82175,vegetables,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82176,",",O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82177,whole,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82178,grains,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82179,",",O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82180,nuts,B-http://purl.obolibrary.org/obo/FOODON_03306632,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82181,",",O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82182,soy,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82183,products,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82184,",",O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82185,fiber,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82186,",",O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82187,and,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82188,phytochemicals,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82189,.,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82575,The,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82576,following,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82577,studies,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82578,were,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82579,conducted,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82580,:,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82581,(,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82582,a,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82583,),O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82584,mineral,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82585,availability,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82586,",",O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82587,in,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82588,vitro,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82589,;,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82590,(,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82591,b,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82592,),O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82593,glycaemic,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82594,index,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82595,(,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82596,GI,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82597,),O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82598,in,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82599,non,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82600,-,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82601,diabetic,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82602,and,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82603,diabetic,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82604,human,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82605,subjects,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82606,;,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82607,(,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82608,c,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82609,),O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82610,the,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82611,cholesterol,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82612,-,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82613,lowering,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82614,effect,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82615,in,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82616,human,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82617,subjects,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82618,with,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82619,moderately,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82620,raised,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82621,serum,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82622,cholesterol,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82623,levels,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82624,.,O,2862.0,"The following studies were conducted : ( a ) mineral availability , in vitro ; ( b ) glycaemic index ( GI ) in non - diabetic and diabetic human subjects ; ( c ) the cholesterol - lowering effect in human subjects with moderately raised serum cholesterol levels ."
82983,Both,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82984,heme,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82985,iron,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82986,absorption,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82987,and,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82988,nonheme,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82989,iron,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82990,absorption,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82991,were,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82992,higher,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82993,when,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82994,high,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82995,(,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82996,30,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82997,%,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82998,),O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82999,rather,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83000,than,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83001,low,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83002,(,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83003,5,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83004,%,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83005,),O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83006,dietary,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83007,fat,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83008,was,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83009,fed,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83010,.,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
84279,In,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84280,young,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84281,children,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84282,",",O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84283,low,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84284,intakes,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84285,of,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84286,n-3,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84287,fatty,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84288,acids,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84289,and,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84290,iron,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84291,are,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84292,a,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84293,potential,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84294,matter,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84295,of,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84296,concern,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84297,",",O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84298,as,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84299,are,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84300,the,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84301,high,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84302,intakes,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84303,of,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84304,energy,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84305,",",O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84306,protein,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84307,",",O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84308,sugared,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84309,beverages,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84310,",",O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84311,and,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84312,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84313,",",O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84314,since,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84315,these,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84316,may,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84317,increase,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84318,the,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84319,risk,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84320,of,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84321,becoming,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84322,overweight,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84323,.,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84415,Intervention,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84416,periods,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84417,were,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84418,preceded,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84419,by,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84420,2,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84421,-,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84422,week,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84423,depletion,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84424,phases,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84425,.,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84593,In,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84594,summary,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84595,",",O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84596,in,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84597,the,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84598,present,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84599,study,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84600,",",O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84601,2,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84602,-,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84603,week,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84604,interventions,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84605,with,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84606,carotenoid,B-http://purl.obolibrary.org/obo/CHEBI_23044,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84607,-,I-http://purl.obolibrary.org/obo/CHEBI_23044,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84608,rich,I-http://purl.obolibrary.org/obo/CHEBI_23044,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84609,juices,I-http://purl.obolibrary.org/obo/CHEBI_23044,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84610,led,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84611,only,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84612,to,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84613,minor,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84614,changes,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84615,in,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84616,investigated,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84617,luminal,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84618,biomarkers,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84619,relevant,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84620,to,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84621,colon,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84622,carcinogenesis,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84623,.,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
85520,Appropriate,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85521,nutritional,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85522,education,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85523,helps,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85524,children,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85525,with,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85526,diabetes,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85527,to,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85528,find,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85529,this,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85530,balance,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85531,and,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85532,enjoy,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85533,a,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85534,better,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85535,quality,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85536,of,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85537,life,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85538,.,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85902,Although,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85903,mushrooms,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85904,have,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85905,long,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85906,been,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85907,regarded,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85908,as,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85909,health,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85910,-,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85911,promoting,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85912,foods,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85913,",",O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85914,research,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85915,specific,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85916,to,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85917,their,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85918,role,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85919,in,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85920,a,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85921,healthful,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85922,diet,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85923,and,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85924,in,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85925,health,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85926,promotion,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85927,has,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85928,advanced,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85929,in,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85930,the,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85931,past,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85932,decade,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85933,.,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
86010,Mushrooms,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86011,are,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86012,a,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86013,rare,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86014,source,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86015,of,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86016,ergothioneine,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86017,as,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86018,well,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86019,as,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86020,selenium,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86021,",",O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86022,fiber,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86023,",",O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86024,and,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86025,several,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86026,other,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86027,vitamins,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86028,and,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86029,minerals,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86030,.,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86519,Personal,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86520,interviews,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86521,with,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86522,"1,016",O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86523,histologically,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86524,confirmed,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86525,GC,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86526,cases,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86527,and,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86528,"1,159",O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86529,population,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86530,controls,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86531,of,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86532,similar,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86533,age,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86534,and,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86535,sex,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86536,revealed,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86537,that,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86538,the,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86539,patients,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86540,were,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86541,more,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86542,often,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86543,of,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86544,lower,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86545,social,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86546,class,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86547,and,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86548,resident,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86549,in,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86550,rural,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86551,areas,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86552,and,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86553,more,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86554,frequently,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86555,reported,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86556,a,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86557,familial,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86558,history,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86559,of,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86560,gastric,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86561,(,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86562,but,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86563,not,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86564,other,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86565,),O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86566,cancer,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86567,.,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86706,Neither,O,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86707,cigarette,O,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86708,smoking,O,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86709,nor,O,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86710,alcoholic,B-http://purl.obolibrary.org/obo/FOODON_00001579;http://purl.obolibrary.org/obo/FOODON_00001094;http://purl.obolibrary.org/obo/FOODON_00003202,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86711,beverage,I-http://purl.obolibrary.org/obo/FOODON_00001579;http://purl.obolibrary.org/obo/FOODON_00001094;http://purl.obolibrary.org/obo/FOODON_00003202,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86712,drinking,O,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86713,were,O,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86714,significantly,O,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86715,related,O,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86716,to,O,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86717,GC,O,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86718,risk,O,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86719,.,O,3004.0,Neither cigarette smoking nor alcoholic beverage drinking were significantly related to GC risk .
86927,We,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86928,evaluated,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86929,the,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86930,changes,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86931,in,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86932,body,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86933,weight,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86934,",",O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86935,fasting,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86936,blood,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86937,glucose,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86938,",",O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86939,glucose,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86940,tolerance,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86941,",",O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86942,blood,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86943,coagulation,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86944,profile,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86945,",",O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86946,and,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86947,platelet,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86948,function,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86949,.,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86950,Diabetic,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86951,rats,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86952,developed,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86953,weight,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86954,loss,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86955,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86956,hyperglycemia,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86957,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86958,glucose,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86959,intolerance,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86960,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86961,inhibition,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86962,of,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86963,platelet,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86964,aggregation,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86965,responses,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86966,to,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86967,arachidonic,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86968,acid,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86969,and,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86970,adenosine,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86971,diphosphate,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86972,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86973,a,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86974,marked,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86975,decrease,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86976,(,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86977,>,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86978,50,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86979,%,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86980,),O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86981,in,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86982,plasma,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86983,fibrinogen,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86984,levels,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86985,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86986,and,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86987,short,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86988,activated,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86989,partial,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86990,thromboplastin,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86991,time,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86992,.,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
87108,These,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87109,findings,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87110,should,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87111,encourage,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87112,further,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87113,clinical,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87114,trials,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87115,to,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87116,assess,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87117,the,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87118,efficiency,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87119,of,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87120,camel,B-http://purl.obolibrary.org/obo/NCBITaxon_9837;http://purl.obolibrary.org/obo/NCBITaxon_9838;http://purl.obolibrary.org/obo/FOODON_03412103;http://purl.obolibrary.org/obo/UBERON_0001913,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87121,milk,I-http://purl.obolibrary.org/obo/NCBITaxon_9837;http://purl.obolibrary.org/obo/NCBITaxon_9838;http://purl.obolibrary.org/obo/FOODON_03412103;http://purl.obolibrary.org/obo/UBERON_0001913,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87122,and,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87123,bovine,B-http://purl.obolibrary.org/obo/FOODON_03414374;http://purl.obolibrary.org/obo/UBERON_0001913,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87124,milk,I-http://purl.obolibrary.org/obo/FOODON_03414374;http://purl.obolibrary.org/obo/UBERON_0001913,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87125,or,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87126,their,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87127,derived,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87128,peptides,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87129,as,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87130,food,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87131,supplements,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87132,or,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87133,potential,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87134,nonpharmacological,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87135,therapies,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87136,for,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87137,dysglycemia,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87138,and,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87139,the,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87140,vascular,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87141,complications,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87142,of,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87143,diabetes,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87144,mellitus,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87145,.,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87294,The,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87295,insulin,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87296,response,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87297,was,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87298,significantly,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87299,increased,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87300,by,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87301,adding,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87302,50,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87303,and,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87304,100,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87305,g,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87306,butter,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87307,",",O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87308,whereas,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87309,addition,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87310,of,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87311,40,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87312,and,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87313,80,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87314,g,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87315,olive,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87316,oil,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87317,had,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87318,no,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87319,effect,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87320,.,O,3021.0,"The insulin response was significantly increased by adding 50 and 100 g butter , whereas addition of 40 and 80 g olive oil had no effect ."
87321,The,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87322,fatty,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87323,acid,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87324,concentration,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87325,was,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87326,higher,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87327,when,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87328,100,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87329,g,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87330,butter,B-http://purl.obolibrary.org/obo/FOODON_03310351,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87331,was,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87332,added,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87333,to,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87334,the,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87335,potato,B-http://purl.obolibrary.org/obo/FOODON_03309707;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449;http://purl.obolibrary.org/obo/ONS_0000085;http://purl.obolibrary.org/obo/FOODON_03316468;http://purl.obolibrary.org/obo/NCIT_C80248,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87336,meal,I-http://purl.obolibrary.org/obo/FOODON_03309707;http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449;http://purl.obolibrary.org/obo/ONS_0000085;http://purl.obolibrary.org/obo/FOODON_03316468;http://purl.obolibrary.org/obo/NCIT_C80248,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87337,than,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87338,when,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87339,it,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87340,was,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87341,not,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87342,(,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87343,0.67,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87344,+,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87345,/-,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87346,0.05,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87347,compared,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87348,with,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87349,0.48,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87350,+,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87351,/-,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87352,0.07,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87353,mmol,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87354,/,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87355,L,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87356,",",O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87357,P,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87358,<,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87359,0.05,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87360,),O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87361,.,O,3022.0,"The fatty acid concentration was higher when 100 g butter was added to the potato meal than when it was not ( 0.67 + /- 0.05 compared with 0.48 + /- 0.07 mmol / L , P < 0.05 ) ."
87558,Relative,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87559,to,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87560,baseline,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87561,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87562,the,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87563,proportion,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87564,of,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87565,calories,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87566,from,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87567,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87568,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87569,soup,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87570,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87571,and,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87572,ONS,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87573,significantly,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87574,increased,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87575,at,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87576,post,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87577,-,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87578,treatment,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87579,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87580,while,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87581,grain,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87582,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87583,meat,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87584,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87585,potato,B-http://purl.obolibrary.org/obo/FOODON_03315354;http://purl.obolibrary.org/obo/NCBITaxon_4113;http://purl.obolibrary.org/obo/FOODON_03301449,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87586,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87587,baked,B-http://purl.obolibrary.org/obo/FOODON_00002456;http://purl.obolibrary.org/obo/FOODON_03303220,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87588,dessert,I-http://purl.obolibrary.org/obo/FOODON_00002456;http://purl.obolibrary.org/obo/FOODON_03303220,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87589,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87590,and,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87591,oil,B-http://purl.obolibrary.org/obo/FOODON_03310387,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87592,and,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87593,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87594,decreased,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87595,(,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87596,P,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87597,<,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87598,0.03,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87599,),O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87600,.,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87781,The,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87782,subjects,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87783,had,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87784,participated,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87785,in,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87786,a,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87787,previous,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87788,study,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87789,",",O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87790,were,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87791,never,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87792,diagnosed,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87793,with,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87794,breast,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87795,cancer,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87796,",",O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87797,provided,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87798,a,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87799,screening,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87800,mammogram,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87801,and,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87802,a,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87803,blood,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87804,sample,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87805,",",O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87806,and,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87807,completed,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87808,validated,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87809,food,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87810,-,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87811,frequency,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87812,questionnaires,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87813,.,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
88109,Cocoa,B-http://purl.obolibrary.org/obo/NCBITaxon_3641;http://purl.obolibrary.org/obo/FOODON_03301072,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88110,may,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88111,also,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88112,have,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88113,a,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88114,beneficial,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88115,effect,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88116,by,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88117,protecting,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88118,against,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88119,oxidative,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88120,stress,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88121,alterations,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88122,and,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88123,via,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88124,decreased,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88125,platelet,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88126,aggregation,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88127,",",O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88128,decreased,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88129,lipid,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88130,oxidation,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88131,",",O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88132,and,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88133,insulin,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88134,resistance,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88135,.,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88136,These,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88137,effects,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88138,are,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88139,associated,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88140,with,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88141,a,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88142,decrease,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88143,of,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88144,blood,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88145,pressure,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88146,and,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88147,a,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88148,favorable,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88149,trend,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88150,toward,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88151,a,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88152,reduction,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88153,in,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88154,cardiovascular,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88155,events,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88156,and,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88157,strokes,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88158,.,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
89218,Atherogenicity,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89219,(,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89220,2.68,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89221,vs.1.91,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89222,),O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89223,and,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89224,thrombogenic,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89225,(,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89226,4.58,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89227,vs.,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89228,2.81,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89229,),O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89230,indices,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89231,were,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89232,lower,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89233,with,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89234,LRS,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89235,compared,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89236,with,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89237,CON,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89238,.,O,3088.0,Atherogenicity ( 2.68 vs.1.91 ) and thrombogenic ( 4.58 vs. 2.81 ) indices were lower with LRS compared with CON .
89398,After,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89399,adjustment,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89400,for,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89401,other,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89402,food,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89403,constituents,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89404,",",O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89405,only,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89406,increased,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89407,vitamin,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89408,C,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89409,consumption,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89410,showed,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89411,an,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89412,inverse,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89413,relation,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89414,to,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89415,risk,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89416,.,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
90263,This,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90264,work,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90265,demonstrates,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90266,the,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90267,successful,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90268,application,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90269,of,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90270,the,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90271,rejection,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90272,threshold,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90273,method,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90274,to,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90275,a,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90276,complex,B-http://purl.obolibrary.org/obo/ENVO_00003862;http://purl.obolibrary.org/obo/CHEBI_33290,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90277,dairy,I-http://purl.obolibrary.org/obo/ENVO_00003862;http://purl.obolibrary.org/obo/CHEBI_33290,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90278,food,I-http://purl.obolibrary.org/obo/ENVO_00003862;http://purl.obolibrary.org/obo/CHEBI_33290,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90279,.,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90444,Currently,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90445,",",O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90446,there,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90447,is,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90448,a,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90449,need,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90450,to,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90451,study,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90452,specific,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90453,well,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90454,-,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90455,defined,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90456,foods,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90457,",",O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90458,as,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90459,opposed,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90460,to,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90461,calculating,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90462,nutrients,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90463,",",O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90464,in,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90465,order,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90466,to,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90467,better,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90468,understand,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90469,these,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90470,relationships,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90471,.,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90640,The,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90641,apparent,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90642,viscosity,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90643,tended,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90644,to,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90645,increase,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90646,with,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90647,the,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90648,addition,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90649,of,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90650,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90651,and,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90652,oil,B-http://purl.obolibrary.org/obo/FOODON_03310387,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90653,.,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90938,Odds,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90939,ratios,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90940,for,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90941,diabetes,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90942,incidence,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90943,across,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90944,quintiles,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90945,of,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90946,factor,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90947,scores,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90948,were,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90949,computed,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90950,by,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90951,use,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90952,of,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90953,logistic,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90954,regression,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90955,",",O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90956,adjusting,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90957,for,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90958,age,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90959,",",O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90960,energy,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90961,intake,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90962,",",O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90963,family,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90964,history,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90965,of,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90966,diabetes,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90967,",",O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90968,country,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90969,of,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90970,birth,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90971,",",O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90972,and,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90973,other,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90974,factor,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90975,scores,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
90976,.,O,3152.0,"Odds ratios for diabetes incidence across quintiles of factor scores were computed by use of logistic regression , adjusting for age , energy intake , family history of diabetes , country of birth , and other factor scores ."
91175,Of,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91176,the,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91177,eleven,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91178,free,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91179,-,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91180,living,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91181,subjects,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91182,three,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91183,were,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91184,normocholesteremic,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91185,",",O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91186,three,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91187,had,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91188,type,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91189,IIa,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91190,hyperlipidemia,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91191,and,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91192,five,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91193,had,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91194,type,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91195,VI,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91196,(,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91197,IIb,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91198,),O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91199,.,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91587,According,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91588,to,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91589,the,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91590,questionnaire,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91591,",",O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91592,energy,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91593,intake,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91594,was,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91595,underreported,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91596,in,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91597,only,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91598,9,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91599,%,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91600,of,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91601,subjects,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91602,and,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91603,was,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91604,not,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91605,associated,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91606,with,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91607,a,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91608,healthier,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91609,diet,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91610,",",O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91611,thus,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91612,",",O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91613,further,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91614,analyses,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91615,were,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91616,based,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91617,on,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91618,the,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91619,questionnaire,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
91620,.,O,3177.0,"According to the questionnaire , energy intake was underreported in only 9 % of subjects and was not associated with a healthier diet , thus , further analyses were based on the questionnaire ."
92092,Their,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92093,calibration,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92094,and,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92095,maintenance,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92096,requirements,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92097,have,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92098,to,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92099,be,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92100,checked,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92101,thoroughly,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92102,before,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92103,they,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92104,can,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92105,be,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92106,regularly,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92107,implemented,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92108,on,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92109,dairy,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92110,farms,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92111,.,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92165,In,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92166,the,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92167,present,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92168,article,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92169,",",O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92170,the,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92171,cytotoxic,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92172,and,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92173,antitumor,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92174,activities,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92175,of,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92176,several,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92177,food,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92178,items,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92179,including,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92180,plants,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92181,and,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92182,animal,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92183,products,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92184,recommended,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92185,by,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92186,TPM,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92187,as,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92188,anticancer,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92189,agents,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92190,are,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92191,discussed,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92192,.,O,3196.0,"In the present article , the cytotoxic and antitumor activities of several food items including plants and animal products recommended by TPM as anticancer agents are discussed ."
92330,Hypersensitivity,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92331,to,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92332,birch,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92333,pollen,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92334,was,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92335,linked,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92336,with,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92337,allergy,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92338,to,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92339,apple,B-http://purl.obolibrary.org/obo/FOODON_00002473;http://purl.obolibrary.org/obo/NCBITaxon_3750,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92340,and,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92341,carrot,B-http://purl.obolibrary.org/obo/NCBITaxon_4039;http://purl.obolibrary.org/obo/FOODON_00003408,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92342,",",O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92343,apple,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92344,seeds,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92345,and,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92346,carrot,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92347,seeds,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92348,and,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92349,also,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92350,with,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92351,their,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92352,fractions,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92353,.,O,3200.0,"Hypersensitivity to birch pollen was linked with allergy to apple and carrot , apple seeds and carrot seeds and also with their fractions ."
92546,In,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92547,the,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92548,gut,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92549,",",O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92550,obesity,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92551,-,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92552,associated,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92553,dysregulation,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92554,of,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92555,microbiota,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92556,and,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92557,impaired,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92558,gut,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92559,barrier,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92560,function,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92561,may,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92562,increase,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92563,endotoxin,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92564,exposure,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92565,.,O,3210.0,"In the gut , obesity - associated dysregulation of microbiota and impaired gut barrier function may increase endotoxin exposure ."
92618,While,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92619,this,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92620,evidence,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92621,suggests,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92622,that,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92623,yogurt,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92624,consumption,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92625,is,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92626,beneficial,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92627,for,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92628,obese,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92629,individuals,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92630,",",O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92631,randomized,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92632,-,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92633,controlled,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92634,trials,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92635,are,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92636,needed,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92637,to,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92638,further,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92639,support,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92640,this,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92641,hypothesis,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92642,.,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92842,Therefore,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92843,",",O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92844,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92845,products,I-http://purl.obolibrary.org/obo/ENVO_00003862,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92846,should,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92847,not,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92848,be,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92849,recommended,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92850,in,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92851,a,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92852,healthy,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92853,vegetarian,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92854,diet,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92855,.,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
93023,These,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93024,plants,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93025,are,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93026,bestowed,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93027,with,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93028,functional,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93029,ingredients,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93030,that,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93031,may,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93032,provide,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93033,protection,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93034,against,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93035,various,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93036,menaces,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93037,.,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93097,Nevertheless,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93098,",",O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93099,interaction,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93100,between,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93101,drugs,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93102,and,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93103,herbs,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93104,/,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93105,botanicals,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93106,should,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93107,be,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93108,well,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93109,investigated,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93110,before,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93111,recommended,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93112,for,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93113,their,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93114,safe,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93115,use,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93116,",",O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93117,and,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93118,such,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93119,information,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93120,must,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93121,be,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93122,disseminated,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93123,to,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93124,the,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93125,allied,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93126,stakeholders,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93127,.,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93231,When,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93232,comparison,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93233,was,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93234,done,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93235,to,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93236,both,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93237,matched,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93238,control,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93239,groups,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93240,",",O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93241,a,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93242,nonsignificant,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93243,negative,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93244,association,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93245,was,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93246,found,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93247,between,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93248,consumption,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93249,of,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93250,cups,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93251,of,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93252,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93253,and,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93254,BC,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93255,(,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93256,odds,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93257,ratios,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93258,of,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93259,greater,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93260,than,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93261,or,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93262,equal,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93263,to,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93264,4,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93265,cups,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93266,of,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93267,coffee,B-http://purl.obolibrary.org/obo/FOODON_03301036;http://purl.obolibrary.org/obo/NCBITaxon_13443,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93268,/,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93269,day,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93270,vs.,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93271,less,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93272,than,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93273,or,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93274,equal,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93275,to,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93276,1,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93277,per,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93278,week,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93279,=,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93280,0.6,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93281,for,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93282,BC,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93283,/,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93284,NC,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93285,and,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93286,0.7,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93287,for,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93288,BC,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93289,/,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93290,SC,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93291,),O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93292,.,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93304,The,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93305,pattern,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93306,was,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93307,stronger,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93308,among,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93309,the,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93310,high,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93311,-,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93312,fat,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93313,consumers,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93314,after,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93315,controlling,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93316,for,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93317,several,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93318,hormonal,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93319,confounding,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93320,factors,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93321,(,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93322,two,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93323,-,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93324,tailed,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93325,P,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93326,-,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93327,value,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93328,for,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93329,linear,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93330,trend,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93331,=,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93332,0.06,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93333,for,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93334,SC,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93335,and,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93336,P,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93337,=,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93338,0.05,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93339,for,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93340,NC,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93341,),O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93342,.,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93422,Participants,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93423,were,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93424,requested,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93425,to,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93426,select,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93427,the,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93428,specific,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93429,diet,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93430,that,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93431,they,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93432,wished,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93433,to,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93434,follow,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93435,during,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93436,the,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93437,12,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93438,h,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93439,prior,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93440,to,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93441,collection,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93442,of,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93443,urine,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93444,.,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93727,The,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93728,histamine,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93729,release,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93730,test,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93731,was,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93732,positive,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93733,for,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93734,carrot,B-http://purl.obolibrary.org/obo/NCBITaxon_4039;http://purl.obolibrary.org/obo/FOODON_00003408,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93735,",",O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93736,celery,B-http://purl.obolibrary.org/obo/FOODON_03301727;http://purl.obolibrary.org/obo/NCBITaxon_117781,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93737,",",O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93738,celeriac,B-http://purl.obolibrary.org/obo/NCBITaxon_278110,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93739,",",O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93740,and,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93741,olive,B-http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93742,pollen,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93743,up,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93744,to,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93745,a,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93746,dilution,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93747,of,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93748,1/10(6,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93749,),O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93750,.,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93800,The,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93801,existence,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93802,of,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93803,monosensitization,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93804,to,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93805,an,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93806,18,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93807,-,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93808,kDa,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93809,protein,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93810,in,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93811,carrot,B-http://purl.obolibrary.org/obo/NCBITaxon_4039;http://purl.obolibrary.org/obo/FOODON_00003408,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93812,and,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93813,specific,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93814,IgE,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93815,to,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93816,olive,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93817,pollen,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93818,has,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93819,not,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93820,been,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93821,reported,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93822,in,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93823,the,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93824,celery,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93825,-,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93826,carrot,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93827,-,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93828,mugwort,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93829,-,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93830,spice,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93831,syndrome,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93832,.,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
94800,This,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94801,point,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94802,",",O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94803,especially,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94804,if,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94805,confirmed,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94806,by,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94807,experiments,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94808,with,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94809,more,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94810,frequent,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94811,after,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94812,meal,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94813,measurements,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94814,and,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94815,of,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94816,longer,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94817,duration,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94818,",",O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94819,should,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94820,be,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94821,taken,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94822,into,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94823,account,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94824,in,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94825,defining,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94826,the,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94827,best,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94828,dietary,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94829,approach,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94830,to,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94831,lower,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94832,plasma,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94833,TG,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94834,levels,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94835,throughout,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94836,the,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94837,whole,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94838,day,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94839,.,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
95814,Fresh,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95815,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95816,and,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95817,citrus,B-http://purl.obolibrary.org/obo/FOODON_03301337;http://purl.obolibrary.org/obo/FOODON_00003324;http://purl.obolibrary.org/obo/NCBITaxon_2706;http://purl.obolibrary.org/obo/FOODON_00001151;http://purl.obolibrary.org/obo/PO_0009001,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95818,fruit,I-http://purl.obolibrary.org/obo/FOODON_03301337;http://purl.obolibrary.org/obo/FOODON_00003324;http://purl.obolibrary.org/obo/NCBITaxon_2706;http://purl.obolibrary.org/obo/FOODON_00001151;http://purl.obolibrary.org/obo/PO_0009001,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95819,consumption,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95820,may,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95821,protect,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95822,against,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95823,diffuse,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95824,and,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95825,cardia,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95826,GC,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95827,",",O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95828,respectively,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95829,.,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95934,In,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95935,this,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95936,study,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95937,",",O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95938,prolamin,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95939,and,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95940,glutelin,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95941,fractions,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95942,were,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95943,isolated,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95944,from,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95945,wheat,B-http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95946,",",O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95947,rye,B-http://purl.obolibrary.org/obo/FOODON_00003734;http://purl.obolibrary.org/obo/NCBITaxon_4550,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95948,",",O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95949,barley,B-http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/FOODON_00003108,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95950,",",O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95951,oats,B-http://purl.obolibrary.org/obo/FOODON_03315188;http://purl.obolibrary.org/obo/FOODON_00003429,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95952,and,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95953,corn,B-http://purl.obolibrary.org/obo/NCBITaxon_381124,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95954,.,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
96110,The,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96111,knowledge,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96112,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96113,uranium,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96114,concentration,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96115,",",O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96116,in,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96117,the,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96118,products,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96119,entering,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96120,the,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96121,human,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96122,diet,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96123,is,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96124,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96125,extreme,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96126,importance,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96127,because,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96128,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96129,their,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96130,chemical,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96131,hazard,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96132,to,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96133,health,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96134,.,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96351,However,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96352,",",O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96353,there,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96354,are,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96355,few,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96356,distinguishable,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96357,differences,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96358,between,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96359,the,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96360,glucoregulatory,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96361,qualities,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96362,of,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96363,the,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96364,proteins,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96365,in,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96366,plant,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96367,-,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96368,based,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96369,foods,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96370,",",O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96371,and,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96372,it,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96373,is,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96374,likely,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96375,their,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96376,numerous,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96377,non,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96378,-,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96379,protein,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96380,components,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96381,(,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96382,e.g.,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96383,",",O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96384,fibers,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96385,and,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96386,phytochemicals,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96387,),O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96388,that,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96389,drive,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96390,the,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96391,relationship,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96392,with,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96393,type,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96394,2,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96395,diabetes,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96396,risk,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96397,reduction,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96398,.,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96794,Scientific,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96795,research,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96796,has,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96797,demonstrated,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96798,that,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96799,the,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96800,molecules,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96801,present,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96802,in,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96803,grapes,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96804,and,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96805,in,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96806,wine,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96807,alter,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96808,cellular,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96809,metabolism,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96810,and,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96811,signaling,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96812,",",O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96813,which,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96814,is,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96815,consistent,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96816,mechanistically,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96817,with,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96818,reducing,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96819,arterial,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96820,disease,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96821,.,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
97188,Several,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97189,lectins,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97190,have,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97191,been,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97192,found,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97193,to,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97194,possess,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97195,anticancer,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97196,properties,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97197,in,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97198,vitro,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97199,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97200,in,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97201,vivo,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97202,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97203,and,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97204,in,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97205,human,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97206,case,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97207,studies,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97208,;,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97209,they,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97210,are,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97211,used,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97212,as,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97213,therapeutic,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97214,agents,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97215,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97216,preferentially,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97217,binding,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97218,to,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97219,cancer,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97220,cell,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97221,membranes,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97222,or,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97223,their,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97224,receptors,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97225,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97226,causing,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97227,cytotoxicity,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97228,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97229,apoptosis,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97230,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97231,and,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97232,inhibition,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97233,of,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97234,tumor,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97235,growth,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97236,.,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97237,These,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97238,compounds,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97239,can,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97240,become,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97241,internalized,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97242,into,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97243,cells,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97244,",",O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97245,causing,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97246,cancer,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97247,cell,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97248,agglutination,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97249,and/or,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97250,aggregation,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97251,.,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97599,While,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97600,the,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97601,pathogenesis,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97602,of,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97603,dementia,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97604,is,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97605,complex,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97606,and,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97607,incompletely,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97608,understood,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97609,",",O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97610,it,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97611,may,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97612,be,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97613,",",O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97614,at,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97615,least,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97616,to,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97617,a,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97618,certain,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97619,extent,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97620,",",O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97621,the,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97622,consequence,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97623,of,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97624,systemic,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97625,vascular,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97626,pathology,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97627,.,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97628,The,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97629,metabolic,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97630,syndrome,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97631,and,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97632,its,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97633,individual,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97634,components,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97635,induce,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97636,a,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97637,proinflammatory,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97638,state,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97639,that,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97640,damages,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97641,blood,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97642,vessels,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97643,.,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97644,This,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97645,condition,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97646,of,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97647,chronic,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97648,inflammation,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97649,may,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97650,damage,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97651,the,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97652,vasculature,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97653,of,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97654,the,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97655,brain,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97656,or,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97657,be,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97658,directly,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97659,neurotoxic,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97660,.,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97675,A,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97676,relationship,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97677,has,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97678,also,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97679,been,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97680,observed,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97681,between,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97682,certain,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97683,dietary,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97684,factors,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97685,",",O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97686,such,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97687,as,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97688,constituents,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97689,of,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97690,the,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97691,',O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97692,Mediterranean,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97693,diet,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97694,',O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97695,",",O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97696,and,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97697,the,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97698,metabolic,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97699,syndrome,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97700,;,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97701,similar,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97702,associations,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97703,have,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97704,been,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97705,noted,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97706,between,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97707,these,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97708,dietary,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97709,factors,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97710,and,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97711,dementia,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97712,.,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97943,Females,O,3394.0,Females reported FS more often than males .
97944,reported,O,3394.0,Females reported FS more often than males .
97945,FS,O,3394.0,Females reported FS more often than males .
97946,more,O,3394.0,Females reported FS more often than males .
97947,often,O,3394.0,Females reported FS more often than males .
97948,than,O,3394.0,Females reported FS more often than males .
97949,males,O,3394.0,Females reported FS more often than males .
97950,.,O,3394.0,Females reported FS more often than males .
98217,Saturated,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98218,fat,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98219,/,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98220,cholesterol,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98221,avoidance,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98222,increased,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98223,significantly,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98224,with,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98225,increased,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98226,socioeconomic,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98227,status,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98228,in,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98229,both,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98230,ethnic,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98231,groups,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98232,.,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98549,Similarly,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98550,",",O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98551,the,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98552,association,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98553,of,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98554,green,B-http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98555,tea,I-http://purl.obolibrary.org/obo/FOODON_03304639;http://purl.obolibrary.org/obo/PATO_0000320;http://purl.obolibrary.org/obo/FOODON_03315081,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98556,consumption,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98557,was,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98558,observed,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98559,among,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98560,never,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98561,smokers,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98562,and,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98563,never,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98564,alcohol,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98565,drinkers,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98566,.,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98567,No,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98568,change,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98569,in,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98570,these,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98571,associations,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98572,was,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98573,seen,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98574,on,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98575,stratification,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98576,by,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98577,each,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98578,confounding,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98579,factors,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98580,.,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98645,All,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98646,reported,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98647,foods,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98648,and,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98649,beverages,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98650,were,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98651,assigned,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98652,to,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98653,one,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98654,of,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98655,76,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98656,food,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98657,groups,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98658,.,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
99437,Because,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99438,vitamin,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99439,C,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99440,is,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99441,the,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99442,major,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99443,water,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99444,-,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99445,soluble,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99446,antioxidant,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99447,in,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99448,mammals,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99449,",",O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99450,we,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99451,examined,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99452,the,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99453,effect,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99454,of,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99455,dietary,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99456,vitamin,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99457,C,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99458,on,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99459,neutrophil,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99460,function,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99461,and,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99462,responses,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99463,to,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99464,intramammary,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99465,infusion,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99466,of,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99467,lipopolysaccahride,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99468,(,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99469,LPS,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99470,),O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99471,in,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99472,periparturient,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99473,dairy,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99474,cows,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99475,.,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99547,Supplementation,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99548,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99549,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99550,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99551,increased,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99552,plasma,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99553,concentrations,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99554,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99555,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99556,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99557,at,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99558,calving,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99559,",",O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99560,but,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99561,no,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99562,differences,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99563,were,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99564,observed,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99565,in,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99566,samples,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99567,taken,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99568,24,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99569,h,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99570,postinfusion,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99571,.,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99725,The,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99726,only,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99727,treatment,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99728,for,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99729,this,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99730,disease,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99731,consists,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99732,of,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99733,a,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99734,lifelong,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99735,gluten,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99736,free,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99737,diet,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99738,;,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99739,this,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99740,is,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99741,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99742,celiac,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99743,people,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99744,can,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99745,not,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99746,consume,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99747,products,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99748,containing,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99749,gluten,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99750,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99751,such,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99752,as,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99753,wheat,B-http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99754,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99755,barley,B-http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/FOODON_00003108,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99756,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99757,and,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99758,rye,B-http://purl.obolibrary.org/obo/FOODON_00003734;http://purl.obolibrary.org/obo/NCBITaxon_4550,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99759,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99760,but,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99761,they,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99762,can,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99763,use,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99764,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99765,and,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99766,corn,B-http://purl.obolibrary.org/obo/NCBITaxon_381124,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99767,.,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99768,Thus,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99769,",",O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99770,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641;http://purl.obolibrary.org/obo/FOODON_03301116,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99771,flour,I-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641;http://purl.obolibrary.org/obo/FOODON_03301116,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99772,is,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99773,mainly,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99774,used,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99775,for,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99776,the,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99777,manufacturing,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99778,of,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99779,the,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99780,basic,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99781,products,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99782,of,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99783,this,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99784,population,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99785,.,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99786,Unfortunately,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99787,",",O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99788,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99789,can,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99790,contain,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99791,high,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99792,contents,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99793,of,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99794,total,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99795,(,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99796,t,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99797,-,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99798,As,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99799,),O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99800,and,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99801,inorganic,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99802,(,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99803,i,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99804,-,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99805,As,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99806,),O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99807,arsenic,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99808,.,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
100070,There,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100071,is,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100072,converging,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100073,evidence,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100074,on,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100075,the,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100076,benefits,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100077,of,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100078,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100079,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100080,for,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100081,preventing,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100082,several,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100083,CVD,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100084,risk,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100085,factors,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100086,",",O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100087,including,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100088,diabetes,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100089,",",O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100090,MetS,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100091,and,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100092,obesity,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100093,.,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100425,The,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100426,results,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100427,suggested,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100428,that,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100429,the,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100430,different,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100431,molecular,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100432,targets,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100433,modulated,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100434,by,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100435,rosemary,B-http://purl.obolibrary.org/obo/NCBITaxon_39367;http://purl.obolibrary.org/obo/FOODON_00002212,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100436,and,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100437,its,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100438,active,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100439,constituents,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100440,are,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100441,useful,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100442,indicators,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100443,of,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100444,success,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100445,in,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100446,clinical,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100447,cancer,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100448,chemo,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100449,-,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100450,prevention,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100451,trials,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100452,.,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100787,We,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100788,used,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100789,Cox,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100790,proportional,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100791,hazards,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100792,regression,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100793,to,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100794,calculate,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100795,associations,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100796,for,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100797,substitutions,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100798,between,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100799,dairy,B-http://purl.obolibrary.org/obo/ENVO_00003862,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100800,products,I-http://purl.obolibrary.org/obo/ENVO_00003862,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100801,with,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100802,the,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100803,rate,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100804,of,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100805,stroke,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100806,.,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100920,In,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100921,conclusion,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100922,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100923,whole,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100924,-,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100925,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100926,yogurt,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100927,as,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100928,a,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100929,substitution,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100930,for,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100931,low,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100932,-,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100933,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100934,yogurt,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100935,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100936,cheese,B-http://purl.obolibrary.org/obo/FOODON_00001013,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100937,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100938,butter,B-http://purl.obolibrary.org/obo/FOODON_03310351,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100939,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100940,buttermilk,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100941,or,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100942,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100943,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100944,regardless,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100945,of,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100946,fat,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100947,content,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100948,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100949,was,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100950,associated,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100951,with,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100952,a,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100953,lower,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100954,rate,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100955,of,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100956,ischaemic,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100957,stroke,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100958,.,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100959,The,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100960,incidence,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100961,and,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100962,severity,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100963,of,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100964,hypertension,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100965,are,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100966,affected,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100967,by,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100968,nutritional,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100969,status,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100970,and,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100971,intake,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100972,of,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100973,many,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100974,nutrients,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100975,.,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100976,Excessive,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100977,energy,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100978,intake,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100979,and,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100980,obesity,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100981,are,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100982,major,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100983,causes,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100984,of,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100985,hypertension,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100986,.,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
101099,Short,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101100,-,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101101,term,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101102,studies,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101103,indicate,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101104,that,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101105,specialized,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101106,diets,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101107,may,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101108,prevent,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101109,or,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101110,ameliorate,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101111,mild,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101112,hypertension,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101113,;,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101114,most,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101115,notable,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101116,are,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101117,the,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101118,Dietary,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101119,Approaches,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101120,to,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101121,Stop,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101122,Hypertension,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101123,(,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101124,DASH,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101125,),O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101126,diet,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101127,",",O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101128,which,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101129,is,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101130,high,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101131,in,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101132,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101133,",",O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101134,vegetables,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101135,",",O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101136,and,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101137,low,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101138,-,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101139,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101140,dairy,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101141,products,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101142,",",O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101143,and,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101144,the,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101145,DASH,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101146,low,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101147,-,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101148,sodium,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101149,diet,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101150,.,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101151,Long,O,3510.0,Long - term compliance to these diets remains a major concern .
101152,-,O,3510.0,Long - term compliance to these diets remains a major concern .
101153,term,O,3510.0,Long - term compliance to these diets remains a major concern .
101154,compliance,O,3510.0,Long - term compliance to these diets remains a major concern .
101155,to,O,3510.0,Long - term compliance to these diets remains a major concern .
101156,these,O,3510.0,Long - term compliance to these diets remains a major concern .
101157,diets,O,3510.0,Long - term compliance to these diets remains a major concern .
101158,remains,O,3510.0,Long - term compliance to these diets remains a major concern .
101159,a,O,3510.0,Long - term compliance to these diets remains a major concern .
101160,major,O,3510.0,Long - term compliance to these diets remains a major concern .
101161,concern,O,3510.0,Long - term compliance to these diets remains a major concern .
101162,.,O,3510.0,Long - term compliance to these diets remains a major concern .
101255,Foods,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101256,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101257,such,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101258,as,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101259,tomatoes,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101260,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101261,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101262,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101263,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101264,broccoli,B-http://purl.obolibrary.org/obo/FOODON_03301713;http://purl.obolibrary.org/obo/FOODON_00003405;http://purl.obolibrary.org/obo/NCBITaxon_36774,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101265,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101266,garlic,B-http://purl.obolibrary.org/obo/FOODON_03305208;http://purl.obolibrary.org/obo/FOODON_00003582;http://purl.obolibrary.org/obo/NCBITaxon_4682,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101267,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101268,onions,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101269,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101270,berries,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101271,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101272,soy,B-http://purl.obolibrary.org/obo/FOODON_00002753,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101273,bean,I-http://purl.obolibrary.org/obo/FOODON_00002753,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101274,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101275,honey,B-http://purl.obolibrary.org/obo/UBERON_0036016,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101276,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101277,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101278,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101279,aloe,B-http://purl.obolibrary.org/obo/NCBITaxon_34199;http://purl.obolibrary.org/obo/NCBITaxon_25641,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101280,vera,I-http://purl.obolibrary.org/obo/NCBITaxon_34199;http://purl.obolibrary.org/obo/NCBITaxon_25641,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101281,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101282,grapes,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101283,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101284,rosemary,B-http://purl.obolibrary.org/obo/NCBITaxon_39367;http://purl.obolibrary.org/obo/FOODON_00002212,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101285,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101286,basil,B-http://purl.obolibrary.org/obo/NCBITaxon_39350;http://purl.obolibrary.org/obo/FOODON_00003044,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101287,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101288,chili,B-http://purl.obolibrary.org/obo/FOODON_03317304;http://purl.obolibrary.org/obo/FOODON_03301511;http://purl.obolibrary.org/obo/NCBITaxon_4071,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101289,peppers,I-http://purl.obolibrary.org/obo/FOODON_03317304;http://purl.obolibrary.org/obo/FOODON_03301511;http://purl.obolibrary.org/obo/NCBITaxon_4071,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101290,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101291,carrots,B-http://purl.obolibrary.org/obo/NCBITaxon_4039,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101292,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101293,pomegranate,B-http://purl.obolibrary.org/obo/NCBITaxon_22663;http://purl.obolibrary.org/obo/FOODON_00003066,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101294,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101295,and,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101296,curcuma,B-http://purl.obolibrary.org/obo/FOODON_00002323;http://purl.obolibrary.org/obo/NCBITaxon_99568,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101297,contain,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101298,active,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101299,components,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101300,that,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101301,can,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101302,influence,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101303,the,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101304,initiation,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101305,and,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101306,the,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101307,progression,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101308,of,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101309,carcinogenesis,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101310,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101311,acting,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101312,on,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101313,pathways,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101314,implied,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101315,in,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101316,cell,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101317,proliferation,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101318,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101319,apoptosis,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101320,and,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101321,metastasis,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101322,.,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
102468,Available,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102469,scientific,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102470,evidence,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102471,agrees,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102472,on,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102473,the,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102474,harmful,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102475,effects,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102476,of,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102477,high,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102478,meat,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102479,/,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102480,animal,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102481,protein,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102482,intake,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102483,and,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102484,low,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102485,calcium,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102486,diets,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102487,",",O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102488,whereas,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102489,high,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102490,content,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102491,of,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102492,fruits,B-http://purl.obolibrary.org/obo/FOODON_03304644,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102493,and,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102494,vegetables,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102495,associated,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102496,with,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102497,a,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102498,balanced,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102499,intake,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102500,of,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102501,low,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102502,-,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102503,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102504,dairy,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102505,products,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/ENVO_00003862,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102506,carries,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102507,the,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102508,lowest,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102509,risk,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102510,for,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102511,incident,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102512,kidney,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102513,stones,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102514,.,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102707,Processed,B-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102708,foods,I-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102709,high,I-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102710,in,I-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102711,salt,I-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102712,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102713,such,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102714,as,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102715,processed,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102716,meat,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102717,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102718,cheese,B-http://purl.obolibrary.org/obo/FOODON_00001013,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102719,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102720,pizzas,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102721,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102722,and,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102723,savory,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102724,snacks,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102725,were,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102726,consumed,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102727,rather,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102728,infrequently,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102729,in,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102730,all,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102731,the,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102732,countries,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102733,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102734,but,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102735,salt,B-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102736,-,I-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102737,rich,I-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102738,foods,I-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102739,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102740,such,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102741,as,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102742,soups,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102743,or,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102744,bread,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102745,and,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102746,salty,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102747,condiments,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102748,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102749,were,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102750,consumed,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102751,frequently,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102752,in,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102753,all,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102754,countries,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102755,.,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102756,The,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102757,majority,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102758,of,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102759,the,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102760,participants,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102761,knew,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102762,that,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102763,high,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102764,salt,B-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102765,intake,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102766,can,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102767,cause,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102768,health,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102769,problems,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102770,(,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102771,85,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102772,%,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102773,),O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102774,and,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102775,thought,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102776,that,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102777,it,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102778,is,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102779,important,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102780,to,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102781,limit,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102782,salt,B-http://purl.obolibrary.org/obo/CHEBI_24866;http://purl.obolibrary.org/obo/CHEBI_26710,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102783,intake,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102784,(,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102785,91,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102786,%,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102787,),O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102788,.,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102963,We,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102964,also,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102965,identified,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102966,the,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102967,mid,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102968,-,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102969,dorsal,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102970,insula,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102971,as,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102972,well,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102973,as,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102974,the,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102975,primary,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102976,and,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102977,secondary,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102978,somatosensory,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102979,cortex,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102980,-,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102981,regions,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102982,previously,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102983,assumed,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102984,to,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102985,integrate,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102986,oral,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102987,-,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102988,sensory,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102989,inputs,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102990,.,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
103438,Preference,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103439,for,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103440,exclusive,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103441,consumption,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103442,of,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103443,reduced,B-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103444,-,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103445,fat,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103446,milk,I-http://purl.obolibrary.org/obo/FOODON_00003265;http://purl.obolibrary.org/obo/UBERON_0001013;http://purl.obolibrary.org/obo/UBERON_0001913,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103447,was,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103448,linked,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103449,to,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103450,significant,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103451,risk,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103452,reduction,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103453,for,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103454,oral,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103455,and,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103456,cervical,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103457,cancers,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103458,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103459,and,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103460,drinking,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103461,only,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103462,whole,B-http://purl.obolibrary.org/obo/UBERON_0001913,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103463,milk,I-http://purl.obolibrary.org/obo/UBERON_0001913,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103464,was,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103465,linked,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103466,to,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103467,significant,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103468,risk,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103469,increases,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103470,for,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103471,cancers,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103472,of,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103473,the,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103474,oral,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103475,cavity,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103476,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103477,stomach,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103478,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103479,rectum,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103480,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103481,lung,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103482,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103483,and,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103484,breast,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103485,.,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103515,The,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103516,effects,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103517,observed,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103518,for,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103519,some,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103520,sites,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103521,may,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103522,be,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103523,confounded,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103524,by,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103525,other,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103526,dietary,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103527,or,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103528,nondietary,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103529,correlates,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103530,of,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103531,risk,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103532,.,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103533,During,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103534,the,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103535,past,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103536,20,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103537,years,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103538,",",O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103539,many,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103540,studies,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103541,have,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103542,focused,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103543,on,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103544,polyphenol,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103545,compounds,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103546,for,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103547,their,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103548,potential,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103549,beneficial,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103550,health,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103551,effects,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103552,.,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103589,Given,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103590,the,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103591,putative,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103592,relationship,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103593,between,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103594,inflammation,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103595,and,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103596,insulin,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103597,resistance,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103598,",",O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103599,the,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103600,consumption,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103601,of,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103602,flavonoids,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103603,or,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103604,flavonoid,B-http://purl.obolibrary.org/obo/CHEBI_47916;http://purl.obolibrary.org/obo/CHEBI_72544,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103605,-,I-http://purl.obolibrary.org/obo/CHEBI_47916;http://purl.obolibrary.org/obo/CHEBI_72544,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103606,rich,I-http://purl.obolibrary.org/obo/CHEBI_47916;http://purl.obolibrary.org/obo/CHEBI_72544,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103607,foods,I-http://purl.obolibrary.org/obo/CHEBI_47916;http://purl.obolibrary.org/obo/CHEBI_72544,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103608,has,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103609,been,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103610,suggested,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103611,to,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103612,reduce,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103613,the,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103614,risk,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103615,of,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103616,diabetes,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103617,by,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103618,targeting,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103619,inflammatory,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103620,signals,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103621,.,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103907,Conjugated,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103908,linoleic,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103909,acid,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103910,(,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103911,CLA,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103912,),O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103913,is,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103914,a,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103915,collective,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103916,term,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103917,for,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103918,positional,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103919,and,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103920,geometric,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103921,isomers,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103922,of,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103923,octadecadienoic,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103924,acid,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103925,in,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103926,which,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103927,the,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103928,double,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103929,bonds,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103930,are,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103931,conjugated,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103932,",",O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103933,i.e.,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103934,contiguous,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103935,.,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103952,It,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103953,is,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103954,formed,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103955,as,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103956,an,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103957,intermediate,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103958,in,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103959,the,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103960,course,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103961,of,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103962,the,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103963,conversion,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103964,of,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103965,linoleic,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103966,acid,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103967,to,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103968,oleic,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103969,acid,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103970,in,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103971,the,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103972,rumen,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103973,.,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
104173,The,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104174,mechanisms,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104175,underlying,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104176,the,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104177,effects,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104178,of,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104179,CLA,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104180,are,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104181,still,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104182,moot,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104183,.,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
105171,A,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105172,lower,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105173,-,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105174,than,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105175,-,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105176,recommended,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105177,potassium,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105178,intake,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105179,is,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105180,a,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105181,well,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105182,-,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105183,established,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105184,risk,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105185,factor,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105186,for,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105187,increased,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105188,blood,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105189,pressure,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105190,.,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105522,The,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105523,adipose,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105524,tissue,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105525,becomes,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105526,hypertrophic,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105527,and,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105528,undergoes,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105529,hyperplasia,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105530,",",O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105531,resulting,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105532,in,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105533,a,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105534,hypoxic,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105535,environment,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105536,",",O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105537,oxidative,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105538,stress,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105539,and,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105540,production,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105541,of,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105542,pro,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105543,-,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105544,inflammatory,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105545,mediators,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105546,that,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105547,can,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105548,be,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105549,responsible,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105550,for,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105551,other,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105552,disorders,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105553,",",O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105554,such,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105555,as,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105556,metabolic,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105557,syndrome,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105558,and,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105559,neurodegeneration,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105560,.,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105584,The,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105585,purpose,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105586,of,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105587,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105588,present,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105589,review,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105590,is,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105591,to,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105592,summarize,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105593,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105594,current,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105595,literature,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105596,concerning,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105597,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105598,beneficial,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105599,effects,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105600,of,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105601,honey,B-http://purl.obolibrary.org/obo/UBERON_0036016,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105602,in,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105603,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105604,management,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105605,of,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105606,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105607,obesity,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105608,-,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105609,related,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105610,dysfunctions,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105611,",",O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105612,including,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105613,neurodegeneration,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105614,.,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105771,This,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105772,paper,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105773,reviews,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105774,the,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105775,recent,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105776,advances,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105777,in,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105778,the,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105779,formulation,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105780,of,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105781,cereal,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105782,-,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105783,based,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105784,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105785,gluten,B-http://purl.obolibrary.org/obo/FOODON_03420177,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105786,-,I-http://purl.obolibrary.org/obo/FOODON_03420177,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105787,free,I-http://purl.obolibrary.org/obo/FOODON_03420177,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105788,products,I-http://purl.obolibrary.org/obo/FOODON_03420177,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105789,by,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105790,utilizing,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105791,alternate,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105792,flours,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105793,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105794,starches,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105795,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105796,gums,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105797,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105798,hydrocolloids,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105799,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105800,enzymes,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105801,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105802,novel,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105803,ingredients,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105804,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105805,and,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105806,processing,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105807,techniques,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105808,.,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
119257,DED,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119258,estimates,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119259,",",O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119260,calculated,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119261,using,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119262,the,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119263,total,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119264,diet,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119265,method,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119266,",",O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119267,the,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119268,food,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119269,only,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119270,method,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119271,and,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119272,a,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119273,novel,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119274,method,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119275,",",O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119276,including,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119277,foods,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119278,and,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119279,solids,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119280,in,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119281,beverages,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119282,",",O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119283,were,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119284,3·70,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119285,(,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119286,sd,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119287,1·09,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119288,),O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119289,",",O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119290,7·58,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119291,(,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119292,sd,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119293,1·72,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119294,),O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119295,and,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119296,8·40,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119297,(,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119298,sd,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119299,1·88,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119300,),O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119301,kJ,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119302,/,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119303,g,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119304,",",O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119305,respectively,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119306,.,O,4158.0,"DED estimates , calculated using the total diet method , the food only method and a novel method , including foods and solids in beverages , were 3·70 ( sd 1·09 ) , 7·58 ( sd 1·72 ) and 8·40 ( sd 1·88 ) kJ / g , respectively ."
119605,The,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119606,source,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119607,of,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119608,monounsaturated,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119609,fatty,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119610,acids,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119611,was,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119612,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119613,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119614,in,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119615,all,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119616,four,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119617,experiments,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119618,.,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119678,Analysis,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119679,of,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119680,variance,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119681,of,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119682,the,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119683,combined,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119684,results,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119685,of,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119686,all,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119687,four,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119688,experiments,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119689,showed,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119690,that,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119691,",",O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119692,in,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119693,comparison,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119694,with,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119695,saturated,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119696,fat,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119697,",",O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119698,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119699,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119700,lowered,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119701,aortic,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119702,cholesterol,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119703,by,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119704,13,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119705,(,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119706,-9,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119707,-,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119708,30,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119709,",",O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119710,95,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119711,%,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119712,confidence,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119713,interval,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119714,),O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119715,%,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119716,in,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119717,the,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119718,aortic,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119719,arch,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119720,",",O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119721,and,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119722,by,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119723,10,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119724,(,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119725,-10,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119726,-,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119727,26,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119728,),O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119729,%,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119730,in,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119731,the,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119732,thoracic,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119733,aorta,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119734,",",O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119735,which,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119736,was,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119737,not,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119738,significant,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119739,.,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119740,In,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119741,the,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119742,comparison,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119743,with,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119744,olive,B-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119745,oil,I-http://purl.obolibrary.org/obo/FOODON_03301826;http://purl.obolibrary.org/obo/FOODON_03315145;http://purl.obolibrary.org/obo/FOODON_03317509;http://purl.obolibrary.org/obo/FOODON_03310387,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119746,",",O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119747,no,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119748,differences,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119749,in,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119750,effects,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119751,on,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119752,aortic,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119753,cholesterol,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119754,content,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119755,were,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119756,detected,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119757,between,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119758,butter,B-http://purl.obolibrary.org/obo/FOODON_03310351,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119759,",",O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119760,lard,B-http://purl.obolibrary.org/obo/FOODON_03302051,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119761,and,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119762,coconut,B-http://purl.obolibrary.org/obo/FOODON_03310046;http://purl.obolibrary.org/obo/FOODON_03303085;http://purl.obolibrary.org/obo/FOODON_00003449;http://purl.obolibrary.org/obo/FOODON_03310387,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119763,oil,I-http://purl.obolibrary.org/obo/FOODON_03310046;http://purl.obolibrary.org/obo/FOODON_03303085;http://purl.obolibrary.org/obo/FOODON_00003449;http://purl.obolibrary.org/obo/FOODON_03310387,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119764,.,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119941,This,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119942,excess,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119943,risk,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119944,was,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119945,confined,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119946,to,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119947,current,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119948,smokers,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119949,",",O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119950,in,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119951,whom,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119952,the,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119953,odds,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119954,ratio,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119955,was,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119956,3.2,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119957,(,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119958,95,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119959,%,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119960,CI,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119961,1.8,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119962,-,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119963,5.7,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119964,),O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119965,;,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119966,the,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119967,risk,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119968,among,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119969,former,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119970,smokers,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119971,resembled,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119972,that,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119973,in,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119974,those,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119975,who,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119976,had,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119977,never,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119978,smoked,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119979,.,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
120123,The,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120124,glucose,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120125,oxidation,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120126,enhancing,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120127,bioactivity,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120128,was,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120129,lost,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120130,from,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120131,cinnamon,B-http://purl.obolibrary.org/obo/FOODON_03301175;http://purl.obolibrary.org/obo/NCBITaxon_128608,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120132,",",O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120133,tea,B-http://purl.obolibrary.org/obo/FOODON_03315081,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120134,",",O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120135,witch,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120136,hazel,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120137,",",O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120138,cloves,B-http://purl.obolibrary.org/obo/FOODON_00001745,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120139,",",O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120140,bay,B-http://purl.obolibrary.org/obo/FOODON_00003802;http://purl.obolibrary.org/obo/PO_0025034,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120141,leaf,I-http://purl.obolibrary.org/obo/FOODON_00003802;http://purl.obolibrary.org/obo/PO_0025034,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120142,and,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120143,allspice,B-http://purl.obolibrary.org/obo/FOODON_03301554;http://purl.obolibrary.org/obo/FOODON_00002667,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120144,by,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120145,poly(vinylpyrrolidone,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120146,),O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120147,(,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120148,PVP,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120149,),O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120150,treatment,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120151,",",O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120152,indicating,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120153,that,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120154,the,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120155,active,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120156,phytochemicals,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120157,are,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120158,likely,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120159,to,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120160,be,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120161,phenolic,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120162,in,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120163,nature,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120164,.,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120664,Results,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120665,indicated,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120666,that,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120667,Western,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120668,style,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120669,diet,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120670,such,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120671,as,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120672,expenditure,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120673,of,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120674,meat,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120675,",",O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120676,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120677,and,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120678,egg,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120679,and,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120680,bread,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120681,had,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120682,negative,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120683,association,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120684,with,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120685,SMR,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120686,.,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
121063,Milk,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121064,small,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121065,extracellular,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121066,vesicles,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121067,(,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121068,sEV,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121069,),O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121070,contain,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121071,proteins,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121072,that,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121073,provide,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121074,potential,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121075,information,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121076,of,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121077,host,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121078,physiology,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121079,and,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121080,immunology,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121081,.,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121878,Acute,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121879,and,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121880,sub,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121881,-,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121882,chronic,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121883,studies,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121884,were,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121885,considered,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121886,for,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121887,inclusion,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121888,.,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
122023,d,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122024,),O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122025,],O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122026,",",O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122027,or,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122028,2.6,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122029,mol,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122030,/,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122031,L,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122032,ethanol,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122033,(,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122034,E,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122035,-,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122036,PE,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122037,),O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122038,or,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122039,water,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122040,(,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122041,W,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122042,-,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122043,PE,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122044,),O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122045,as,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122046,their,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122047,respective,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122048,controls,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122049,.,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122607,In,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122608,a,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122609,hospital,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122610,-,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122611,based,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122612,case,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122613,-,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122614,control,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122615,study,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122616,for,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122617,type,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122618,2,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122619,diabetes,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122620,in,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122621,Kumasi,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122622,(,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122623,diabetes,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122624,cases,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122625,",",O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122626,538,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122627,;,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122628,controls,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122629,",",O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122630,668,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122631,),O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122632,dietary,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122633,intake,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122634,was,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122635,assessed,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122636,by,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122637,a,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122638,specific,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122639,food,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122640,frequency,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122641,questionnaire,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122642,.,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
123082,The,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123083,"""",O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123084,healthy,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123085,"""",O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123086,DP,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123087,explained,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123088,the,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123089,largest,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123090,amount,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123091,of,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123092,variance,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123093,in,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123094,intake,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123095,.,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123516,When,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123517,the,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123518,pH,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123519,of,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123520,the,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123521,salad,B-http://purl.obolibrary.org/obo/FOODON_00001290;http://purl.obolibrary.org/obo/FOODON_03316042;http://purl.obolibrary.org/obo/FOODON_03315498,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123522,dressing,I-http://purl.obolibrary.org/obo/FOODON_00001290;http://purl.obolibrary.org/obo/FOODON_03316042;http://purl.obolibrary.org/obo/FOODON_03315498,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123523,was,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123524,adjusted,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123525,to,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123526,pH,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123527,7,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123528,prior,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123529,to,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123530,spiking,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123531,with,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123532,mustard,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123533,",",O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123534,recovery,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123535,improved,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123536,to,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123537,94.1%+/-,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123538,7.6,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123539,%,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123540,.,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123759,Increased,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123760,risks,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123761,were,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123762,found,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123763,for,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123764,more,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123765,frequent,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123766,intake,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123767,of,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123768,meat,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123769,[,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123770,odds,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123771,ratio,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123772,(,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123773,OR,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123774,),O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123775,in,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123776,the,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123777,highest,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123778,vs.,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123779,lowest,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123780,consumption,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123781,tertile,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123782,=,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123783,1.4,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123784,",",O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123785,95,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123786,%,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123787,confidence,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123788,interval,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123789,(,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123790,CI,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123791,),O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123792,1.0,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123793,-,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123794,2.0,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123795,],O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123796,",",O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123797,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123798,(,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123799,OR,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123800,=,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123801,1.6,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123802,",",O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123803,95,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123804,%,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123805,CI,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123806,1.1,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123807,-,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123808,2.4,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123809,),O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123810,",",O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123811,fresh,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123812,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123813,(,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123814,OR,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123815,=,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123816,1.4,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123817,",",O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123818,95,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123819,%,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123820,CI,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123821,1.0,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123822,-,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123823,2.1,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123824,),O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123825,",",O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123826,and,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123827,vegetables,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123828,(,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123829,OR,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123830,=,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123831,1.4,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123832,",",O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123833,95,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123834,%,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123835,CI,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123836,0.9,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123837,-,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123838,2.2,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123839,),O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
123840,.,O,4316.0,"Increased risks were found for more frequent intake of meat [ odds ratio ( OR ) in the highest vs. lowest consumption tertile = 1.4 , 95 % confidence interval ( CI ) 1.0 - 2.0 ] , milk ( OR = 1.6 , 95 % CI 1.1 - 2.4 ) , fresh fruit ( OR = 1.4 , 95 % CI 1.0 - 2.1 ) , and vegetables ( OR = 1.4 , 95 % CI 0.9 - 2.2 ) ."
124179,This,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124180,paper,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124181,reviews,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124182,the,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124183,literature,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124184,on,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124185,fermented,B-http://purl.obolibrary.org/obo/UBERON_0001913,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124186,milk,I-http://purl.obolibrary.org/obo/UBERON_0001913,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124187,products,I-http://purl.obolibrary.org/obo/UBERON_0001913,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124188,as,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124189,a,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124190,source,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124191,of,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124192,ACE,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124193,-,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124194,I,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124195,peptides,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124196,and,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124197,various,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124198,factors,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124199,affecting,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124200,the,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124201,production,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124202,and,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124203,activity,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124204,of,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124205,ACE,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124206,-,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124207,I,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124208,peptides,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124209,.,O,4329.0,This paper reviews the literature on fermented milk products as a source of ACE - I peptides and various factors affecting the production and activity of ACE - I peptides .
124310,Among,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124311,the,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124312,identified,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124313,constituents,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124314,are,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124315,several,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124316,proteins,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124317,considered,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124318,to,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124319,influence,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124320,wine,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124321,stability,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124322,and,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124323,previously,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124324,described,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124325,potential,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124326,grape,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124327,allergens,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124328,.,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124382,We,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124383,have,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124384,recently,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124385,reported,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124386,that,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124387,patients,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124388,with,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124389,fibromyalgia,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124390,(,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124391,FM,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124392,),O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124393,may,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124394,be,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124395,at,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124396,increased,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124397,risk,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124398,for,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124399,cardiovascular,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124400,disease,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124401,.,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
125357,Sorghum,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125358,is,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125359,the,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125360,fifth,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125361,cereal,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125362,most,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125363,produced,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125364,in,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125365,the,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125366,world,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125367,after,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125368,wheat,B-http://purl.obolibrary.org/obo/NCBITaxon_4565;http://purl.obolibrary.org/obo/FOODON_03315184,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125369,",",O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125370,rice,B-http://purl.obolibrary.org/obo/NCBITaxon_4530;http://purl.obolibrary.org/obo/FOODON_03301641,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125371,",",O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125372,maize,B-http://purl.obolibrary.org/obo/NCBITaxon_4577;http://purl.obolibrary.org/obo/NCBITaxon_381124,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125373,",",O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125374,and,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125375,barley,B-http://purl.obolibrary.org/obo/NCBITaxon_4513;http://purl.obolibrary.org/obo/FOODON_00003108,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125376,.,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125422,Pigmented,B-http://purl.obolibrary.org/obo/FOODON_03309978;http://purl.obolibrary.org/obo/NCBITaxon_4557,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125423,sorghum,I-http://purl.obolibrary.org/obo/FOODON_03309978;http://purl.obolibrary.org/obo/NCBITaxon_4557,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125424,grain,I-http://purl.obolibrary.org/obo/FOODON_03309978;http://purl.obolibrary.org/obo/NCBITaxon_4557,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125425,is,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125426,a,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125427,rich,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125428,source,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125429,of,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125430,antioxidants,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125431,like,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125432,polyphenols,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125433,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125434,mainly,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125435,tannins,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125436,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125437,which,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125438,have,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125439,multiple,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125440,benefits,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125441,on,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125442,human,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125443,health,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125444,such,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125445,as,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125446,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125447,antiproliferative,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125448,properties,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125449,associated,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125450,with,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125451,the,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125452,prevention,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125453,of,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125454,certain,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125455,cancers,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125456,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125457,antioxidant,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125458,activities,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125459,related,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125460,to,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125461,the,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125462,prevention,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125463,of,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125464,associated,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125465,diseases,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125466,to,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125467,oxidative,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125468,stress,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125469,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125470,antimicrobial,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125471,and,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125472,anti,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125473,-,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125474,inflammatory,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125475,effects,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125476,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125477,it,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125478,also,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125479,improves,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125480,glucose,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125481,metabolism,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125482,.,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125858,The,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125859,risk,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125860,of,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125861,RCC,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125862,decreased,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125863,with,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125864,increasing,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125865,consumption,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125866,frequencies,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125867,of,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125868,white,B-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323;http://purl.obolibrary.org/obo/FOODON_03301326;http://purl.obolibrary.org/obo/FOODON_00003406;http://purl.obolibrary.org/obo/NCBITaxon_3716,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125869,cabbage,I-http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323;http://purl.obolibrary.org/obo/FOODON_03301326;http://purl.obolibrary.org/obo/FOODON_00003406;http://purl.obolibrary.org/obo/NCBITaxon_3716,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125870,(,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125871,p,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125872,for,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125873,trend,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125874,=,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125875,0.07,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125876,),O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125877,.,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125988,We,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125989,also,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125990,determined,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125991,if,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125992,intake,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125993,of,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125994,fiber,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125995,(,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125996,soluble,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125997,and,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125998,insoluble,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125999,),O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126000,",",O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126001,physical,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126002,activity,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126003,",",O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126004,and,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126005,nonsteroidal,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126006,anti,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126007,-,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126008,inflammatory,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126009,medications,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126010,(,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126011,NSAIDs,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126012,),O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126013,or,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126014,aspirin,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126015,modified,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126016,the,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126017,associations,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126018,between,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126019,fluid,B-http://purl.obolibrary.org/obo/UBERON_0006314,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126020,intake,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126021,and,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126022,rectal,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126023,cancer,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126024,.,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126138,NSAIDs,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126139,modified,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126140,the,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126141,association,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126142,of,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126143,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126144,consumption,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126145,with,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126146,rectal,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126147,cancer,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126148,:,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126149,1,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126150,),O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126151,risk,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126152,associated,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126153,with,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126154,beer,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126155,increased,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126156,among,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126157,men,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126158,who,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126159,did,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126160,not,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126161,take,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126162,NSAIDs,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126163,and,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126164,had,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126165,a,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126166,high,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126167,beer,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126168,intake,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126169,(,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126170,OR,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126171,=,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126172,1.60,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126173,;,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126174,95,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126175,%,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126176,CI,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126177,=,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126178,1.08,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126179,",",O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126180,2.39,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126181,),O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126182,and,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126183,2,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126184,),O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126185,risk,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126186,associated,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126187,with,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126188,long,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126189,-,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126190,term,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126191,alcohol,B-http://purl.obolibrary.org/obo/CHEBI_30879,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126192,intake,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126193,increased,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126194,in,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126195,a,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126196,linear,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126197,fashion,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126198,in,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126199,women,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126200,who,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126201,did,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126202,not,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126203,use,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126204,NSAIDs,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126205,(,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126206,OR,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126207,=,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126208,1.98,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126209,;,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126210,95,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126211,%,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126212,CI,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126213,=,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126214,1.15,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126215,",",O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126216,3.40,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126217,),O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126218,.,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126426,Associations,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126427,with,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126428,changes,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126429,in,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126430,frequency,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126431,of,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126432,consumption,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126433,were,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126434,estimated,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126435,by,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126436,odds,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126437,ratios,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126438,(,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126439,ORs,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126440,),O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126441,and,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126442,95,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126443,%,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126444,confidence,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126445,intervals,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126446,(,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126447,CIs,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126448,),O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
126449,.,O,4405.0,Associations with changes in frequency of consumption were estimated by odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) .
127044,The,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127045,study,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127046,subjects,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127047,were,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127048,children,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127049,(,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127050,n,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127051,=,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127052,770,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127053,),O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127054,who,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127055,participated,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127056,in,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127057,the,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127058,4th,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127059,year,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127060,(,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127061,2008,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127062,),O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127063,of,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127064,the,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127065,Korean,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127066,Child,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127067,-,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127068,Adolescent,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127069,Cohort,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127070,Study,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127071,(,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127072,KoCAS,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127073,),O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127074,.,O,4421.0,The study subjects were children ( n = 770 ) who participated in the 4th year ( 2008 ) of the Korean Child - Adolescent Cohort Study ( KoCAS ) .
127229,At,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127230,follow,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127231,-,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127232,up,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127233,",",O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127234,sugar,B-http://purl.obolibrary.org/obo/FOODON_03420108,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127235,intake,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127236,from,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127237,fruit,B-http://purl.obolibrary.org/obo/PO_0009001,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127238,at,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127239,baseline,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127240,was,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127241,still,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127242,negatively,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127243,associated,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127244,with,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127245,the,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127246,above,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127247,outcomes,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127248,",",O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127249,but,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127250,only,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127251,the,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127252,relationship,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127253,with,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127254,BMI,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127255,z,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127256,-,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127257,scores,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127258,retained,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127259,statistical,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127260,significance,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127261,(,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127262,β,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127263,=,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127264,-0.08,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127265,",",O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127266,p,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127267,<,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127268,0.05,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127269,),O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127270,.,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127355,Consequently,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127356,",",O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127357,this,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127358,information,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127359,could,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127360,be,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127361,of,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127362,value,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127363,to,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127364,obesity-,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127365,and,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127366,metabolic,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127367,disease,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127368,-,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127369,prevention,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127370,strategies,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127371,.,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127483,After,O,4437.0,"After 15 weeks , the rats were sacrificed for pathological examination ."
127484,15,O,4437.0,"After 15 weeks , the rats were sacrificed for pathological examination ."
127485,weeks,O,4437.0,"After 15 weeks , the rats were sacrificed for pathological examination ."
127486,",",O,4437.0,"After 15 weeks , the rats were sacrificed for pathological examination ."
127487,the,O,4437.0,"After 15 weeks , the rats were sacrificed for pathological examination ."
127488,rats,O,4437.0,"After 15 weeks , the rats were sacrificed for pathological examination ."
127489,were,O,4437.0,"After 15 weeks , the rats were sacrificed for pathological examination ."
127490,sacrificed,O,4437.0,"After 15 weeks , the rats were sacrificed for pathological examination ."
127491,for,O,4437.0,"After 15 weeks , the rats were sacrificed for pathological examination ."
127492,pathological,O,4437.0,"After 15 weeks , the rats were sacrificed for pathological examination ."
127493,examination,O,4437.0,"After 15 weeks , the rats were sacrificed for pathological examination ."
127494,.,O,4437.0,"After 15 weeks , the rats were sacrificed for pathological examination ."
127692,The,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127693,following,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127694,NHPs,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127695,are,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127696,included,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127697,in,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127698,this,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127699,clinical,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127700,review,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127701,:,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127702,alpha,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127703,-,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127704,lipoic,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127705,acid,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127706,",",O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127707,chromium,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127708,",",O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127709,magnesium,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127710,",",O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127711,bitter,B-http://purl.obolibrary.org/obo/NCBITaxon_3673;http://purl.obolibrary.org/obo/FOODON_03301593;http://purl.obolibrary.org/obo/FOODON_00003597,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127712,melon,I-http://purl.obolibrary.org/obo/NCBITaxon_3673;http://purl.obolibrary.org/obo/FOODON_03301593;http://purl.obolibrary.org/obo/FOODON_00003597,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127713,",",O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127714,cinnamon,B-http://purl.obolibrary.org/obo/FOODON_03301175;http://purl.obolibrary.org/obo/NCBITaxon_128608,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127715,",",O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127716,fenugreek,B-http://purl.obolibrary.org/obo/NCBITaxon_78534,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127717,",",O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127718,gymnema,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127719,",",O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127720,milk,B-http://purl.obolibrary.org/obo/UBERON_0001913,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127721,thistle,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127722,",",O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127723,Reishi,B-http://purl.obolibrary.org/obo/FOODON_03412361;http://purl.obolibrary.org/obo/FOODON_03301303;http://purl.obolibrary.org/obo/FAO_0000012;http://purl.obolibrary.org/obo/FOODON_00003528,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127724,mushroom,I-http://purl.obolibrary.org/obo/FOODON_03412361;http://purl.obolibrary.org/obo/FOODON_03301303;http://purl.obolibrary.org/obo/FAO_0000012;http://purl.obolibrary.org/obo/FOODON_00003528,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127725,and,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127726,white,B-http://purl.obolibrary.org/obo/NCBITaxon_3498;http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323;http://purl.obolibrary.org/obo/FOODON_00003676;http://purl.obolibrary.org/obo/FOODON_00003135,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127727,mulberry,I-http://purl.obolibrary.org/obo/NCBITaxon_3498;http://purl.obolibrary.org/obo/HANCESTRO_0005;http://purl.obolibrary.org/obo/PATO_0000323;http://purl.obolibrary.org/obo/FOODON_00003676;http://purl.obolibrary.org/obo/FOODON_00003135,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127728,.,O,4446.0,"The following NHPs are included in this clinical review : alpha - lipoic acid , chromium , magnesium , bitter melon , cinnamon , fenugreek , gymnema , milk thistle , Reishi mushroom and white mulberry ."
127729,Given,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127730,the,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127731,potential,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127732,of,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127733,NHPs,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127734,to,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127735,additively,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127736,cause,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127737,hypoglycemia,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127738,when,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127739,used,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127740,concurrently,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127741,with,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127742,conventional,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127743,medications,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127744,",",O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127745,pharmacists,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127746,should,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127747,be,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127748,up,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127749,to,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127750,date,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127751,with,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127752,current,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127753,evidence,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127754,around,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127755,NHPs,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127756,that,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127757,may,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127758,affect,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127759,diabetes,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127760,care,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127761,to,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127762,prevent,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127763,adverse,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127764,reactions,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127765,and,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127766,interactions,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127767,.,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
128344,In,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128345,skin,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128346,prick,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128347,tests,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128348,",",O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128349,we,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128350,used,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128351,three,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128352,different,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128353,extracts,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128354,(,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128355,juice,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128356,",",O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128357,freeze,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128358,-,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128359,dried,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128360,extract,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128361,",",O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128362,and,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128363,low,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128364,-,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128365,temperature,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128366,acetone,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128367,powder,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128368,extract,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128369,),O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128370,of,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128371,two,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128372,apple,B-http://purl.obolibrary.org/obo/FOODON_00002473;http://purl.obolibrary.org/obo/NCBITaxon_3750,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128373,strains,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128374,",",O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128375,Golden,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128376,Delicious,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128377,and,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128378,Granny,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128379,Smith,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128380,.,O,4463.0,"In skin prick tests , we used three different extracts ( juice , freeze - dried extract , and low - temperature acetone powder extract ) of two apple strains , Golden Delicious and Granny Smith ."
128431,Skin,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128432,prick,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128433,tests,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128434,for,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128435,apple,B-http://purl.obolibrary.org/obo/FOODON_00002473;http://purl.obolibrary.org/obo/NCBITaxon_3750,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128436,",",O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128437,peach,B-http://purl.obolibrary.org/obo/FOODON_03315502;http://purl.obolibrary.org/obo/FOODON_03301719;http://purl.obolibrary.org/obo/NCBITaxon_3760,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128438,",",O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128439,and,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128440,hazelnut,B-http://purl.obolibrary.org/obo/FOODON_00002933,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128441,were,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128442,positive,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128443,in,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128444,51,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128445,(,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128446,64.6,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128447,%,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128448,),O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128449,",",O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128450,61,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128451,(,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128452,77.2,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128453,%,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128454,),O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128455,",",O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128456,and,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128457,71,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128458,(,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128459,89.9,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128460,%,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128461,),O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128462,patients,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128463,",",O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128464,respectively,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128465,.,O,4466.0,"Skin prick tests for apple , peach , and hazelnut were positive in 51 ( 64.6 % ) , 61 ( 77.2 % ) , and 71 ( 89.9 % ) patients , respectively ."
128611,We,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128612,also,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128613,found,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128614,an,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128615,easy,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128616,extraction,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128617,procedure,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128618,(,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128619,juice,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128620,extract,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128621,),O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128622,suitable,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128623,for,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128624,apple,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128625,skin,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128626,prick,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128627,testing,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128628,",",O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128629,superior,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128630,even,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128631,to,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128632,freeze,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128633,-,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128634,dried,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128635,extraction,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128636,or,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128637,the,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128638,low,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128639,-,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128640,temperature,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128641,acetone,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128642,powder,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128643,technique,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128644,.,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128832,This,O,4481.0,This is also demonstrated in an in vivo human study .
128833,is,O,4481.0,This is also demonstrated in an in vivo human study .
128834,also,O,4481.0,This is also demonstrated in an in vivo human study .
128835,demonstrated,O,4481.0,This is also demonstrated in an in vivo human study .
128836,in,O,4481.0,This is also demonstrated in an in vivo human study .
128837,an,O,4481.0,This is also demonstrated in an in vivo human study .
128838,in,O,4481.0,This is also demonstrated in an in vivo human study .
128839,vivo,O,4481.0,This is also demonstrated in an in vivo human study .
128840,human,O,4481.0,This is also demonstrated in an in vivo human study .
128841,study,O,4481.0,This is also demonstrated in an in vivo human study .
128842,.,O,4481.0,This is also demonstrated in an in vivo human study .
129209,Results,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129210,associating,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129211,diet,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129212,with,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129213,chronic,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129214,disease,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129215,in,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129216,a,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129217,cohort,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129218,of,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129219,34192,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129220,California,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129221,Seventh,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129222,-,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129223,day,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129224,Adventists,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129225,are,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129226,summarized,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129227,.,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129398,The,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129399,lifetime,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129400,risk,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129401,of,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129402,IHD,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129403,was,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129404,reduced,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129405,by,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129406,approximately,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129407,31,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129408,%,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129409,in,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129410,those,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129411,who,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129412,consumed,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129413,nuts,B-http://purl.obolibrary.org/obo/FOODON_03306632,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129414,frequently,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129415,and,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129416,by,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129417,37,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129418,%,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129419,in,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129420,male,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129421,vegetarians,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129422,compared,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129423,with,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129424,nonvegetarians,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129425,.,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
130924,Critical,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130925,knowledge,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130926,on,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130927,these,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130928,compounds,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130929,and,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130930,their,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130931,signaling,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130932,pathways,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130933,may,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130934,help,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130935,in,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130936,formulation,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130937,of,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130938,effective,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130939,anticancer,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130940,drugs,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130941,.,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
131752,Breads,B-http://purl.obolibrary.org/obo/FOODON_03413114;http://purl.obolibrary.org/obo/NCBITaxon_3832,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131753,with,I-http://purl.obolibrary.org/obo/FOODON_03413114;http://purl.obolibrary.org/obo/NCBITaxon_3832,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131754,guar,I-http://purl.obolibrary.org/obo/FOODON_03413114;http://purl.obolibrary.org/obo/NCBITaxon_3832,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131755,gum,I-http://purl.obolibrary.org/obo/FOODON_03413114;http://purl.obolibrary.org/obo/NCBITaxon_3832,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131756,had,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131757,the,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131758,most,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131759,heterogeneous,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131760,cell,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131761,size,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131762,distribution,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131763,",",O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131764,and,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131765,guar,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131766,gum,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131767,was,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131768,therefore,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131769,selected,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131770,for,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131771,further,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131772,formulations,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131773,.,O,4580.0,"Breads with guar gum had the most heterogeneous cell size distribution , and guar gum was therefore selected for further formulations ."
131806,Bread,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131807,with,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131808,1.9,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131809,%,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131810,guar,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131811,gum,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131812,(,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131813,w,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131814,/,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131815,w,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131816,",",O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131817,total,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131818,flour,B-http://purl.obolibrary.org/obo/FOODON_03301116,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131819,basis,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131820,),O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131821,and,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131822,5,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131823,%,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131824,buckwheat,B-http://purl.obolibrary.org/obo/FOODON_03309980;http://purl.obolibrary.org/obo/FOODON_03301116,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131825,flour,I-http://purl.obolibrary.org/obo/FOODON_03309980;http://purl.obolibrary.org/obo/FOODON_03301116,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131826,(,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131827,of,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131828,all,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131829,flours,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131830,and,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131831,substitutes,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131832,),O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131833,mimicked,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131834,French,B-http://purl.obolibrary.org/obo/HANCESTRO_0363,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131835,bread,I-http://purl.obolibrary.org/obo/HANCESTRO_0363,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131836,quality,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131837,attributes,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131838,.,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131981,Dietary,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131982,Zn,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131983,levels,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131984,were,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131985,increased,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131986,by,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131987,addition,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131988,of,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131989,ZnO,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131990,to,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131991,83,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131992,and,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131993,80,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131994,mg,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131995,of,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131996,Zn,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131997,/,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131998,kg,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
131999,of,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
132000,DM,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
132001,.,O,4587.0,Dietary Zn levels were increased by addition of ZnO to 83 and 80 mg of Zn / kg of DM .
